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 INVITED SPEAKER 
 INV 01 
H 2 S Homeostasis and the Transsulfuration Pathway 
 R. Banerjee  1  
 
1
 University of Michigan, Biological Chemistry, Ann Arbor, United 
States 
 Despite the excitement about the discovery of a third gaseous sig-
naling molecule and the consequent profusion of literature on H 2 S 
biology, progress in the fi eld has been impeded by the lack of sul-
fi de-specifi c sensors for detection/imaging, and an understanding of 
how cells maintain very low steady-state levels of H 2 S, amplifying 
the signal as needed. The enzymes of the transsulfuration pathway, 
cystathionine b-synthase (CBS) and cystathionine g-lyase (CSE) are 
important for the endogenous production of H 2 S. We have quan-
tifi ed CBS and CSE levels in murine liver, brain and kidney and 
shown that at physiologically relevant concentrations of substrate, 
and adjusting for the differences in CSE versus CBS, CSE is the 
primary source of hepatic H 2 S. We will discuss new data on esti-
mation of hepatic sulfur fl ux both through H 2 S biogenesis and O 2 -
dependent H 2 S catabolism, which are very high and comparable to 
the fl ux of sulfur into the antioxidant pool, glutathione. These data 
implicate regulation of H 2 S clearance as a potentially important 
 “ off-switch ” in H 2 S signaling. We will also discuss advances in H 2 S 
detection and imaging via a collaborative study with the He labora-
tory (University of Chicago), which has developed sulfi de-specifi c 
fl uorescent sensors. 
 INV 02 
Cystathionine gamma-lyase dependent H 2 S formation 
in perivascular adipose tissue in experimental metabolic 
syndrome 
 J. Beltowski  1  
 
1
 Medical University, Department of Pathophysiology, Lublin, 
Poland 
 Background: Perivascular adipose tissue (PAT)-derived H 2 S 
decreases vascular tone and inhibits atherogenesis. Obesity is associ-
ated with impaired anticontractile effect of PAT, however, effect of 
obesity on H 2 S has not been studied. 
 Aim: To examine the effect of experimental metabolic syndrome on 
cystathionine  γ -lyase (CSE)-H 2 S system in PAT. 
 Methods: Obesity was induced by feeding rats a calorie diet 
for either 1 (O1) or 3 (O3) months. H 2 S production by isolated 
PAT was measured by electrochemical sensor, and phenyleph-
rine-induce contractility of aortic rings with or without PAT was 
examined. 
 Results: Both O1 and O3 groups were characterized by increased 
adiposity and plasma leptin, but only O3 group was hyperinsuline-
mic and insulin-resistant. H 2 S production by PAT and anticontrac-
tile effect of PAT on aortic rings were augmented and impaired in 
the O1 and O3 groups, respectively. CSE expression and activity in 
PAT was normal in the O1 but reduced in the O3 group. Inhibitor 
of mitochondrial H 2 S metabolism, stigmatellin, increased H 2 S 
production by PAT to a lesser extent in the O1 than in the control 
group, suggesting impaired H 2 S oxidation in obese rats. This effect 
most likely resulted from adipose tissue hypoxia observed in obe-
sity. Insulin sensitizer, rosiglitazone, increased CSE expression and 
activity as well as H 2 S production in the O3 group but had no effect 
in either lean or O1 animals. 
 Discussion and Conclusions: Early obesity, not associated with 
hyperinsulinemia/insulin resistance, results in overproduction of 
H 2 S in PAT because mitochondrial oxidation of the gas is reduced. 
In contrast, in more advanced metabolic syndrome when insulin 
resistance appears, H 2 S production is impaired due to reduced CSE 
expression. 
 INV 03 
Novel defects in folate and homocysteine metabolism  – new 
views on homocysteine metabolism 
 H. Blom  1  
 
1
 VU University Medical Center Amsterdam, Institute for 
Cardiovascular Research (ICaR-VU), Amsterdam, Netherlands 
 Over the last year we discovered two novel inborn errors of folate 
and homocysteine metabolism: dihydrofolate reductase (DHFR) 
defi ciency and adenosine kinase (ADK) defi ciency. 
 The clinical and biochemical presentations of both defects will be 
described and their impact on folate and homocysteine metabolism 
discussed. 
 Both defects provide new insights in regulation of this metabolism, 
and their importance in health and disease. 
 INV 04 
Choline and the brain 
 J. K. Blusztajn  1  
 
1
 Boston University School of Medicine, Department of Pathology 
and Laboratory Medicine, Boston, United States 
 Choline is an essential nutrient for humans. Metabolically cho-
line is used for the synthesis of phospholipids, and as a precur-
sor of the neurotransmitter acetylcholine. Following oxidation 
to betaine, choline functions as a methyl group donor, and thus 
its supply infl uences DNA and histone methylation  – two central 
epigenomic processes that regulate gene expression. Studies in 
rodents have shown that high choline intake during gestation and 
the perinatal period improves cognitive function in adulthood, 
prevents age-related memory decline, and protects the brain from 
damage and functional deterioration associated with epilepsy 
and other insults (e.g. fetal alcohol syndrome). The behavioral 
changes are accompanied by modifi ed patterns of expression of 
cortical and hippocampal genes including those encoding key pro-
teins that contribute to the mechanisms of learning and memory. 
These actions of choline correlate with cerebral cortical changes 
in global- and gene-specifi c DNA cytosine methylation and with 
changes of the methylation pattern of lysine residues 4, 9 and 
27 of histone H3. Moreover, gestational choline modulates the 
expression of DNA- and histone methyltransferases. In addition 
to the central role of DNA and histone methylation in brain devel-
opment, these processes are highly dynamic in adult brain, modu-
late the expression of genes critical for synaptic plasticity, and are 
involved in mechanisms of learning and memory. A recent study 
documented that in a cohort of normal elderly people, verbal and 
visual memory function correlated positively with the amount of 
dietary choline intake, further supporting the idea that adequate 
choline nutrition is essential for the maintenance of cognitive 
function in aging humans. 
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 INV 05 
Maternal choline intake in humans alters metabolic, 
epigenomic and epigenetic marks 
 M. A. Caudill  1  
 
1
 Cornell University, Ithaca, United States 
 The effect of varied maternal choline intake on metabolic, epig-
enomic and epigenetic readouts in humans is unknown. We 
recently conducted a 12-wk controlled feeding study in which 
pregnant women were randomized to choline intakes of either 
480 or 930 mg/d throughout their third trimester. The higher 
maternal choline intake yielded greater use of choline as a 
methyl donor in both maternal and fetal compartments (Yan et al. 
2011, Submitted) and influenced the epigenomic state of the pla-
cental tissue. In addition, varied maternal choline intake altered 
the epigenetic state of genes that regulate fetal HPA axis activity 
and consumption of 930 versus 480 mg/d yielded lower concen-
trations of the HPA axis product, cortisol, in venous cord blood 
(Jiang et al. In Preparation). These data suggest for the first time 
in humans that maternal intake of the methyl donor, choline, may 
modulate fetal programming with possible long-term effects on 
health. 
 INV 06 
Choline intake and cancer risk: epidemiologic studies 
 E. Cho  1 
 
1
 Brigham and Women ’ s Hospital and Harvard Medical School, 
Department of Medicine, Boston, United States 
 Background: Choline and betaine are involved in methyl group 
metabolism as methyl donors and, thus, may be related to a reduced 
cancer risk. Choline is also a precursor for cell membrane phospho-
lipids, phosphatidylcholine and sphingomyelin. 
 Aim: Few epidemiologic studies have examined intakes of these 
nutrients in relation to risk of cancer. We have investigated choline 
intake in relation to risk of colorectal adenoma, which is a precursor 
for colorectal cancer, colorectal cancer, and breast cancer in large 
prospective follow-up studies. 
 Methods: We examined intake of choline and betaine and risk 
of colorectal adenoma, colorectal cancer, and breast cancer 
among women in the Nurses ’ Health Study and men in the Health 
Professionals Follow-up Study. Nutrient intake was assessed with 
a validated food-frequency questionnaire multiple times since 
baseline. 
 Results: Contrary to expectation, choline intake was associated with 
an elevated risk of colorectal adenoma. Betaine intake had a non-
linear inverse association with risk of colorectal adenoma. Among 
individual sources of choline, choline from phosphate-dylcholine 
and from sphingomyelin were each positively related to adenoma 
risk. However, we did not fi nd any association between choline and 
betaine intake and colorectal cancer risk. We also found that higher 
choline intake was not associated with premenopausal breast cancer 
risk but was associated with a modest elevated risk of postmeno-
pausal breast cancer. 
 Discussion: We found no evidence that higher intakes of choline 
and betaine reduce risk of colorectal adenoma, colorectal cancer 
and breast cancer. Findings from these studies and other studies on 
intakes of choline and betaine and cancer risk in humans will be 
discussed. 
 INV 07
Role of Vitamin B6 and its Metabolite in Cardiac Dysfunction 
in Ischemic Heart Disease 
 N. S. Dhalla 1 
 
1
 St. Boniface Hospital Research Centre, Institute of Cardiovascular 
Sciences, Winnipeg, MB, Canada 
 Although plasma level of vitamin B in patients with myocardial 
infarction (MI) was depressed, the role of vitamin B in ischemic 
heart disease is poorly understood. Since cardiac dysfunction in MI 
is associated with a defect in purinergic system, the effects of vitamin 
B and its metabolite, pyridoxal-5 ’ -phosphate (PLP) were examined 
by employing an experimental model of MI in rats. Unlike vitamin 
B, treatment of MI animals with PLP for 4 to 6 weeks was found to 
attenuate the MI-induced cardiac dysfunction. Treatment of isolated 
hearts with PLP, unlike vitamin B, also attenuated the ischemia-
reperfusion induced myocardial dysfunction. These benefi cial effects 
of PLP appear to be due to depression in Ca2 + -infl ux and subsequent 
attenuation of intracellular Ca2 + -overload because ATP-induced 
increase in [Ca2 + ]i in cardiomyocytes and specifi c ATP-binding to 
the sarcolemmal membrane were decreased by PLP. Although vita-
min B defi ciency in rats for a prolonged period was also observed to 
decrease the ATP-induced increase in [Ca2 + ]i in cardiomyocytes, the 
KCl-induced increase in [Ca2 + ]i was markedly augmented. These 
results indicate that vitamin B may exert its cardioprotective effects 
by reducing the intracellular Ca2 + through the formation of its 
metabolites. (The infrastructure support for this project was provided 
by the St. Boniface Hospital Research Foundation.) 
 INV 08
Folic acid and homocysteine: from coronary vasodilation to 
neuroprotection 
 D. Djuric 1 
 
1
 University of Belgrade,  “ Richard Burian ” School of Medicine, 
Institute of Medical Physiology, Belgrade, Serbia 
 Background: Numerous studies have linked folate defi ciency with 
risk of arterial disease, neurodegenerative diseases, dementia and 
seizures. It is of interest whether dietary supplements of folic acid 
can improve vascular or neural function of subjects at risk. 
Aims and Methods: The fi rst aim of study was to assess the effects 
of folic acid administration (100  μ M) on coronary fl ow and oxida-
tive stress markers (nitrite outfl ow, superoxide anion, TBARS) with 
or without L-NAME (NO synthase inhibition, 30  μ M) in isolated 
rat heart. The second aim was to examine the effects of folic acid 
administration (5 mg/kg, 10 mg/kg, 15 mg/kg, i.p, respectively), 
on behavioral and electroencephalographic characteristics of 
DL-homocysteine thiolactone-induced seizures (8 mmol/kg, i.p) in 
adult rats. 
 Results: The fi ndings of the fi rst study are: 1. folic acid induced 
rat coronary vasodilation, 2. it was accompanied by signifi cant 
increase in nitrite outfl ow, decreased superoxide anion production, 
and (surprisingly) increased TBARS production, 3. L-NAME did 
not change signifi cantly folic acid-induced responses. The fi ndings 
of second study are: 1. there were no behavioral and EEG signs of 
seizure activity in groups of rats treated by folic acid alone, 2. how-
ever, following high dose of folic acid administration (15 mg/kg) 
the incidence of seizures were signifi cantly lower and latency was 
signifi cantly prolonged. 
 Conclusions: The obtained fi ndings suggest that folic acid possess 
vasodilatory, antioxidative and anticonvulsive properties in adult rats. 
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 INV 09
Infl ammatory markers, kynurenines, and B-vitamins in 
relation to chronic disease and mortality in a prospective 
population based study 
 *S. Eussen 1 , G. Tell 2 , S. E. Vollset 2 , O. Nyg å rd 3 , Ø . Midttun 4 , P. M. 
Ueland 5 
 
1
 University of Bergen, Department of Public Health and Primary 
Health Care, and Section for Pharmacology, Bergen, Norway 
 
2
 University of Bergen, Department of Public Health and Primary 
Health Care, Bergen, Norway 
 
3
 University of Bergen, Section for Cardiology, Bergen, Norway 
 
4
 Bevital A/S, Bergen, Norway 
 
5
 University of Bergen, Section for Pharmacology, Bergen, Norway 
 Background: It is hypothesized that infl ammation plays a key role 
in the onset of many chronic diseases. Although inverse associa-
tions of vitamins B6 and B2 with CVD and cancers are shown, 
mechanisms are unclear. However, studies have revealed lower 
vitamin B6 levels with increased C-reactive protein (CRP) - a 
commonly used infl ammatory marker as well as neopterin and the 
kynurenine/tryptophan ratio (KTR). Infl ammation increases levels 
of neopterin and also the conversion of tryptophan to kynurenine, 
which is further metabolised using vitamins B6 and B2 as cofac-
tors. The combination of low plasma vitamin B6 and presence of 
infl ammation has recently been linked to high 3-hydroxykynure-
nine, a metabolite downstream of kynurenine. The vitamins B6 
and B2 may form a link between the kynurenine pathway and CVD 
and cancer 
 Aim: To prospectively investigate associations of vitamins B6 and 
B2, kynurenine metabolites and infl ammatory markers with cancer 
and CVD incidence, and mortality. 
 Methods: Blood samples within The Hordaland Health study 
(HUSK, n = 7.047) were taken in 1997-1999 in which we mea-
sured vitamin B2 (ribofl avin and fl avin mononucleotide) and B6 
(pyridoxal ’ 5-phosphate, pyridoxal and 4-pyridoxic acid) species, 
kynurenines (kynurenine, kynurenic acid, anthranilic acid, 3-hy-
droxy-kynurenine, xanthurenic acid, 3-hydroxyanthranilic acid), and 
infl ammatory markers (CRP, neopterin, KTR). The HUSK study has 
been linked to the Cardiovascular Disease Registry Health Region 
West (data through 2008; n = 2185), the Cancer Registry of Norway 
(data through 2007; n = 746), and the Cause of Death Registry (data 
through 2008; n = 851). 
 Results: Data are currently being analysed, and results will shed light 
on major gaps in the research fi eld of infl ammation, kynurenines, and 
B-vitamins in chronic infl ammatory diseases. 
 Discount and conclusions: This is the fi rst prospective study 
focusing on the combination of infl ammatory markers, several 
kynurenines and B-vitamins in relation to infl ammatory diseases. 
 INV 10
Immune activation and moderate hyperhomocysteinemia 
 S. Schroecksnadel 1 , K. Kurz 2 , *D. Fuchs 1 
 
1
 Innsbruck Medical University, Biocenter, Division of Biological 
Chemistry, Innsbruck, Austria 
 
2
 Innsbruck Medical University, Internal Medicine, Innsbruck, 
Austria 
 Moderate hyperhomocysteinemia is often associated with infl am-
mation and immune activation. In vitro, stimulated peripheral 
blood mononuclear cells release homocysteine. This effect is sup-
pressed by anti-infl ammatory drugs like aspirin, salicylic acid and 
atorvastatin. Likewise, in various diseases including coronary 
artery disease (CAD), rheumatoid arthritis, certain types of can-
cer and various forms of dementia but also in older aged healthy 
normals, signifi cant correlations between increased concentrations 
of homocysteine and higher concentrations of immune activation 
markers like neopterin or soluble TNF-receptors have been doc-
umented [1]. B-vitamin supplementation in patients was found 
to decrease homocysteine concentrations but did not infl uence 
immune activation markers, as it had no drastic infl uence on the 
clinical performance. 
 In patients after multiple trauma and with sepsis, total homo-
cysteine concentrations increase during follow-up. This is pref-
erentially true in non-survivors but not in survivors [2]. Because 
the patients receive standardized parenteral nutrition after the 
end of hypodynamic shock, different supply with vitamins is 
unlikely to be the reason for the increase of homocysteine, rather 
it is associated with a stronger pro-inflammatory response. This 
study further supports the conclusion that underlying immuno-
pathogenetic mechanisms may contribute to the development of 
moderate hyperhomocysteinemia in various diseases. Because 
of an increased demand of B-vitamins in inflammatory con-
ditions, B-vitamins like folate, B12 and B6 may need to be 
supplemented. 
 
[1] Schroecksnadel K, et al. Curr Pharm Biotechnol 2004;5:107-18. 
 [2] Ploder M, et al. Mol Med 2010;16:498-504. 
 INV 11
The role of epigenetics in neurodegeneration: the 
Alzheimer ’ s Disease paradigm 
 *A. Fuso 1 
 
1
 Sapienza University of Rome, Dept. of Surgery  “ P. Valdoni ” , Rome, 
Italy 
 Neurodegeneration is the progressive loss of neurons function, 
generally resulting in cell death and neurodegenerative diseases. 
The greatest risk factor for neurodegenerative diseases is aging, 
which is infl uenced by physiological and environmental stimuli. 
Epigenetic modifi cations can mediate environmental insults that a 
person encounters during his life. As a matter of fact, epigenetic 
mechanisms can be considered as a link between environment and 
its effect on the genome. Advances in epigenetic research stressed 
the involvement of epigenetics in different neurodegenerative 
diseases. 
 In the last years, my laboratory was aimed at studying the role of 
DNA methylation in Alzheimer ’ s Disease (AD), the most representa-
tive among neurodegenerative diseases. 
 To this scope, we analyzed methylation of genes associated to 
the disease in a murine AD model and, very recently, in AD 
patients. 
 We found that PSEN1 gene, involved in amyloidogenesis, is regu-
lated by methylation in hyperhomocysteinemic mice (a condition 
exacerbating AD-like features) and in brains of AD patients. 
 Our results demonstrate the existence of specifi c mechanisms 
by which epigenetics affects the progress of neurodegeneration. 
Moreover, we evidenced that DNA methylation could be underesti-
mated in the current studies. 
 Besides the new insights in the comprehension of complex diseases, 
the most appealing part of this story is that epigenetic modifi cations 
are reversible, suggesting that epigenetic drugs to be used in disease 
treatment. 
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 INV 12
New insights into cobalamin absorption and metabolism 
using accelerator mass spectrometry 
 *R. Green 1 , J. W. Miller 1 
 
1
 University of California Davis, Pathology and Laboratory Medicine, 
Sacramento, United States 
 Much of our understanding of cobalamin (Cbl) derives from radio-
cobalt tracer studies. We now study Cbl absorption and metabolism 
with unprecedented resolution using a novel technique developed by 
our group in which 14C is incorporated into the lower axial ligand of 
cyanoCbl (14C-cyanoCbl) through bacterial synthesis (Proc Nat Acad 
Sci 2006;103:5694-9). Following oral 14C-cyanoCbl, blood was ana-
lyzed for 14C by accelerator mass spectrometry (AMS). The plasma 
response was consistent with the expected behavior of oral Cbl. 14C 
reached a peak level within 6-8h, and was bound to the physiological 
transport protein, transcobalamin (TC). We also reported surprising 
degradation of 10-50 % of the tracer dose which was excreted in the 
urine, 100-fold greater than in previous reports using 57Co-labeled 
cyanoCbl (0.1-0.5 % ). We have analyzed the plasma clearance of 
TC-bound 14C-Cbl. Following oral 14C-cyanoCbl (1.3  μ g, 50 nCi), 
blood specimens were obtained and the TC-bound fraction of plasma 
14C appearing in plasma at timed intervals was determined by an 
immunoaffi nity method. The mean apparent plasma TC-bound 14C-
Cbl half-life in 9 normal subjects was 4.3h, longer than previously 
published values that ranged from 6 min to 1.5h. We also studied 
a patient with pernicious anemia. A small peak of 14C was identi-
fi ed in the plasma 5h following the oral dose, earlier than observed 
in the control subjects. However, when the immunoaffi nity purifi ed 
TC-bound fraction was examined for 14C, none was detected, sug-
gesting that the non-TC 14C was a degradation product of the 14C-
cyanoCbl. For improved clinical reliability, plasma measurement of 
tagged Cbl in an absorption test should therefore be accompanied by 
purifi cation of the TC-bound fraction. 
 INV 13
Epigenomics effects of defi ciency in methyl donors 
 *J.-L. Gu é ant 1 
 
1
 Inserm U954, Facult é de M é decine, Vandoeuvre les Nancy, France 
 Background: The defi ciency in methyl donors, folate, vitamin B12 
and choline infl uences the risk to develop complex degenerative 
diseases 
 Aim: To dissect the consequences defi ciency in methyl donors 
related with epigenomic mechanisms in brain, myocardium and liver, 
at different steps of life 
 Methods: We studied cellular models (NIE-115 cells with stable 
expression of transcoblamin fused to oleosine, with sequestration of 
vitamin B12 and decreased methionine synthase and folate defi cient 
H19-7 cells) and rat models with defi ciency during pregnancy and 
aging 
 Results: Defi ciency in methyl donors suppresses foetal growth in 
relation with Insulin-like growth factor 2, H19 and Ghrelin impaired 
expression. Expression of chimeric protein produces slower prolif-
eration and speedier differentiation of neuroblastoma cells through 
altered expression of PP2A, proNGF, and TACE and apoptosis 
and Parkinson-like phenotype by transfecting rat  substantia nigra . 
Altered differentiation of neuronal progenitors is observed in H19-7 
cells and in specifi c brain areas of defi cient pups, with maintained 
tissue and behaviour anomalies during aging. Expression of pro-
teins involved in neuroplasticity is decreased in hippocampus and 
cerebellum of females, in relation with epigenomic dysregulation of 
ERa pathways. It leads to cardiac hypertrophy and liver steatosis in 
relation with decreased expression of PPARa and ERRa and inac-
tivation of PGC1a by imbalanced hypomethylation/acetylation and 
subsequent impaired mitochondrial fatty acid oxidation 
 Discussion  – conclusion: The defi ciency in methyl donors infl uences 
the risk to develop complex degenerative diseases by epigenetic 
and epigenomic mechanisms related with the foetal programming 
hypothesis 
 INV 14
B-Vitamin Dependent Methionine Metabolism in 
Pathogenesis, Prevention, and Treatment of Alcoholic Liver 
Disease 
 *C. Halsted 1 
 
1
 University of California Davis, Internal Medicine, Davis, United 
States 
 Question: Do defi ciencies of folate and B6 regulate the pathogenesis 
of ALD through their effects on hepatic methionine metabolism ? 
 Methods and results: Ethanol fed micropigs fed a folate defi cient 
diet developed ALD in association with reduced levels of liver SAM 
and increased SAH with increased expressions of selected liver 
injury genes that were prevented by SAM. Intragastric ethanol fed 
mice developed ALD with reduced SAM:SAH ratios and increased 
expressions of genes associated with altered histone lysine patterns. 
A clinical study of chronic alcoholics with and without ALD found 
decreased serum folate levels and low B6 levels in ALD patients 
that correlated with increased serum cystathionine, consistent 
with reduced activity of B6-dependent cystathionase. A controlled 
6-month clinical trial of supplemental SAM had no effect on liver 
histology in ALD while serum B6 levels were unchanged. 
 Conclusions: Aberrant B6 and folate dependent hepatic methionine 
metabolism is found in clinical and experimental ALD, is consistent 
with altered epigenetic gene regulation, and may be prevented but 
not treated by SAM supplementation. 
 References: [1] Halsted CH et al, Proc Nat Acad Sci 2002; 
99:10072-7; [2] Esfandiar F et al, Am J Physiol 2005;289:G54-63; 
[3] Villanueva J et al,Alcohol Clin Exp Res 2007;31:1934-43; [4] 
Esfandiari F et al, Hepatology 2010; 51:932-41; [5] Medici V et al, J 
Hepatology 2010; 53: 551-57; [6] Medici V et al, Alc Clin Exp Res 
2011, In Press. 
 INV 15
Insights into Functional Cobalamin Defi ciency: The  cblC 
Proteome 
 *L. Hannibal  1 , P. M. DiBello 1 , M. Yu 1 , A. Miller 1 , S. Wang 1 , B. 
Willard 1 , D. S. Rosenblatt 1 , D. W. Jacobsen 1 
 
1
 Cleveland Clinic, Department of Pathobiology, Cleveland, United 
States 
 Background: Mutations in the MMACHC gene disrupt processing 
of the upper-axial ligand of newly internalized cobalamins, leading 
to a functional defi ciency of the vitamin and the cblC disorder. The 
full spectrum of protein changes that accompany human functional 
cobalamin defi ciency is unknown. 
 Aim: We hypothesized that the proteome of skin fi broblasts from 
cblC patients will differ from that of normal subjects, and that these 
differences may correlate with the clinical manifestations of the 
disease. 
Brought to you by | University of Queensland - UQ Library
Authenticated
Download Date | 9/21/15 2:40 AM
Advances and Controversies in B-Vitamins and Choline, Leipzig, Germany, March 2012  A7
 Methods: To test this hypothesis, the proteomes of normal and 
cblC fi broblasts were quantitatively examined by two dimen-
sional difference in-gel electrophoresis and liquid chromato-
graphy-electrospray ionization-mass spectrometry. The effect of 
hydroxocobalamin supplementation on the cblC proteome was 
also assessed. 
 Results: The cblC fi broblasts exported increased levels of both 
homocysteine and methylmalonic acid compared to normal fi bro-
blasts. The cblC cells also had decreased levels of total intracellular 
folates. Major changes ( > 2-fold) were observed in the expression 
levels of proteins involved in cytoskeleton organization and assem-
bly, the neurological system, and cell signaling. Supplementation 
with hydroxocobalamin did not restore the cblC proteome to the pat-
terns of expression observed in control cells. 
 Discussion and Conclusion: The metabolic profi le of culture 
dcblC fi broblasts is consistent with the clinical phenotype of 
functional cobalamin defi ciency in vivo. Pathway analysis of 
the differentially expressed proteins demonstrated strong asso-
ciations with those implicated in neurological, muscular, skeletal 
and cardiovascular disorders in the cblC cell lines. Altogether, 
these results concur with the observed phenotype of patients with 
the cblC disorder and their variable response to treatment with 
hydroxocobalamin. 
 INV 16
Osteoporosis  – New Diagnostic and Clinical Aspects 
 *M. Herrmann 1 
 
1
 Consultant Chemical Pathologist, Mortlake, Australia 
 Osteoporosis is one of the leading age related diseases with 2.2 
million Australians being affected. Fragility fractures represent the 
most frequent complication in these patients and are associated with 
substantial morbidity and mortality. However, osteoporosis is still a 
largely under-recognized disease and accounts for less than 1 % of all 
problems managed by general practitioners. 
 In recent years substantial progress has been in made in under-
standing the pathomechanisms leading to bone loss and osteopo-
rosis. Besides classical age related factors, such as immobility, 
sex hormone defi ciency and vitamin D defi ciency additional fac-
tors including bone marrow fat and hyperhomocysteineaemia have 
been established. In addition, there is substantial data supporting a 
mechanistic link between bone and energy metabolism, which sheds 
further light on the inverse relationship between fracture risk and 
body weight. 
 Although the diagnosis of osteoporosis is still based on a detailed 
history, the measurement bone mineral density and long known 
biochemical tests, signifi cant advances have been made in utiliz-
ing this information more rationally. For example, osteocalcin is 
traditionally known as a bone formation marker. Today we know 
that osteoclastic bone resorption signifi cantly contributes to circu-
lating osteocalcin levels. Furthermore, there is mounting evidence 
that OC is a hormone like molecule with important metabolic 
functions. 
 Similar to cardiovascular disease treatment decisions are increas-
ingly based on individual fracture risk using risk calculators, such 
as the FRAX or the Garvan Institute calculator. Advances have also 
been made in the therapeutic fi eld. Besides classical agents, such as 
bisphosphonates a number of new drugs have been introduced or are 
currently being explored including the RANKL inhibitor denosumab 
or the cathepsin K inhibitor odanacatib. 
 The aim of this talk is to provide an overview about new mechanistic, 
diagnostic and clinical aspects of osteoporosis. 
 INV 17
Plasma phospholipids in diabetic and elderly subjects are 
related to C1-metabolism: possible impact on disease risk 
 *W. Herrmann 1 , Y. Rabagny 1 , J. Jung 1 , F. Lammert 1 , R. Obeid 1 
 
1
 Saarland University Hospital, Departments of Clinical Chemistry/ 
Laboratory Medicine, Homburg/Saar, Germany 
 Background: Type 2 diabetes mellitus is associated with higher 
risks for coronary heart disease, polyneuropathy, nephropathy, and 
neurodegenerative diseases. The underlying mechanisms are not 
well understood. Low B-vitamins and hyperhomocysteinemia are 
common in diabetic patients. Changes in methyl group metabolism 
and medications might affect phospholipids (PL) in diabetics and 
this might be related to clinical outcomes. Unsaturated fatty acids, 
decreases in lysophosphatidylcholine (LPC) and sphingomyelin 
(SM) concentrations have been linked to diabetes and alterations in 
SMs and ceramids might play a role in amyloidogenesis and infl am-
matory stress related neuronal apoptosis. Our study is concerned 
with alteration in PL metabolism in diabetics and elderly subjects. 
 Methods: The study included 92 type 2 diabetics and 67 controls. 
Additionally, a double blind intervention study over one year on 60 
elderly people with either 500  μ g folic acid, 500  μ g vitamin B12, 
50 mg vitamin B6, 1200 IU vitamin D and 456 mg Ca + + /day; or 
with 1200 IU Vitamin D and 456 mg Calcium/day. We measured 
B-vitamin markers (fasting Hcy, MMA, folate, B12, holoTC), and 
blood methylation markers [S-adenosylmethionine (SAM), and 
S-adenosylhomocysteine (SAH), choline, betaine]. Concentrations 
of numerous species of phospholipids [phosphatidylcholine (PC), 
lysophosphatidylcholine (LPC), phosphatidylethanolamine (PE), 
and sphingomylein (SM)] were measured in plasma. 
 Results: Compared to controls lower concentrations of certain spe-
cies of LPC and SM were found in diabetics. Diabetics treated with 
statins displayed compared to those without statins signifi cantly 
lower concentrations of certain species of LPC and SM. Diabetics 
on metformin had signifi cantly decreased concentrations of total and 
certain species of LPC and PE compared to those without metformin. 
We also found signifi cantly higher ratio of methylated PL to non-
methylated PL in metformin treated diabetics. Certain species of SM 
and LPC showed signifi cant correlations to markers of infl ammation, 
renal function and glucose metabolism. Backward regression ana-
lysis revealed that betaine and choline were independent variables 
explaining signifi cant changes in phospholipids concentrations. The 
one-year intervention trial with B and D vitamins resulted in signifi -
cant alterations of some phospholipid species. 
 Conclusion: It is concluded that changes in phospholipids might be 
triggered by alterations of methyl donors (folate, choline, betaine) 
and might be important for the development of age related diseases 
like diabetes, infl ammation, neurodegeneration or renal dysfuntion. 
Further studies should provide information about the usefulness of 
certain phospholipid species as biomarkers for the above discussed 
diseases. 
 INV 18
Metabolic and Functional Effects of Choline in Children with 
Cystic Fibrosis 
 *S. Innis 1 , B. Keller 1 , A. G. Davidson 1 
 
1
 University of British Columbia, Paediatrics, Vancouver, Canada 
 Although considerable advances in care of patients with Cystic 
Fibrosis (CF) have led to an increased lifespan and life quality, 
CF remains a complex disease with many clinical complications, 
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including liver disease, that are incompletely understood. This is 
emphasized by a wide variability in complications and their severity 
among CF individuals with the same mutation. Other factors must, 
therefore, converge to exacerbate or minimize the underlying CF gene 
defect. Nutrition is key among these variables. Choline and methio-
nine are major dietary methyl sources, but methionine also provides 
sulphur, crucial for protein, cysteine, glutathione and taurine, while 
choline functions in phospholipids and acetylcholine. Plasma cho-
line, and its metabolites betaine and dimethylglycine are reduced, but 
malabsorption of choline containing lipids and bile acids is increased 
in CF children. We conducted a prospective 6 month intervention 
with 2 g/day choline bitartartate in 29 CF children. Cross-sectional 
studies with 45 children without CF and 84 children with CF were 
done to separate effects of age and disease on choline and its metabo-
lites. Lower plasma choline, betaine and dimethylglycine in children 
with CF were increased, and homocysteine was decreased by choline 
supplementation. A subset of children with CF responded to choline 
with a lowering of blood pressure and improved pulmonary function, 
measured by spirometry. Urinary glycine excretion was reduced, but 
polyamine excretion was increased in CF children. Choline improves 
but does correct the methyl and sulphur amino acid abnormalities in 
CF, possibly due to continuing malabsorption of glycine and methi-
onine which interact with choline metabolism. 
 Funded by Cystic Fibrosis Fdn. 
 INV 19
Homocysteine in alcoholic liver disease 
 *D. Jacobsen 1 
 
1
 Case Western Reserve University/Cleveland Clinic, Departments of 
Molecular Medicine/Cell Biology, Cleveland, United States 
 Background: Although hyperhomocysteinemia is associated with 
alcoholic liver disease, the molecular mechanisms for the production 
of elevated homocysteine (Hcy) are largely unknown. 
 Aim: We hypothesized that reactive oxygen species, produced as 
a result of EtOH-induced upregulation of cytochrome P450 2E1 
(CYP2E1), results in the inactivation of B12-dependent methionine 
synthase (MS) and/or the cblC protein MMACHC, a B12 processing 
enzyme. 
 Methods: To test the hypothesis in vitro, we utilized HepG2 cells 
transfected with CYP2E1 (E47) and control cells transfected with 
empty vector (C34) both kindly provided by Dr. Arthur Cederbaum. 
Intracellular B12 was determined by HPLC after feeding [ 57 Co]-cy-
anocobalamin. To test the hypothesis in vivo, we determined hepatic 
MS enzyme activity in wild type and CYP2E1 null mice (CYP2E1 -/- ) 
fed a diet with increasing levels of EtOH for 25 days. 
 Results: MS activity was 18 % lower in E47 compared to C34 cells 
prior to EtOH treatment, and was further reduced by 15 % in E47 
after EtOH treatment. EtOH had no effect on MS activity in non-
CYP2E1-expressing C34 cells. There was a concomitant increase 
in Hcy in E47 cells with low MS activity, and a dramatic decrease 
in glutathione in untreated and EtOH-treated E47 cells. Intracellular 
B12 profi les were similar in both C34 and E47 with or without EtOH. 
In wild-type mice, there was a 60 % decrease in hepatic MS activity 
after EtOH feeding. In contrast EtOH had no effect on hepatic MS 
activity in CYP2E1 -/- mice. 
 Discussion and Conclusion: CYP2E1 expression, in the absence 
of EtOH, was associated with reduced MS activity, increased Hcy 
and reduced glutathione in E47 compared to C34. Thus, MS enzyme 
activity is signifi cantly reduced in CYP2E1-expressing cells bothin 
vitroandin vivo. The B12 processing enzyme MMACHC appears to 
be unaffected by CYP2E1 expression and EtOH treatment. 
 INV 20
Cellular damage by homocysteine: the role of protein 
N-homocysteinylation 
 *H. Jakubowski 1,2,3 
 
1
 UMDNJ-New Jersey Medical School, International Center for 
Public Health, Department of Microbiology & Molecular Genetics, 
Newark, United States 
 
2
 Polish Academy of Sciences, Institute of Bioorganic Chemistry, 
Pozna n´ , Poland 
 
3
 University of Life Sciences, Department of Biochemistry and 
Biotechnology, Pozna n´ , Poland 
 Protein-related homocysteine (Hcy) metabolism generates: 1) a 
chemically reactive thioester, Hcy-thiolactone; 2) Hcy-modifi ed 
protein,  N -Hcy-protein; and 3) an isopeptide,  N ε -homocysteinyl-
lysine ( N ε -Hcy-Lys). Hcy-thiolactone is generated in an enzymatic 
error-editing reaction in protein biosynthesis when Hcy is errone-
ously selected in place of methionine by methionyl-tRNA syn-
thetase.  N -Hcy-protein is formed in a chemical reaction - called 
protein  N -homocysteinylation - of Hcy-thiolactone with an  ε -amino 
group of a protein lysine residue protein.  N ε -Hcy-Lys is a product 
of proteolytic degradation of  N -Hcy-protein. Each of those Hcy 
metabolites has been linked to atherothrombotic disease. In par-
ticular, protein  N -homocysteinylation impairs or alters the protein ’ s 
biological function, causes protein damage by a thiyl radical-me-
diated oxidation, and induces an auto-immune response. Dozens of 
protein targets for  N -homocysteinylation, as well as specifi c  N -Hcy 
lysine residues in individual proteins, have been identifi ed  in vitro 
and  in vivo .  N -Hcy-proteins undergo structural changes, which 
generate toxic amyloid-like aggregates.  N -homocysteinylation of 
proteins involved in blood homeostasis ( e.g. , fi brinogen) or tissue 
biogenesis ( e.g. , collagen, elastin) leads to thrombosis or connec-
tive tissues abnormalities, respectively, frequently observed in 
severe hyperhomocysteinemia. 
 INV 21
Methionine metabolism in liver diseases 
 *K. Kharbanda  1 
 
1
 Veterans Affairs Nebraska-Western Iowa Health Care, System, 
Research Service and University of Nebraska-Medical Center, 
Omaha, United States 
 Alcoholic liver disease is a major health care problem. Research 
in many laboratories, including ours has demonstrated that etha-
nol feeding impairs several of the multiple steps in methionine 
metabolism. Ethanol consumption has been reported to predomi-
nantly inhibit the activity of two vital cellular enzymes, methionine 
synthase and methyl adenosyltransferase involved in remethylat-
ing homocysteine and generating S-adenosylmethionine (SAM), 
respectively. By way of compensation in some species, ethanol 
increases the activity of the enzyme betaine homocysteine methyl-
transferase that catalyzes an alternate pathway in methionine meta-
bolism and utilizes hepatic betaine to remethylate homocysteine 
to form methionine. All these alterations in enzyme activities by 
ethanol exposure principally result in a decrease in the vital liver 
metabolite, S-adenosylmethionine (SAM), and increase in two toxic 
metabolites, homocysteine and S-adenosylhomocysteine (SAH). 
The loss of SAM and an increase in SAH causes a decrease in the 
hepatocellular SAM:SAH ratios that leads to a plethora of detri-
mental functional consequences in the liver by particularly affecting 
many SAM-dependent methylation reactions. This defect ultimately 
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results in compromised liver function and progressive liver injury. 
Betaine administration, by remethylating homocysteine via the 
BHMT-catalyzed pathway, removes SAH, restores SAM levels and 
normalizes hepatic SAM:SAH ratios to maintain these and other 
essential methylation reactions. To conclude, betaine is a promis-
ing therapeutic agent in relieving the methylation and other defects 
associated with alcoholic abuse. 
 INV 23
Vitamin B-6 and folate affect the association between 
 MAT1A variants and hypertension, stroke, and markers of 
DNA damage 
 *C. Q. Lai  1 , L. D. Parnell 1 , A. M. Troen 1 , J. Shen 1 , H. Caouette 1 , D. 
Warodomwichit 1 , Y.-C. Lee 1 , J. W. Crott 1 , W. Q. Qiu 1 , I. H. Rosenberg 1 , 
K. L. Tucker 1 , J. M. Ordovas 1 
 
1
 Human Nutrition Research Center on Aging at Tufts University, 
Nutrition and Genomics Laboratory, Jean Mayer-US Department of 
Agriculture, Boston, United States 
 Background: The S-adenosylmethionine synthetase type 1 (MAT1A) 
gene encodes a key enzyme in one-carbon nutrient metabolism. 
 Aim: This study aimed to determine the association ofMAT1Avari-
ants with homocysteine, DNA damage, and cardiovascular disease 
(CVD). 
 Methods: Eight variants of MAT1A were examined for associations 
with hypertension, stroke, CVD, homocysteine, and DNA damage 
in 1006 participants of the Boston Puerto Rican Health Study. Two 
variants were replicated in 1147 participants of the Nutrition, Aging, 
and Memory in Elders Study. 
 Results: Two variants and haplotypes were strongly associated 
with hypertension and stroke, independent of methylenetetrahydro-
folate reductase genotypes. Homozygotes of theMAT1Ad18777A 
(rs3851059) allele had a signifi cantly greater likelihood of stroke 
(OR = 4.30; P  = 0.006), whereas 3U1510A (rs7087728) homozy-
gotes had a lower likelihood of hypertension (OR = 0.67; P  = 0.022) 
and stroke (OR = 0.35; P  = 0.015). A similar trend of association 
was observed in a second elderly population. Furthermore, strong 
interactions betweenMAT1Agenotypes and vitamin B-6 status were 
found. Nonrisk allele 3U1510A carriers had a lower 8-hydroxyde-
oxyguanosine (8-OHdG) concentration — a biomarker of oxidative 
DNA damage — when plasma vitamin B-6 was high, whereas risk-
allele 3U1510G homozygotes had higher 8-OHdG concentrations, 
regardless of vitamin B-6 status. 
 Discussion and Conclusions: MAT1Avariants were strongly asso-
ciated with hypertension and stroke. Improving folate and vitamin 
B-6 status might decrease CVD risk of a subset of the population, 
depending on genotype. These fi ndings suggest that impairments in 
methylation activity, independent of homocysteine, have an effect 
on CVD risk. 
 INV 24
Homocysteine and ADMA Infl uence Cerebrovascular and 
Myocardial Function through distinct mechanisms 
 *S. Lentz 1 
 
1
 University of Iowa, 200 Hawkins Drive, C32 GH, Iowa City, United 
States 
 Background: The endogenous nitric oxide synthase inhibitor 
asymmetric dimethylarginine (ADMA) is produced from pro-
teins containing methylated arginine residues and is degraded 
by dimethylarginine dimethylaminohydrolase (DDAH). Homo-
cysteine and ADMA are metabolically linked through the methi-
onine cycle, and homocysteine inhibits the expression and activity 
of DDAH. Clinically, hyperhomocysteinemia is associated with 
both elevation of ADMA and adverse cerebral and cardiac vascu-
lar outcomes. 
 Aim: The goal of this study was to determine the mechanisms by 
which homocysteine and ADMA contribute to cerebrovascular dys-
function and myocardial ischemia-reperfusion (I/R) injury. 
 Methods: Heterozygous DDAH1-defi cient (DDAH1  + /- ) mice, 
DDAH1 transgenic (DDAH1 TG) mice and wild-type littermates 
(WT mice) were studied. Some DDAH1 TG and WT mice were 
fed a high methionine/low folate diet to induce moderate hyperho-
mocysteinemia. Endothelial function and cross-sectional area were 
measured in cerebral arterioles, and regional myocardial ischemia 
was produced by 30 minutes of myocardial ischemia followed by 
120 minutes of reperfusion. 
 Results: Hyperhomocysteinemic mice developed endothelial dys-
function and hypertrophy of cerebral arterioles. Endothelial dysfunc-
tion correlated strongly with plasma levels of total homocysteine 
but not with plasma ADMA. Overexpression of DDAH1 protected 
from cerebrovascular hypertrophy but not from endothelial dysfunc-
tion in hyperhomocysteinemic mice. After myocardial I/R injury, 
larger infarcts were observed in DDAH1  + /- mice than in WT mice. 
DDAH1 TG mice were protected from myocardial I/R damage, and 
hyperhomocysteinemia led to markedly increased myocardial injury 
both in DDAH1 TG and WT mice. Hyperhomocysteinemic mice 
had increased generation of superoxide during reperfusion, whereas 
DDAH1  + /- mice had diminished cardiac levels of nitric oxide oxida-
tion products. 
 Discussion and Conclusion: These fi ndings suggest that homo-
cysteine and ADMA produce adverse effects on cerebrovascular and 
myocardial function through distinct mechanisms. The observation 
that DDAH1 protects from cerebrovascular hypertrophy and myo-
cardial injury in hyperhomocysteinemia suggests that ADMA may 
be a contributing factor (but not a primary cause) of vascular events 
in some cases of hyperhomocysteinemia. 
 INV 25
Betaine, both a methyl donor and an osmolyte 
 *M. Lever 1 
 
1
 Canterbury Health Laboratories, Biochemistry Unit, Christchurch, 
New Zealand 
 Because of its behaviour as a solute, betaine (N,N,N-
trimethylglycine) enhances the stability of proteins. Its concentra-
tions in most tissues greatly exceed circulating concentrations, and 
are osmoregulated. This intracellular betaine has an important role 
in regulating cell volume. Its accumulation is both a major use of 
methyl groups, and a potential supply of them. The transfer of a 
methyl group from betaine to homocysteine is catalyzed by betaine 
homocysteine methyl transferase (BHMT), found in highest con-
centrations in human liver and renal cortex. BHMT is an abundant 
liver protein and its functions have not been fully elucidated. Its 
expression is osmoregulated and subject to control by hormones 
and betaine. 
 The supply of betaine is by the mitochondrial oxidation of choline 
and directly from the diet. Plasma concentrations are controlled 
and urinary excretion is minimal. Betaine defi ciency has not been 
well defi ned, but could arise from poor diet with inadequate cho-
line and betaine, from defective conversion of choline to betaine, 
or from an excessive loss of betaine. An abnormal betaine loss 
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in the urine is common in diabetes and related conditions, and in 
patients treated with fi brates. Sweat has also been found to have 
high betaine content. Betaine defi ciency may be common in the 
metabolic syndrome. Betaine (often marketed as  “ TMG ” ) is sold 
as a dietary supplement with strong claims about its health ben-
efi ts. These claims are not supported by clinical studies. There is 
evidence that betaine supplements improve athletic performance, 
and long-term betaine supplementation of pigs improves the qua-
lity of pork (higher lean meat to fat ratio). Benefi ts in mouse and rat 
studies include less atherogenic plasma lipid profi les and decreased 
arterial plaque deposition. There is confl icting cross-sectional evi-
dence in human populations. On the one hand high plasma betaine 
concentrations are associated with a favourable blood lipid profi le 
and low BMI, on the other hand high plasma betaine concentrations 
have been associated with increased incidence of vascular events. 
In patients with elevated LDL cholesterol, urine betaine excretion 
is a major determinant of plasma homocysteine. In prospective 
studies both high and low plasma betaine concentrations predict 
heart failure and cardiovascular events, especially in diabetes. Both 
high and low betaine excretion predicts heart failure. The few stud-
ies of betaine supplementation demonstrate its safety, a lowering 
of plasma homocysteine and benefi cial effects in alcoholic liver 
disease. 
 The connection between the known functions of betaine and lipid 
metabolism is obscure. Even if betaine defi ciency is established to 
be a risk factor for a disease, there is still a need to demonstrate that 
betaine supplementation has a health benefi t. 
 INV 26
Antiepileptic drugs and B-Vitamins: epidemiological and 
electrophysiological data 
 *M. Linnebank 1 
 
1
 University Hospital Zurich, Department of Neurology, Zurich, 
Switzerland 
 Antiepileptic drugs (AED) are used for the treatment of epilepsy, 
psychiatric diseases and pain syndromes. Treatment with several 
AED seems to be associated with reduced folate and vitamin B12 
serum levels, but respective studies were small. This prospec-
tive monocenter study aimed at testing which are associated with 
folate and vitamin B12 serum levels in a large population of 2730 
AED-treated and 170 untreated patients with epilepsy and 200 
healthy individuals. Treatment with carbamazepine, gabapentin, 
oxcarbazepine, phenytoin, primidone or valproate was associated 
with lower mean serum folate levels or with a higher frequency 
of folate levels below the reference range in comparison with all 
other patients, untreated patients or controls. Treatment with phe-
nobarbital, pregabalin, primidone or topiramate was associated 
with lower vitamin B12 levels compared with the entire group of 
patients. Vitamin B12 serum levels were higher in patients treated 
with valproate compared with the entire group of patients, untreated 
patients and healthy controls. Folate or vitamin B12 levels below 
the reference range were associated with higher mean corpuscular 
volume (MCV) and higher homocysteine plasma levels. Vitamin 
substitution for three months in 141 patients with folate or vitamin 
B12 levels below the reference range yielded normal vitamin levels 
in 95 % of the supplemented patients and reduced MCV and homo-
cysteine plasma levels. In conclusion, treatment with most of the 
commonly used AED is associated with reduced folate or vitamin 
B12 serum levels and is a risk factor for hyperhomocysteinemia. 
Oral substitution is effective to restore vitamin, MCV and homo-
cysteine levels. 
 INV 27
Fatty acid metabolism in choline and methionine defi ciency 
in mice may infl uence progression to steatohepatitis but not 
fi brosis 
 *D. Macfarlane 1 
 
1
 University of Dundee, Clinical Research Centre, Dundee, United 
Kingdom 
 Background: We have previously shown that abnormalities 
of fatty acid metabolism may promote the development of ste-
atohepatitis induced by a methionine and choline defi cient diet 
(MCDD). However, its infl uence on progression to hepatic fi brosis 
is unknown. 
 Aims: To investigate the infl uence of fatty acid metabolism on the 
progression to fi brosis in fatty liver. 
 Methods: C57Bl6 mice (male, aged 14 weeks, n = 7/group) were fed 
a MCDD, or choline defi cient diet (CDD), to induce steatosis with-
out infl ammation or insulin resistance, or a supplemented control 
diet (CS) for 4 weeks and injected twice weekly with carbon tetra-
chloride (CCl 4 , 0.3 μ l/g in olive oil (OO), 1:3 v/v) or vehicle (OO) 
to induce hepatic fi brosis. 
 Results: Liver TG pools were similarly elevated in both CDD 
and MCDD mice ( ∼ 2 fold), and were unaffected by CCl 4 . MCDD, 
but not CDD, caused liver infl ammation (increased hepatic neu-
trophils) and increased mRNA levels of the pro-infl ammatory 
cytokines TNFa and IL-1b. MCDD, but not CDD, also increased 
mRNA levels of the pro-fi brotic cytokine TGFb and increased 
hepatic stellate cell activation (alpha smooth muscle actin (aSMA) 
mRNA levels and staining). CCl 4 further increased aSMA staining 
in MCDD mice alone, but there was no additional effect of CCl 4 on 
gene expression in either group. Picosirius red staining confi rmed 
CCl 4 induced fi brosis, but there was no increase in either model of 
fatty liver. 
 Discussion and Conclusion: These fi ndings suggest that whilst 
abnormalities of hepatic fatty acid metabolism may promote the 
development of steatohepatitis, they do not increase susceptibil-
ity to liver fi brosis. Additional factors such as reduced leptin lev-
els or increased matrix metalloproteinase activity may act to limit 
progression. 
 INV 28
Folate Intake Modulates Carcinogenesis: Mechanisms and 
Consequences 
 *J. B. Mason 1 
 
1
 Tufts University, Human Nutrition Research Center, Boston, United 
States 
 Epidemiologic evidence generally indicates that an abundant 
intake of foodstuffs rich in folate conveys protection against the 
development of colorectal cancer and perhaps some other com-
mon cancers as well. Preclinical models substantiate that the rela-
tionship is a genuinely causal one. Emerging data suggests that 
availability of the other  ‘ one-carbon vitamins ’ -B2, B6, and B12 
- may also impact on the phenomenon in a synergistic fashion. It 
is entirely possible that the cancer preventive effects of folate and 
other B-vitamins are mediated through several cellular pathways, 
but recent observations most strongly implicate the Wnt signaling 
pathway. 
 However, the issue is rather complex because some observations 
in animal and human studies demonstrate that an overly abundant 
intake of folate among those who harbor existing foci of neoplasia 
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might instead produce a paradoxical promotion of tumorigenesis. 
The pharmaceutical form of the vitamin, folic acid, might affect the 
process in a manner that is distinct from natural forms of the vitamin, 
although this remains a speculative concept. We should not allow 
the complex nature of this relationship to compel us to ignore it, as 
understanding its true nature will greatly facilitate our ability to con-
struct intelligent, effective, and safe strategies for the prevention of 
birth defects and cancer. 
 INV 29
Haptocorrin a teaser for researchers and for routine 
measurement of cobalamin 
 *E. Nexo 1 
 
1
 Aarhus University Hospital, Clinical Biochemistry, Aarhus, 
Denmark 
 Haptocorrin (HC) is the youngest of the soluble cobalamin-bind-
ing proteins and has evolved after diversion of the bony fi sh. It is 
expressed in most but not all mammals, notably not in mice. 
 In humans, HC is present in plasma and in most extracellular fl uids, 
such as saliva and milk. 
 In plasma, HC carries most of the circulating cobalamin and in addi-
tion a comparable amount of degradation products (analogues). 
Interestingly, analogues accumulate on HC during foetal life, but no 
analogues are present on HC in human milk. 
 The level of plasma cobalamin is driven by the level of HC rather 
than by holoTC, the active part of plasma cobalamin. Decreased 
level of HC, and thereby plasma cobalamin, is observed during preg-
nancy, while a moderate increase in HC is related to liver diseases 
and certain forms of cancer. Extreme levels are seen in patients with 
fi brolamellar hepatocellular carcinoma, where HC may serve as a 
tumour marker. 
 High levels of HC interferes with measurement of cobalamin result-
ing in spurious low or high cobalamin levels depending on the ana-
lytical method employed. This problem can be solved by removal of 
unsaturated HC, a pre-treatment that is mandatory in order to obtain 
a correct estimate of cobalamin in human milk. 
 The function of HC remains unsolved. Life goes on without its pres-
ence. Mice do not express HC but express transcobalamin where 
humans have HC. The presence of HC in milk combined with its 
ability to bind analogues led to a suggested function in modifying 
the intestinal microbiota of the newborn, but recent studies could not 
confi rm such a function. 
 In conclusion, haptocorrin remains a challenge. Researchers need to 
clarify its function and in the routine lab, it may interfere with mea-
surement of cobalamin. 
 INV 30
Intracellular cobalamin and methylation markers in patients 
with type 2 diabetes 
 *R. Obeid 1 , W. Herrmann 1 , J. Jung 1 , J. Falk 1 , K. Fassbender 1 , P. 
Kostopoulos 1 
 
1
 Universit ä tskliniken des Saarlandes, Klinische Chemie & 
Laboratoriumsmedizin, Homburg/Saar, Germany 
 Background: Vitamin B12 defi ciency might be related to peripheral 
neuropathy (PNP) in patients with type 2 diabetes. Elevated con-
centration of methylmalonic acid (MMA) and total homocysteine 
(tHcy) are common in PNP patients. The current study aimed at 
studying mechanisms responsible for altered cobalamin homeostasis 
in diabetics and the relationship between cobalamin status and hypo-
methylation as one important mechanism in PNP. 
 Methods: The study included 92 patients type 2 diabetes and dif-
ferent degrees of PNP and 72 controls. We measured cobalamin 
markers (tHcy, MMA, total cobalamin, holoTC), RBC-cobalamin, 
blood methylation markers [S-adenosylmethionine (SAM), 
S-adenosylhomocysteine (SAH)], and diabetic parameters (HbA1C, 
glucose). We also investigated the grad of PNP. 
 Results: Diabetic patients had compared with controls signifi cantly 
higher plasma SAH (15.2 vs. 11.8 nmol/L: p = 0.001) and lower SAM/
SAH ratio (9.0 vs. 8.2). In contrast to serum MMA that was higher 
in diabetics (256 vs. 207 nmol/L: p = 0.01), concentrations of total 
cobalamin and holoTC did not differ signifi cantly between the groups. 
However, RBC-cobalamin was signifi cantly lower in diabetics com-
pared to the controls (median 230 vs. 260 pmol/L). An inverse cor-
relation between MMA and RBC-cobalamin was found (r = 10.40, 
p < 0.001). SAM/SAH ratio correlated positively to RBC-cobalamin 
and negatively to serum MMA, suggesting that low cellular cobala-
min status is associated with lower methyl group synthesis. Cobalamin 
markers were related to metformine usage. Serum holoTC increased 
with worsening of PNP symptoms; possibly due to impaired cellular 
uptake of holoTC. Two mechanisms of cobalamin resistance will be 
discussed. 
 Conclusion: Diabetic patients showed an impaired cobalamin status 
despite normal holoTC and total cobalamin in serum. Altered coba-
lamin metabolism may play a role on PNP. 
 INV 31
Hydrogen Sulfi de and Oxygen Sensing 
 *K. Olson 1 
 
1
 Indiana University School of Medicine-South Bend, Physiology, 
South Bend, United States 
 Hydrogen sulfi de (H 2 S) has been shown to have numerous effects 
on biological systems and it has been classifi ed along with NO 
and CO as a  “ gasotransmitter ” . Recent evidence suggests that 
H 2 S is the elusive oxygen  “ sensor ” that directly couples tissue 
Po 2 to appropriate physiological responses. In the cardiovascu-
lar system this enables pulmonary and systemic blood vessels 
to directly match perfusion to either ventilation or metabolism, 
respectively, and it is the mechanism for chemoreceptor trans-
duction of blood and environmental Po 2 . This O 2 -sensing mecha-
nism consists of a simple balance between H 2 S production in the 
cytoplasm and its Po 2 -dependent oxidation by the mitochondria. 
A number of observations support this hypothesis; 1) the effects 
of hypoxia and H 2 S on a variety of tissues including vascular and 
non-vascular smooth muscle and chemoreceptor cells are virtu-
ally identical, 2) H 2 S  “ donors ” augment hypoxic responses and 
inhibition of H 2 S production inhibits hypoxic responses, 3) dele-
tion of cystathionine  γ -lyase, an H 2 S-producing enzyme blunts 
hypoxic hyperventilation, 4) inhibitory effects of H 2 S on chemo-
receptor potassium channels is consistent with hypoxic activation, 
and 5) the transition from O 2 -dependent H 2 S consumption to H 2 S 
production occurs precisely over the physiological Po 2 transition 
from normoxia to hypoxia. H 2 S-mediated O 2 sensing is also sup-
ported by anecdotal evidence including the reciprocal relationship 
between H 2 S and O 2 in the environment, the origin of eukaryotic 
cells from the combination of sulfi de reducing Archaea and sulfi de 
oxidizing  α -protobacteria and by studies that show H 2 S increases 
O 2 consumption in many tissues. Support: NSF IBN0235223, 
IOS0641436 and IOS1051627. 
Brought to you by | University of Queensland - UQ Library
Authenticated
Download Date | 9/21/15 2:40 AM
A12  Advances and Controversies in B-Vitamins and Choline, Leipzig, Germany, March 2012
 INV 32
Mechanisms of H 2 S signalling in hemodialysis 
 *A. F. Perna 1 , Diego Ingrosso 2 
 
1
 First Division of Nephrology, Department of Cardio-thoracic and 
Respiratory Sciences, via Pansini 5, Second University of Naples, 
Faculty of Medicine and Surgery, Naples, Italy 
 
2
 Department of Biochemistry and Biophysics  “ F. Cedrangolo ” , via 
Costantinopoli 16, Second University of Naples, Faculty of Medicine 
and Surgery, Naples, Italy 
 Hydrogen sulfi de, H 2 S, is a gaseous compound involved in a num-
ber of biological responses, e.g. blood pressure, vascular function, 
energy metabolism. In particular, H 2 S is able to lower blood pres-
sure, to protect from injury in models of ischemia-reperfusion, and 
to induce a hypometabolic state. In chronic kidney disease (CKD), 
low plasma hydrogen sulfi de levels have been established in humans 
and in animal models. The enzymes involved in its production are 
cystathionine  β -synthase, cystathionine  γ -lyase, and 3-mercaptopy-
ruvate sulfurtransferase. The mechanisms for H 2 S decrease in CKD 
are related to the reduced gene expression (demonstrated in uremic 
patient blood cells) and decreased protein levels (in tissues such as 
liver, kidney, brain in a chronic kidney disease rat model). It has been 
shown that alterations in this pathway complicate the uremic state 
and are linked to chronic kidney disease progression. It remains to be 
established if low H 2 S is causally linked to CKD progression and if 
interventions aimed to restore the status quo ante are able to modify 
this picture. 
 INV 33
Ribofl avin as a determinant of iron status 
 *H. Powers 1 
 
1
 University of Sheffi eld, Faculty of Medicine, Dentistry and Health, 
Sheffi eld, United Kingdom 
 Background: Ribofl avin, in the form of derivatives fl avin adenine 
dinucleotide (FAD) and fl avin mononucleotide (FMN) is essential 
for many redox reactions in intermediary metabolism. Additionally, 
experimental evidence suggests that the importance to oxidation/
reduction reactions may extend to aspects of iron handling. The rel-
evance of this to human populations is uncertain. 
 Aim: To investigate the effect on haematological status of improving 
ribofl avin status in young women in the United Kingdom. 
 Methods: A randomised placebo controlled trial was conducted in 
women aged 19 to 25 years with biochemical evidence of poor ribo-
fl avin status. Women were randomised to receive 2mg or 4mg ribo-
fl avin, or a placebo, daily, for 8 weeks. Effects of the intervention on 
measures of iron status and iron bioavailability were determined. 
 Results: There was a dose-response improvement in ribofl avin sta-
tus in response to the supplement. Improvement in ribofl avin status 
elicited an increase in hemoglobin and red blood cell number, being 
greatest in those women with poorer ribofl avin status at the outset. 
Women in the lowest tertile for ribofl avin status at baseline showed 
a signifi cantly greater improvement in hemoglobin and red blood 
cell number than women in the highest tertile (P < 0.01) and those 
in the middle tertile (P < 0.05). There was no change in dietary iron 
or ribofl avin during the study. Results could not be explained by an 
improved iron bioavailability but there was a suggestion that the sup-
plement might have enhanced mobilisation of ferritin iron stores. 
 Discussion and Conclusion: Improving ribofl avin status can have 
a benefi cial effect of measures of iron status, independent of dietary 
iron. 
 INV 34
Advances In Cobalamin Research: Targeting 
The Transcobalamin Receptor TCblR/CD320 
 *E. V. Quadros 1 
 
1
 SUNY-Downstate Medical Center, Departments of Medicine/Cell 
Biology/Biochemistry, Brooklyn, New York, United States 
 Background: Cellular uptake of cobalamin (Cbl) is mediated 
by TCblR, a membrane receptor for transcobalamin (TC)-bound 
Cbl. Identifi cation of the gene encoding this protein asCD320has 
enabled us to produce the gene knockout mouse and characterize 
the protein. 
 Aim: Characterize the CD320knockout mouse; Identify structural 
and functional domains of the receptor; study the expression of 
TCblR in various tumor cell lines and use monoclonal antibodies for 
targeted delivery of toxins and drugs to cancer cells 
 Methods: The CD320knockout C57B1/6N mouse was generated 
from 129P2 Ola ES cells. Monoclonal antibodies to the extracel-
lular domain of TCblR were produced using recombinant TCblR 
expressed in HEK293 cells 
 Results: The CD320knockout is not lethal and the mice develop and 
reproduce normally. While serum, liver and kidney B12 is normal, 
Selective depletion of Cbl is seen primarily in the CNS and less so in 
bone marrow and spleen. The Peripheral nerve and spinal cord show 
myelin loss that is a hallmark of human B12 defi ciency. The cell 
cycle associated receptor expression is up regulated in some cancers 
and monoclonal antibodies to the receptor, are effectively interna-
lized by cells. The two LDLR-A domains in the extracellular region 
and the cytoplasmic tail are critical determinants of TC-Cbl binding 
and internalization. 
 Discussion and Conclusions: The CD320knockout mouse with the 
characteristic demyelination is an excellent model to identify path-
ways and genes involved in metabolic disorders contributing to the 
demyelinating pathology and monoclonal antibodies to the external 
domain of the receptor provide a vehicle to deliver cytoxic drugs and 
toxins to cancer cells. 
 INV 35
Genetic and nutritional variation in one-carbon metabolism 
infl uences reproductive outcomes 
 *R. Rozen 1 
 
1
 McGill-Montreal Children ’ s Hospital Research Institute Room 242, 
Montreal, Canada 
 Homocysteine remethylation is an important metabolic reaction 
because it generates methionine and S-adenosylmethionine for 
methylation reactions. It also serves to limit accumulation of homo-
cysteine, a potentially toxic amino acid. The major homocysteine 
remethylation pathway uses 5-methyltetrahydrofolate (synthesized 
by methylenetetrahydrofolate reductase (MTHFR)). An alternate 
pathway uses betaine, derived from choline, as a methyl donor. We 
have been studying reproductive outcomes (including resorptions, 
embryonic delays, and heart defects) in mice with a defi ciency of 
MTHFR (Mthfr + /-) and in mice fed diets that are low in folate 
(7-fold lower) or choline (8-fold lower), compared to the recom-
mended diets for rodents. We have also examined outcomes in mice 
fed high folate diets (20x and 10x higher than recommended) since 
some populations are consuming higher levels of folic acid due to 
food fortifi cation or vitamin supplementation. Our fi ndings suggest 
that diets low in methyl donors, or high in folate, lead to adverse 
reproductive outcomes. In pursuing some of the mechanisms that 
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lead to the complications in methyl defi ciency states, we have iden-
tifi ed changes in some infl ammatory mediators including ApoAI, 
PPAR α , IFN γ and IL-10. Details of these experiments will be 
presented. 
 INV 36
Normal prions as a new target of cobalamin defi ciency in rat 
CNS 
 *G. Scalabrino  1 
 
1
 University of Milan, Citt à Studi Department, Laboratory of 
Neuropathology, Milan, Italy 
 It is known that cobalamin (Cbl) defi ciency damages myelin by 
increasing tumour necrosis factor(TNF)- α and decreasing epider-
mal growth factor(EGF) levels in rat central (CNS) and peripheral 
nervous system (PNS), and that TNF- α and EGF regulate normal 
prion protein (PrP C ) expression. We investigated whether: a) the 
octapeptide repeat (OR)-region of PrP C (which is claimed to be 
myelinotrophic) is involved in the pathogenesis of rat Cbl-defi cient 
(Cbl-D) neuropathy; and b) Cbl defi ciency modifi es PrP C levels of 
spinal cord (SC) and PNS in the rat. We intracerebroventricularly 
administered antibodies against the OR-region (OR-Abs) to Cbl-D 
rats to prevent SC and PNS myelin damage and maximum nerve 
conduction velocity (MNCV) abnormalities, and PrP C s to otherwise 
normal (ON) rats to reproduce Cbl-D-like lesions. The OR-Abs (but 
not when inactivated) normalized myelin ultrastructure and TNF- α 
levels in the SC and peripheral nerves, and MNCV values of Cbl-D 
rats. PrP C levels had increased in SC and peripheral nerves of Cbl-D 
rats by the time myelin lesions appeared. These increases were medi-
ated by excess TNF- α . There were no changes in hepatic PrP C levels 
of Cbl-D rats. Cbl defi ciency greatly reduced SC PrP C -mRNA levels, 
which were subsequently increased by Cbl and EGF, which proved to 
be effective in preventing the typical Cbl-D lesions. The SC and PNS 
of ON-, PrP C -treated rats showed typical Cbl-D lesions, signifi cantly 
increased TNF- α levels, and signifi cantly decreased MNCV values. 
Therefore: a) the number of OR regions in rat CNS and PNS seem 
to be  “ buffered ” by Cbl; b) Cbl defi ciency causes a vicious circle 
between TNF- α and PrP C s in rat CNS and PNS; and c) new PrP C 
synthesis is a common effect of different myelinotrophic agents in 
rat SC. 
 INV 37
Cellular choline metabolism is related to endoplasmic 
reticulum stress in vascular and metabolic diseases 
 *G. Schmitz 1 , S. Wallner 1 , T. Kopf 1 , M. Peer 1 , A. Sigruener 1 , 
E. Orsó 1 
 
1
 University Hospital Regensburg, Institute for Clinical Chemistry 
and Laboratory Medicine, Regenburg , Germany
 Choline is interrelated to folate in one-carbon metabolism serving as 
methyl-donors for homocysteine re-methylation. Polymorphisms in 
choline and folate pathways require folate or choline to balance re-
methylation through the non-affected pathway. Organ specifi c PEMT 
activity determines the pattern of convertible and non-convertible 
PC/PS/PE iso-species and the ER stress response in diabesity. 
Availability of choline or disturbed incorporation in phospholipids 
are critical determinants of hyperhomocysteinemia. Disruption of the 
choline-phospholipid axis leads to the formation of acyl-glycerols 
and affects lipid storage as a hallmark of fatty liver diseases. A fruc-
tose-fed rat model revealed that the fenofi brate induced increase in 
homocysteine may refl ect a  “ choline stealing ” phenomenon due to 
channeling of choline towards PC metabolism rather than methyl-
group donation. In response to HDL3 macrophages up-regulate their 
 “ convertible ” PC species 36:1, 36:4 and 38:4 and  “ non-convertible ” 
PC 36:5 and 38:6 in parallel with the down-regulation of all other 
 “ non-convertible ” PC-species. We tested the in vivo response of 
blood monocytes to an oral fat load. Control and metabolic syn-
drome patients showed either an increase or unchanged levels of all 
 “ convertible ” PC species. Among the  “ non-convertible ” PC species 
only 34:0 was upregulated in control subjects, while most PC species 
were stable or showed a downregulation (32:0, 36:3). Under these 
conditions the integration of ER-stress (metabolic overload, cancer) 
oxidative stress (ROS, glutathione) and the chronic infl ammatory 
response (CRP, NF κ B) in the elderly is critical to the pathogenesis of 
vascular- and metabolic disease as well as cancer. 
 INV 38
Renal function determines response to B-vitamin therapy for 
homocysteine 
 *J. D. Spence 1 
 
1
 Robarts Research Institute, University of Western Ontario, Stroke 
Prevention & Atherosclerosis Prevention Centre, Canada 
 Background: B-vitamin therapy to lower homocysteine has been 
thought to be ineffective in reducing cardiovascular risk. However, 
interpretation of clinical trial results has not adequately taken account 
of the role of renal function. 
 Aim: To interpret clinical trial results in the light of new evidence 
that B-vitamin therapy is harmful in patients with impaired renal 
function. 
 Methods: Contrasting benefi cial effect of B-vitamin therapy in the 
VISP effi cacy analysis, from which patients with renal impairment 
were excluded, with those of the DIVINe study, in patients with dia-
betic nephropathy. 
 Results: In the VISP effi cacy analysis, from which patients with 
GFR in the lowest 10 % ( < 50). 
 Discussion and Conclusion: Increased production of asymmetric 
dimethylarginine, an antagonist of NO, and accumulation of cyanide 
from cyanocobalamin (leading to consumption of hydrogen sulfi de 
(an endothelium-derived relaxing factor) may explain the harm-
ful effects of B-vitamins in renal failure. To lower tHcy in patients 
with renal failure it will be better to use methylcobalamin and more 
intensive dialysis; thiols such as mesna are also being studied in this 
group. 
 INV 39
Choline - containing phospholipids on brain functional 
pathways 
 *S. K. Tayebati  1 , F. Amenta 1 
 
1
 Universit à di Camerino, Scienze del Farmaco e dei Prodotti della 
Salute, Camerino, Italy 
 Choline (Ch) is involved in relevant neurochemical processes. It is 
the precursor and metabolite of acetylcholine (ACh). It plays a role in 
single-carbon metabolism and is an essential component of different 
membrane phospholipids (PLs). These PLs are structural components 
of cell membranes, and involved in intraneuronal signal transduc-
tion. An increased ACh release was found after Ch treatment in rat 
corpus striatum slices. An in vivo proton magnetic resonance study 
has analyzed Ch ingestion effect. This work which represents the fi rst 
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non invasive study for exploringin vivohuman brain neurochemistry 
showed the transfer of an oral Ch load in the brain of normal volun-
teers. These results were not confi rmed by otherin vivostudies. Cellular 
membranes breakdown is suggested as a feature of neurodegeneration 
in acute (stroke) and chronic (Alzheimer ’ s and vascular dementias) 
brain disorders. The effects of exogenous CCPLs on different brain 
areas were largely studied. Our group has assessed the infl uence of 
treatment with the CCPL, choline alphoscerate (GPC) on brain cholin-
ergic neurotransmission markers in an animal model of brain vascular 
injury. A neuroprotective effect of GPC alone or in association with 
acetylcholinesterase inhibitor, galantamine was found. These results 
suggest that GPC could stimulate the expression of vesicular ACh 
transporter and Ch transporter primarily in areas involved in cognitive 
processes. These cholinergic markers could represent an appropriate 
mean to investigate brain cholinergic pathways. In the lack of novel 
therapeutic strategies, safe compounds developed since a long time 
such as the CCPLs could have still a place in pharmacotherapy and 
would merit to be investigated by new clinical studies. 
 INV 40
Choline as a treatment for fetal alcohol spectrum disorders 
 *J. Thomas 1 
 
1
 San Diego State University, Department of Psychology, Center for 
Behavioral Teratology, San Diego, United States 
 Background: Children exposed to alcohol prenatally may suffer 
from a range of physical, neurological, and behavioral alterations, 
referred to as fetal alcohol spectrum disorders (FASD). Identifi cation 
of effective treatments for FASD is critical. 
 Aim: Using an animal model, we have been investigating the ability 
of choline, an essential nutrient, to reduce the severity of FASD. 
 Methods: Rats were exposed to alcohol during development and the 
effects of choline administration on physical, behavioral, and neural 
development were evaluated. 
 Results: Choline supplementation during prenatal alcohol exposure 
reduces alcohol-related birth weight defi cits and alterations in motor 
and cognitive development. However, even if administered post-
natally, choline reduces the severity of alcohol-induced defi cits on 
cognitive tasks that depend on the functional integrity of the hip-
pocampus and/or prefrontal cortex. Moreover, choline attenuates 
alcohol-related alterations in hippocampal cholinergic receptors, and 
alters alcohol ’ s effects on global DNA methylation. 
 Discussion and Conclusion: Choline supplementation can mitigate 
alcohol ’ s teratogenic effects on behavioral development, likely act-
ing, in part, by altering cholinergic functioning and epigenetic mech-
anisms. These data have important implications for individuals with 
FASD and suggest that dietary interventions may reduce the severity 
of some prenatal alcohol effects, even when administered postna-
tally. Supported by AA12446 & 014811. 
 INV 41
Disturbance of thiamine metabolism in diabetes and 
the development and treatment of diabetic vascular 
complications 
 *P. J. Thornalley 1 
 
1
 University of Warwick, Clinical Sciences Research Institute, 
Coventry, United Kingdom 
 Background: Thiamine (vitamin B 1 ) is an essential micronutrient 
required for health. Converted to thiamine pyrophosphate, it is the 
cofactor for enzymes pyruvate dehydrogenase, alpha-ketoglutarate 
dehydrogenase and transketolase. 
 Aim: Studies have been performed over the past 10 years to char-
acterize the mishandling of thiamine in experimental and clinical 
diabetes and evaluate the effect of thiamine supplements on the 
development of vascular complications. 
 Methods: Experimental studies employed cell cultures in low and 
high glucose concentrations and streptozotocin-induced diabetic 
rats with maintenance insulin therapy to moderate diabetes. Clinical 
studies have involved cross-sectional observational studies and ran-
domized, double-blind intervention trials. 
 Results: There is increased renal clearance of thiamine in experi-
mental and clinical diabetes linked to decreased re-uptake of thia-
mine in the proximal tubules in diabetes associated with decreased 
expression of thiamine transporter proteins in the proximal tubular 
epithelium. Similar impaired re-uptake and retention of thiamine in 
diabetes is present in the retina and peripheral nerve. It is improved 
but not corrected by intensive glycaemic control. Thiamine supple-
mentation prevented the development of diabetic nephropathy in 
experimental diabetes and reversed early stage diabetic nephrop-
athy in patients with type 2 diabetes in two clinical intervention 
studies. 
 Discussion and Conclusion: Tissue-specifi c mishandling of thia-
mine in diabetes occurs at sites of development of vascular com-
plications and may predispose to vascular disease and thiamine 
supplements prevent and reverse early stage vascular complications 
of diabetes. 
 INV 42
Mechanisms of Neurological complications in HHCY 
 *A. Troen 1 
 
1
 The Hebrew University of Jerusalem, Institute of Biochemistry, 
Food Science and Nutrition, Rehovot, Israel 
 The basis for association of elevated plasma total homocysteine 
with neurological dysfunction has been explored in a wide vari-
ety of cellular and animal models. These studies demonstrate that 
experimental exposure to homocysteine and/or perturbation of 
homocysteine metabolism and its associated pathways can induce 
a remarkable range of molecular, cellular and neurological abnor-
malities. These abnormalities include changes in processes that 
may contribute to chronic neurodegenerative and cerebrovascular 
disease (vascular dysfunction, infl ammation and oxidative stress, 
abnormal NO signaling, etc.), as well as some that are specifi cally 
involved in Alzheimer ’ s disease (such as enhanced amyloidogen-
esis and tau phosphorylation). While most studies report on the 
harmful effects of exposure, few studies have indicated that dam-
age can be reversed. Nevertheless, the diversity of hypothetical 
mechanisms provides a similar diversity of non-exclusive, potential 
therapeutic targets. However, the validity and generalizability of the 
experimental models and their hypothetical mechanisms to human 
neurological dysfunction remains uncertain. Part of the problem 
lies in defi ning the nature of the relevant exposure. Elevated homo-
cysteine in humans is a non-specifi c biomarker for perturbed metab-
olism which can be caused by discrete or overlapping nutritional 
defi ciencies, genetic abnormalities, or endocrine and pathological 
conditions. Although homocysteine may be intrinsically cytotoxic, 
different metabolic disturbances upstream of hyperhomocysteine-
mia can have different neurological effects. Thus different models 
of experimental homocysteinemia can lead to different neurologi-
cal outcomes. Furthermore, the generalizability of fi ndings and 
postulated mechanisms in these models may be constrained by the 
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method of inducing homocysteinemia; the timing and duration of 
exposure; age, sex, genetic background, and co-existing physiologi-
cal or pathological phenotypes. In this respect, the experimental data 
mirrors the inconsistent associations observed in the epidemiologi-
cal literature between homocysteine, folate and vitamin B12 with 
different cognitive domains and neuropatholgical outcomes. Indeed 
the inconsistent results from randomized controlled clinical trials 
of B-vitamin therapy for homocysteine lowering and neuroprotec-
tion, show that homocysteine lowering alone may be insuffi cient 
to yield therapeutic benefi t, leaving open the question of homo-
cysteine ’ s role in neurological disease. Better differentiation of 
the metabolic and pathologic mechanisms linking homocysteine to 
neurological dysfunctions in humans will be important to improve 
future interventions. 
 INV 43
Homocysteine mediated decrease in bone blood fl ow and 
remodeling: Role of Folic Acid 
 *N. Tyagi  1 
 
1
 University of Louisville, Department of Physiology and Biophysics, 
Louisville, Kentucky, United States 
 Background: Homocysteine (Hcy) is a non-essential sulfur-con-
taining amino acid. Defi ciency in cystathionine- β -synthase, (CBS) 
enzyme lead to increased serum concentrations of Hcy, which is 
known as hyperhomocysteinemia (HHcy), is associated with bone 
disorders. Although, Hcy accumulates collagen in bone and contrib-
ute to decrease in bone strength. The mechanism of Hcy induced 
bone disorders and remodeling is unclear. 
 Material and Methods: Wild type (WT) and cystathionine- β -
synthase heterozygous (CBS + / – , genetically HHcy) mice were 
used in this study and supplemented with or without FA (300 mg/
kg, Hcy reducing agent) in drinking water for 6 weeks. The tibial 
bone blood fl ow was measured by laser Doppler and ultrasonic fl ow 
probe method. The tibial bone density (BD) was assessed by dual 
energy X-ray absorptiometry. The bone homogenates were analyzed 
for oxidative stress, NOX-4 as oxidative marker and thioredoxin-1 
(Trx-1) as anti-oxidant marker, bone remodeling (MMP-9) and 
bio-availability of nitric oxide (eNOS/iNOS/NO) by Western blot 
method. 
 Results: The results suggested that there was decrease in tibial 
blood fl ow in CBS + / – mice. The BD was also reduced in CBS + / – 
mice. There was an increase in NOX-4, iNOS, MMP-9 protein as 
well as MMP-9 activity in CBS + / – mice and decrease in Trx-1, 
eNOS protein levels, in part by decreasing NO bio-availability 
in CBS + / – mice. Interestingly, these effects were ameliorated by 
FA. 
 Conclusions: The results of the present study suggest that FA supple-
mentation may have therapeutic potential against genetically HHcy 
induced bone loss 
 INV 44
Diet as source of methyl donors nutrients: from raw to 
 “ ready-to-eat ” foods 
 *G. Varela Moreiras 1 
 
1
 Universidad CEU San Pablo, Urb. Montepr í ncipe, Madrid, Spain 
 By defi nition, a methyl donor is a substance capable of donat-
ing a methyl group. Dietary methyl groups derive from foods 
that contain methionine, one-carbon units and choline or betaine. 
Transmethylation metabolic pathways closely interconnect choline, 
methionine, methyltetrahydrofolate (methyl-THF) and vitamins 
B-6 and B-12. Many important biochemical processes and healthy/
unhealthy situations may rely on methylation capacity, although the 
research in this area is still emerging. The pathways intersect at the 
formation of methionine from homocysteine. Perturbing the metabo-
lism of one of these pathways results in compensatory changes in the 
others. There may also be of value dietary measures that integrate 
all these nutrients,  “ methylation capacity ” . Different scenarios are 
approached at the presentation. 
 To promote methyl donor nutrients intake from food sources is a 
healthy strategy taking into account that chronic excessive intakes 
through fortifi ed food products or supplements may be harmful in 
some populations groups. Recently, an expansion of the consump-
tion of ready-to-eat foods constitutes an important portion of the 
diet resulting in an increasing concern about their nutrient density. 
Accordingly, the nutritional composition should be well known to 
estimate its contribution. This presentation confi rms the increased 
consumption of ready-to-eat products in Europe, showing the impor-
tance of giving data about their nutritional composition. In addition, 
the  “ worldwide map of methyl-nutrients fortifi cation ” will be ana-
lyzed. An important question also to be addressed is how much is too 
much ? Finally, the  “ risk/benefi t ” dilemma is also considered in the 
 “ new ” methyl-donors fortifi ed world. 
 INV 45
Molecular mechanisms of homocysteine effects on bone 
cells 
 *E. Paschalis 1 
 
1
 Hanusch Hospital, Ludwig Boltzmann Institute of Osteology, 
Vienna, Austria 
 Elevated homocysteine (Hcys) serum levels are reported to be a 
risk factor for several chronic disorders such as cardiovascular 
disease, atherosclerosis, chronic renal failure, diabetes, and meta-
bolic syndrome. Moreover, hyperhomo-cysteinemia is known to 
affect bone development and homeostasis. Biochemically, Hcys 
inhibits lysyl oxidase (LOX), the enzyme responsible for col-
lagen cross-linking and affects, thereby, bone quality, amongst 
other effects. 
 The aim of the present study was to elucidate whether Hcys affects 
proliferation and differentiation of osteoblastic cells as well as their 
matrix synthesis. 
 MC3T3-E1 preosteoblastic cells were treated with Hcys up to 21 
days. Gene expression was analyzed by RT-PCR, gene chips and 
immune-blots. CpG methylation of Fasand Loxgene promoters was 
determined. Changes in collagen cross-linking were measured by 
Fourier Transform Infra Red spectroscopy. 
 The results indicate that Hcys affects proliferation of MC3T3-E1 cells 
and differentiation by up-regulation of Run x2 and genes modulating 
RUNX2 function. Most interestingly, Hcys down regulated expres-
sion of LOX by CpG methylation of its promoter DNA via interleu-
kin-6 that up regulated DNA-(cytosine-5)-methyltransferase-1, the 
enzyme responsible for epigenetic DNA methylation. 
 Down-regulation of LOX resulted in changes of collagen cross-link-
ing and partial denaturation of collagen triple helices, as expected, by 
unlocking the RGD-motif. This resulted in up-regulation of SAA3, 
an acute phase protein related to chronic pathologies, and MMP13, a 
protease known to induce bone resorption. 
 The data of the present study suggest that hyperhomocysteinemia 
affects bone quality by down-regulation LOX and the development 
of degenerative skeletal diseases by up-regulation of SAA3. 
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 INV 46
Exploring the genetics of choline metabolism: Unexpected 
observations 
 *S. Zeisel 1 
 
1
 University of North Carolina at Chapel Hill, Nutrition Research 
Institute, Kannapolis, United States 
 Choline is known to be important for methyl donation, membrane 
synthesis and for neurotransmission. Humans eating diets low in 
this nutrient develop liver and muscle dysfunction. In addition, dur-
ing pregnancy choline is important for normal fetal development. 
While conducting studies in humans it became apparent that poly-
morphisms in genes of choline and folate metabolism modulated 
the dietary requirements for choline. For this reason we conducted 
studies to help us to understand the importance of these genes. 
Phosphatidylethanolamine-N-methyltransferase (PEMT) is induced 
by estrogen, and for this reason young women have a decreased 
dietary need for choline because they use this enzyme to endoge-
nously produce phosphatidylcholine, a source of choline. We iden-
tifi ed a very common single nucleotide polymorphism (SNP) in 
this gene that abrogates estrogen induction of the gene and thereby 
increases dietary requirements for choline. Pemtknockout mice have 
diminished docosahexaenoic acid in membrane phosphatidylcholine, 
have excessS-adenosylmethionine and have increased DNA methy-
lation with increased neurogenesis. Choline dehydrogenase (CHDH) 
forms betaine from choline. Chdhknockout mice have mitochondrial 
dysfunction, decreased ATP synthesis, and sperm motility abnor-
malities. Humans with a functional SNP inCHDHalso have abnor-
mal mitochondrial and low ATP in sperm. Betaine homocysteine 
methyltransferase (BHMT) uses the methyl group of betaine to form 
methionine from homocysteine. Bhmtknockout mice have fatty liver, 
decreased fat mass, increased glucose oxidation, increased insulin 
sensitivity, and develop liver cancers. These studies in mice suggest 
that choline has a role in energy metabolism that is unexpected. 
 This work was support by grants from the NIH (DK55865 and 
DK36530) 
 ORAL PRESENTATIONS 
Vitamin B12 physiology 
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Haptocorrin  – The key to vitamin B12 dependent tumour 
targeting ? 
 *E. Furger 1 , D. Frei 2 , R. Waibel 1 , R. Schibli 1 , A. Prota 2 , E. Fischer 1 
 
1
 Paul Scherrer Institut, Center for Radiopharmaceutical Sciences, 
Villigen, Switzerland 
 
2
 Paul Scherrer Institut, Biomolecular Research, Villigen, 
Switzerland 
 Background: In the human blood stream vitamin B12 (Cbl) is trans-
ported by Haptocorrin (HC) and transcobalamin (TC). In contrast to 
TC, the physiological function of HC is largely unknown. Recently, 
we could show that a radio-labelled, HC-selective Cbl-derivative 
(Tc-99m-Cbl(PAMA4) homes for tumours. 
 Aim: To explore the potential of HC-binding drugs as tools for 
tumour targeting and treatment. 
 Methods: We established two HC expressing mouse models of 
human cancer. Mice were injected with Tc-99m-Cbl(PAMA4) and 
imaged with SPECT/CT. Accumulation in tumors and organs was 
quantifi ed by  ex vivo biodistribution studies. 
 We established the recombinant expression and purifi cation of HC 
(rhHC) in HEK293 cells. The structure of rhHC was solved with 
molecular replacement and refi ned to a resolution of 2.6 Å . 
 Binding of Tc-99m-Cbl(PAMA4) was monitored by spectral analysis 
and gel shift assays. 
 Results: rhHC was expressed and purifi ed to  > 99  % purity. 
Crystallisation lead to structure determination of rhHC in complex 
with Cbl. 
 Biodistribution studies showed specifi c accumulation of Tc-99m-
Cbl(PAMA4) in mouse models of human cancer. Compared to 
reported Cbl-derivatives, uptake of Tc-99m-Cbl(PAMA4) in non-
targeted organs and tissue was low. 
 Discussion and Conclusion: We demonstrated that HC-selective 
ligands specifi cally accumulate in HC-expressing tumours. In addi-
tion, we identifi ed structural features of HC that account for ligand 
selectivity and can be exploited for future drug design. 
 WS1 02
Clinical and biochemical assessment of high serum vitamin 
B12 levels 
 *J. F. B. Arendt 1 , E. Nexo 1 
 
1
 Aarhus University Hospital, Department of Clinical Biochemistry, 
Aarhus, Denmark 
 Introduction: Measurement of serum cobalamin (Cbl) is routinely 
used to assess suspected Cbl defi ciency. Surprisingly, 15 % of all 
samples analysed for serum Cbl show values above the reference 
range of 200-600 pmol/L. 
 Aim: We hypothesized that increased Cbl levels are caused by altera-
tions in the circulating Cbl binding proteins haptocorrin (HC) and/
or transcobalamin (TC), and that such changes may be of clinical 
importance. 
 Materials and methods: We collected 834 blood samples from 
hospital treated patients with serum Cbl levels:  < 200, 200-600, 
601-1000 and  > 1000 pmol/L. In-house ELISAs were used for 
measurement of HC and TC. Data on diagnoses and medication 
was obtained from the electronic patient medical chart in the 
Region of Central Denmark and the Aarhus University Prescription 
Database. 
 Results: In 38 % of patients, high Cbl levels were attributable to Cbl 
supplementation. Among non-treated patients higher HC levels were 
associated with higher Cbl levels, while TC levels were within refer-
ence range for all Cbl levels. Signifi cantly higher proportions were 
found for diagnoses of alcoholism, liver disease, cancer and non-
malignant bronchopulmonary disease when comparing non-treated 
patients with both high HC and high Cbl levels and patients with high 
HC levels and normal/low Cbl levels. 
 Conclusion: Unexplained high Cbl levels are mostly due to high 
HC levels and several diagnoses may be important to consider when 
patients show high Cbl levels. 
 WS1 03
Effi cacy of treatment options in vitamin B12 defi ciency 
 *B. Hokin 1 
 
1
 Sydney Adventist Hospital Pathology, Pathology, Wahroonga, 
Australia 
 Method: Informed consenting vegetarian subjects (n = 122), not tak-
ing vitamin supplements, with vitamin B12 defi ciency were recruited 
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for the study. Each participant had blood taken for a full blood 
count, twenty-test biochemistry screen, and serum vitamin B12 and 
homocysteine levels. A validated wellbeing questionnaire was also 
administered. 
 Participants were assigned to one of six age and gender matched 
groups: 
 Controls who received a placebo; 
 Low-dose tablets (2 ug vitamin B12/day) 
 High dose tablets (50 ug vitamin B12 once/week) 
 Vitamin B12 fortifi ed Soy beverage (containing 2 ug vitamin B12/
day) 
 Meat substitute containing 0.6 or 0.8 ug vitamin B12/day) 
 IM injection (100 ug vitamin B12/month) 
 Participants received treatment for three months. After a four -week 
equilibration period, participants were again tested for serum vitamin 
B12 and homocysteine levels and the Wellbeing questionnaire was 
again administered. 
 Results:  
 Control  IM 
Injection 
 Lodose 
tablet 
 Hi dose 
tablet 
 Fortifi ed 
Meat 
substitute 
 Fortifi ed 
soymilk 
alternative 
 Dose B12 
received 
Nil 100 ug/
month
2 ug/
day
50 ug/
week
0.8 ug/
day
2 ug/day
 Total B12/month Nil 100 60 50 24 60
 Mean  % increase 
in serum B12 
-2.3  + 21  + 18.7  + 12.7  + 5.7  + 31.7
 P value 0.18 0.0009 0.03 0.003 0.24  < 0.0001
 Mean  % decrease 
in homocysteine 
-4.2 -3.6 -3.8 -11.0 -5.6 -16.9
 P value 0.07 0.11 0.008 0.003 0.09 0.0007
 Initial wellness 
score 
84 79 87 80 78 80
 Final wellness 
score 
88 83 95 86 81 86
 P value 0.23 0.11 0.009 0.0002 0.18 0.01
 Conclusions: Vitamin B12 fortifi ed soy milk alternative is effective 
in treatment of vitamin B12 defi ciency. 
 Daily low-dose tablets are more effective than weekly high-dose tab-
lets. There is an inverse relationship between vitamin B12 levels and 
homocysteine (body reserves). People  ‘ feel better ’ after treatment 
with vitamin B12. 
 WS1 04
Repression signaling pathways of  MDR-1 gene : A link 
between vitamin B12 and chemotherapy ? 
 *E. Gkikopoulou 1 , V. Marguerite 1 , J.-L. Gu é ant 1 , M. Merten 1 
 
1
 Inserm U954, Facult é de M é decine, Vandoeuvre les Nancy, 
France 
 Background: A key factor of chemioresistance is an increased 
expression of  MDR-1 gene, partly controlled by cellular methy-
lation reactions. Until now, the physiology of these reactions is 
not clearly known. The main intracellular metabolic pathway, 
generating methyl donors, is the methionine cycle, the activity 
of which is strongly depending on B-group vitamins (B12, B9). 
Thus,  MDR-1 gene expression may be controlled by the activ-
ity of the methionine cycle and consequently presence of these 
vitamins. 
 Aim: The aim of this study is to determine if, and to elucidate how, 
the methionine cycle infl uences the  MDR-1 gene expression. 
 Methods: Chromatography, pharmacotoxicology, gene and protein 
expression studies have been used on the human hepatocarcinoma 
cell line HepG2. 
 Results: We showed that cobalamin induces a dose-dependent 
repression of  MDR-1 gene expression. However, this is not linked 
to changes in the methylation profi le of its promoter but in meth-
ylation of membrane phospholipids. Furthermore, we showed 
that  MDR-1 cobalamin-induced repression was associated with 
phospholipase D activation, Akt phosphorylation, and Cox-2 
co-repression. 
 Discussion/Conclusion: We show for the fi rst time a link between 
a cobalamin-sensitive activity of the methionine cycle and repres-
sion of  MDR-1 gene. This includes a pathway involving phos-
pholipase D and Akt activation as well as Cox-2 repression. This 
also suggests that patients ’ vitamin status should be taken into 
account as it might infl uence their sensitivity to chemotherapy. 
Furthermore, the involved intracellular pathways might be poten-
tial targets in order to potentialize current, or develop new, anti-
cancerous therapies. 
 WS1 05
Responsiveness of urinary methylmalonic acid 
and other B 12 biomarkers to oral supplements of 
vitamin B 12 
 *M. Hill 1 , M. Barker 1 , J. Flatley 1 , C. Garner 1 , S. Moat 2 , S. Olpin 3 , N. 
Manning 3 , H. Powers 1 
 
1
 University of Sheffi eld, Faculty of Medicine, Dentistry and Health, 
Sheffi eld, United Kingdom 
 
2
 University Hospital of Wales, Clinical Biochemistry and Clinical 
Immunology, Cardiff, United Kingdom 
 
3
 Sheffi eld Children ’ s Hospital, Clinical Chemistry, Sheffi eld, United 
Kingdom 
 Background: There is a consensus of opinion that plasma B 12 is 
lacking as a marker of vitamin B 12 status. Although alternative 
biomarkers have received attention urinary methylmalonic acid 
(uMMA) has been neglected. 
 Aim: A study was conducted to determine the responsiveness of 
uMMA and conventional biomarkers of B 12 status, to graded oral 
supplements of vitamin B 12 , in a healthy elderly population. 
 Methods: A double-blind, placebo-controlled, randomized trial was 
carried out in 100 men and women aged 65 to 86 years, with gener-
ally poor B 12 status. Treatment groups were placebo, 10 μ g, 100 μ g 
or 500  μ g B 12 daily for 8 weeks. Fasted urine samples were col-
lected at baseline and every two weeks, for measurement of uMMA 
and creatinine, and blood samples were collected at baseline and 
after 56 days, for measurement of plasma B 12 and MMA and serum 
holotranscobalamin (holoTC). 
 Results: Response in urinary and plasma MMA varied by smoking 
habit. For ever-smokers, urinary and plasma MMA decreased sig-
nifi cantly in the 10ug group with no further improvement at higher 
doses, whereas for never-smokers a signifi cant response was only 
observed in the 500ug group. Both plasma B 12 and serum holoTC 
increased in response to 10 μ g B 12 and showed a further increase 
with 500 μ g B 12 . Even after receiving 500 μ g B 12 for 8 weeks, 
8 % and 12 % of people had plasma B 12  < 200pmol/L and serum 
holoTC  < 37 pmol/L, respectively; 24 % and 16 % of people had 
plasma MMA  > 0.37pmol/L and uMMA  > 2.0  μ mol/mmol creati-
nine, respectively. 
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 Discussion and conclusions: Whilst 10  μ g of B 12 can increase 
circulating B 12 and holoTC in an elderly population with moderate 
B 12 defi ciency, higher doses are required to correct metabolic defi -
ciency. The effects of smoking habit need further consideration. 
 WS1 06
Bioavailability of Vitamin B12 in fi sh roe; Characterization of 
a rainbow trout enzyme-resistant B12-binder 
 *E. Greibe 1 , J. Miller 2 , R. Green 2 , E. Nexo 1 
 
1
 Aarhus University Hospital, Department of Clinical Biochemistry, 
Aarhus, Denmark 
 
2
 UC Davis Medical Center, Department of Pathology and Laboratory 
Medicine, Sacramento, United States 
 Background: Though seafood is considered a rich source of vitamin 
B12, little is known concerning the bioavailability of this vitamin in 
seafood. 
 Aim: To explore the bioavailability of vitamin B12 in rainbow trout 
roe and to characterize any B12 binding proteins in the roe. 
 Method: We administered 1 pmol 57Co-labelled B12 (57Co-
B12) - either free or completely bound to human recombinant 
haptocorrin (rhHC) or rainbow trout B12 binding protein - orally 
to rats, and 57Co-B12 in the feces was measured. Homogenized 
trout roe was incubated with 57Co-B12 and characterized with 
regard to B12 binding capacity, affi nity and glycosylation. The 
protein was purifi ed from roe fl uid by affi nity chromatography on 
B12-coupled sepharose. Protein stability at low pH and against 
treatment with increasing conc. of chymotrypsin and trypsin was 
investigated. 
 Results: Absorption studies in rats showed that 63 % , 27 % and 26 % 
of the orally administered 57Co-B12 was excreted in feces when 
bound to trout B12-binder, human rhHC or unbound, respectively. 
This indicates a poor bioavailability for B12 bound to trout binder. 
Characterization of the B12-binder from trout roe suggests a glyco-
protein with high resemblance to human HC and IF. In accord with 
the known properties of HC, the protein is stable at pH 2 and has 
binding affi nity for cobinamide, but like IF the protein resists degra-
dation by chymotrypsin or trypsin. 
 Conclusion: We observed poor bioavailability of vitamin B12 pres-
ent in rainbow trout roe fl uid, most likely caused by the presence of 
an enzyme-resistant B12 binding protein. Our results warrant fur-
ther studies on bioavailability of vitamin B12 in seafood. 
 B-vitamins and choline in neuropsychiatric 
disorders 
 WS2 01
Evidence of abnormal folate metabolism, RFC1 
polymorphism, and DNA hypomethylation in mothers of 
children with autism 
 *J. James 1 , S. Melnyk 1 
 
1
 University of Arkansas for Medical Sciences, Pediatrics, Little 
Rock, Arkansas, United States 
 Objectives: To measure plasma transmethylation metabolites and 
DNA methylation status in a local cohort of autism and control moth-
ers and to determine the frequency of folate-relevant polymorphisms 
in DNA from 530 case-parent triads and 560 controls obtained from 
the NIMH repository. 
 Methods: Fasting plasma samples from 58 local autism mothers 
and 80 matched control mothers were analyzed for folate, methi-
onine, S-adenosylmethionine, S-adenosylhomocysteine, adenosine, 
and homocysteine by HPLC- EC. Genome-wide DNA methylation 
(as  % 5-methylcytosine) was measured by LC/mass spectrometry. 
Candidate genes included MTHFR C677T, MTHFR A1298C, MTRR 
A66G, TCII C776G, and RFC1 A80G. 
 Results: Maternal DNA from the autism mothers was signifi -
cantly hypomethylated and plasma homocysteine, adenosine, and 
S-adenosylhomocysteine were signifi cantly elevated among autism 
mothers. In the case-control analysis of over 2100 repository DNA 
samples, the RFC1 G allele frequency was increased among case 
mothers, but not among fathers or affected children. Log linear 
analysis of the RFC1 A80G genotype within family trios revealed 
that the maternal G allele was associated with a signifi cant increase 
in risk of autism whereas the inherited genotype of the child was 
not. Plasma folate levels were signifi cantly reduced among the local 
autism mothers. 
 Conclusions: Taken together, these results support a broader para-
digm of autism gene-environment interaction that encompasses the 
mother as a genetic/epigenetic case as well as a fetal environmental 
factor. Inclusion of maternal genetic/epigenetics in the autism gene-
environment paradigm could provide new insights into the etiology 
of this complex disorder. 
WS2 02 – WITHDRAWN 
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Vitamin B12 And Folate Intake, Homocysteine Levels And 
Their Association With Cognitive Functioning In Dutch 
Elderly People 
J. P. van Wijngaarden1, *R. Dhonukshe-Rutten1, E. M. Brouwer-Brolsma1, 
N. M. van Schoor2, N. van der Velde3, K. Swart2, A. W. Enneman3, S. C. 
van Dijk3, A. G. Uitterlinden3, P. Lips2, C. P. G. deGroot1
1Wageningen University, Human Nutrition, Wageningen, 
Netherlands
2Erasmus MC, Rotterdam, Netherlands
3EMGO institute, VUmc, Amsterdam, Netherlands 
Background:  Elevated plasma homocysteine (Hcy) levels have 
been reported as a possible risk factor for cognitive decline in com-
munity-dwelling elderly people. Vitamin B12 and folate play an 
important role in Hcy metabolism. Our B-PROOF[1]study provides 
the unique opportunity to study these associations in a large study 
population in which cognitive functioning was assessed through a 
battery of tests. 
Aim:  To evaluate the cross-sectional association of vitamin B12 and 
folate intake and Hcy levels with cognitive function in Dutch elderly 
(N   =   2855) who participate in the B-PROOF study. 
Methods:  Our subjects had a mean age of 74.1 yr (SD 6.5), 50 
% female, and median of 14.4   µ mol/L (IQR 13.0-16.6). Vitamin 
B12 and folate intake was measured with a validated Food 
Frequency Questionnaire. Cognitive functioning was assessed 
with the Mini-Mental State Examination (MMSE) and six specific 
cognitive tests. The results of these tests were combined into four 
cognitive domains; Attention and Working Memory, Information 
Processing Speed, Executive Function and Episodic Memory, 
using compound Z-scores. Multiple Linear Regression analysis 
was performed to examine the association of vitamin B12 and 
folate intake and plasma Hcy levels with cognitive domains 
(n = 856). The association of Hcy levels with global cognitive 
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functioning (MMSE) was calculated with Poisson-regression 
analysis (n = 2855). 
Results: Hcy levels are inversely associated with cognitive function-
ing in the domains ‘Information Processing Speed’ (β = −0.018, p 
= 0.01) and ‘Episodic Memory’ (β = −0.09, p = 0.02). This would 
imply that if the Hcy level would be 10   µ mol/l higher, the par-
ticipants would translate 2 symbols less in 90 seconds, need 3 more 
seconds to connect 25 numbers and recall 0.2 words less out of 15 
words. Participants in the highest Hcy quartile (>16.5 µ mol/l) score 
11 % lower on the MMSE test (Rate Ratio 1.11, p = 0.04) than par-
ticipants in the lowest quartile (12–13 µ mol/l). Associations were 
adjusted for sex, age, education, smoking, alcohol intake and depres-
sion. We did not observe an association between folate or vitamin 
B12 intake and cognitive function (p > 0.05). 
Discussion and Conclusions: We observed a modest inverse asso-
ciation of plasma Hcy levels with cognitive function in a Dutch 
population of elderly people. Vitamin B12 and folate intake were not 
associated with cognitive function. 
[1] B-Proof is an acronym for B-vitamins for the prevention of os-
teoporotic fractures 
 WS2 03
Folic acid effi cacy as an alternative drug added to 
sodium valproate in the treatment of acute phase of 
mania in bipolar disorder: a double-blind randomized 
controlled trial 
 *A. Heshmatzadeh Behzadi 1 
 
1
 Tehran University Of Medical sciences, Psychiatry, Tehran, Iran, 
Islamic Republic of Iran 
 Objective : The purpose of this study was to evaluate the effi cacy of 
using folic acid as an adjuvant therapy with sodium valproate in the 
manic phase of patients with bipolar disorder, in comparison with a 
control group treated with sodium valproate and a placebo. 
 Material and Methods: Following a double-blind randomized con-
trolled trial, 88 clinically manic patients with diagnosis of type I 
bipolar disorder (BID) were divided randomly into two groups (case 
and control). The case group was treated with folic acid and sodium 
valproate and the control group with sodium valproate and placebo. 
The severity of mania was assessed using the Young Mania Rating 
Scale (YMRS) at the beginning and end of the fi rst, second and third 
weeks of the study. 
 Results: Eighty-eight patients with BID (mean age 35.0  ± 8.4 years, 
M/F 1.4) were randomly divided into two groups. The two groups 
were similar regarding their age (P  = 0.31), gender (P  = 0.45), mean 
dosage of sodium valproate (1180  ± 240 mg vs. 1300  ± 300 mg, P  = 
0.68) and the initial YMRS scores (P  = 0.74). From 44 patients in 
each group, 41 (93.2 % ) patients in the case group and 43 (97.7 % ) 
patients in the control group fi nished the protocol successfully.
The case group’s mean manic YMRS measurements (SD) before 
the initiation of therapy and in the fi rst, second and third weeks 
of treatment were 34.0  ± 7.7, 26.7  ± 2.1, 18.1  ± 2.1 and 7.1  ± 0.9 
respectively. The control group’s measurements were 34.7  ± 3.8, 
27.3  ± 2.3, 20.7  ± 2.5 and 10.1  ± 1.1. There was a statistically sig-
nifi cant difference in YMRS scaling results between the case and 
control groups after 3 weeks of treatment (7.1  ± 0.9 vs. 10.1  ± 1.1, 
P  = 0.005). 
 Conclusion: Based on our fi ndings, folic acid seems to be an effec-
tive adjuvant to sodium valproate in the treatment of the acute phase 
of mania in patients with bipolar disorder. 
 Keywords: Mania, Folic Acid, Sodium Valproate, Bipolar Disorder 
 WS2 04
Folate, vitamin B12, homocysteine and polymorphisms of 
genes participating in one-carbon metabolism in late onset 
Alzheimer ’ s disease 
 *F. Copped è 1 , P. Tannorella 2 , I. Pezzini 2 , F. Migheli 2 , G. Ricci 3 , E. 
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1
 University of Pisa-Pisa University Hospital, DAI of Neuroscience, 
Pisa, Italy 
 
2
 University of Pisa, DSUA, Pisa, Italy 
 
3
 University of Pisa, Neuroscience, Pisa, Italy 
 
4
 University of Florence, Neurological and Psychiatric Sciences, 
Florence, Italy 
 
5
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 Background: Increasing evidence points to one-carbon metabolism 
impairments in individuals with Alzheimer ’ s disease. 
 Aim: We screened 378 late onset Alzheimer ’ s disease (LOAD) 
patients and 308 matched controls for the presence of the common 
 MTHFR 677C > T,  MTRR 66A > G,  MTR 2756 A > G, and  TYMS 28bp 
repeat polymorphisms, searching for association with disease risk 
and age at onset. Moreover, we searched for correlation between 
each of the studied polymorphisms and available data on plasma 
homocysteine (hcy), serum folate and vitamin B12 values. 
 Methods: Genotyping was performed by means of PCR-RFLP tech-
nique. Correlation between the studied polymorphisms and biochem-
ical data was performed by means of analysis of variance. 
 Results: A signifi cant increased frequency of the  MTHFR 677T allele 
(0.48 vs. 0.42;  p = 0.019) and of the  MTRR 66G allele (0.49 vs. 0.43; 
 p = 0.044) was observed in the LOAD group. Signifi cantly increased 
mean plasma hcy levels (22.7 ± 1.7 vs 14.5 ± 1.7  μ mol/L;  p = 0.037) 
and decreased serum folate values (5.7 ± 0.5 vs. 7.8 ± 0.8 ng/mL; 
 p = 0.005) were observed in LOAD subjects with respect to controls. 
Signifi cant interactions were also observed between the  MTHFR 
677T allele and both serum folate and vitamin B12 levels ( p < 0.05), 
between the  MTRR 66G allele and vitamin B12 levels ( p < 0.01), and 
between the  MTR 2756G allele and plasma hcy values ( p < 0.05). 
 Discussion and Conclusion: Overall, present results support a con-
tribution for one-carbon metabolism to LOAD pathogenesis. 
 WS2 05
High prevalence of functional vitamin defi ciencies in a 
psychogeriatric ward 
 *W. Abbott-Johnson 1 , N. Squelch 1 , K. Schilling 2 , B. Hokin 3 , P. 
Varghese 4 , H. Johnson 5 , F. Dark 6 , M. Rozario 7 , D. Lie 2 
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 Princess Alexandra Hospital, Older Persons Mental Health, 
Brisbane, Australia 
 
2
 Metro South Mental Health Service, Older Persons Mental Health, 
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3
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4
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5
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6
 Metro South Mental Health Service, Mobile Intensive Treatment 
Team, Brisbane, Australia 
 
7
 University of Queensland, Centre for Research in Geriatric 
Medicine, Brisbane, Australia 
 Background: Although vitamin B12 and folate affect cognition, lit-
tle is known about functional defi ciencies of vitamin B12 and folate 
in psychogeriatric patients. 
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 Aims: 1) determine vitamin B12 and folate status.2) examine the 
relationship between methylmalonate (MMA) and vitamin B12.3) 
determine the relationship between vitamin B12 levels and use of 
proton pump inhibitors (PPI). 4) compare vitamin status between 
various diagnostic categories. 
 Methods: 71 consecutive patients admitted to a psychogeriatric 
ward were assessed for vitamin B12 (RR 133-680 pmol/L), MMA 
(RR  < 0.4  μ mol/L) [for vitamin B12 levels  ≤  220 pmol/L], red 
cell (RC) folate ( > 356 nmol/L), homocysteine (HCY) (RR  < 
15  μ mol/L) and creatinine. Diagnoses were determined accord-
ing to DSM IV criteria (Major Depressive Episode [MDE] 31, 
schizophrenia 15/schizoaffective 4, Bipolar Affective Disorder 
[BPAD] 12, other 9). Vitamins and PPIs taken at admission were 
recorded. 
 Results: Three of 70 (4 % ) and 26 (37 % ) of patients had vitamin 
B12  < 133 and 134-220 respectively. Six of 25 (24  % ) of patients 
with lower normal vitamin B12 had impaired MMA. Vitamin B12 
levels were similar for patients on PPI and not on PPI. Median 
RC folate was 1127  ± 490 and two patients were folate defi cient. 33 
(46 % ) had elevated HCY including all patients with renal failure. 
Vitamin B12, RC folate and HCY did not vary between diagnoses 
of MDE, schizophrenia/schizoaffective disorder and BPAD. 
 Conclusions: Functional vitamin B12 defi ciency existed within the 
normal reference range. Vitamin B12 levels were not related to use 
of PPIs. Folate defi ciency was rare and elevated HCY was common 
especially in renal failure. 
 WS2 06
Homocysteine Intrahippocampal Injection-increased MDA, 
SOA, Bax levels as well as impaired Memory Retention in the 
Rat. 
 *A. Ataie 1 , M. Sabetkasaei 1,2 
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 Background: Homocysteine (Hcy) is a toxic metabolite of Methion-
ine and its increased level in plasma, called  Hyperhomocysteinemia . 
Recently the roles of Homocysteine in some neurodegenerative dis-
eases for example Alzheimer ’ s disease and Parkinson disease were 
investigated in some studies. In this study we investigated the effect 
of Homocysteine (Hcy) on oxidative stress in rat ’ s hippocampus 
 Methods: Hcy was injected (0.2 micromoles) intrahippocam-
pal in rat ’ s brain. Five days after Hcy injection two parameters 
of oxidative stress, Malondy Aldehydes (MDA) and Super Oxide 
Anion (SOA) were analyzed in homogenate rat ’ s brain with spec-
trophotometer .On the other hand the effect of Hcy on the Memory 
was studied by Passive Avoidance Learning Apparatus. Also 
Immunohistochemical assays were done on hippocampus slices of 
rat ’ s brain. 
 Results: Results indicated that Hcy induced lipid peroxidation and 
increased malondialdehyde (MDA) and superoxide anion (SOA) 
levels signifi cantly ( p < 0.05) in the homogenate rat ’ s brain. In 
addition, Hcy impaired memory retention in the passive avoidance 
learning test signifi cantly. Also histopathological study revealed 
that Hcy could express Bax (Apoptotic biomarker) in DG layers of 
hippocampus. 
 Conclusion: These results suggest that Hcy may induce lipid 
peroxidation in hippocampus as well as impaired memory reten-
tion. In addition Hcy may induce Apoptosis and cell death in rat 
hippocampus. 
 B-vitamins and choline in gestation & birth 
defects 
 WS3 01
Paternal folate status and placental and fetal brain DNA 
methylation in the offspring 
 *N. Chang 1 , H. Kim 1 , K. N. Kim 1 , Y. J. Choi 1 
 
1
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 To investigate the effect of paternal folate status on placental and 
fetal brain DNA methylation, rats were divided into four groups: 
paternal folate-supplemented (PS), paternal folate-defi cient (PD), 
maternal folate-supplemented (MS), and maternal folate-defi cient 
(MD). Folic acid-supplemented groups were fed with 8 mg folic 
acid/kg diet, while no folic acid was added to folate-defi cient 
groups. Four weeks after the experimental diet started, rats were 
mated (PS × MS, PS × MD, PD × MS and PD × MD) and placenta and 
fetal brain were isolated at day 20 of gestation. The placental folate 
content decreased in the PD × MS (8.5  ± 0.46 nmol/g of wet tissue) 
group, as compared to the PS × MS (10.4  ± 0.59 nmol/g) group, fol-
lowed by PS × MD (8.4  ± 0.36 nmol/g) and PD × MD (6.8  ± 0.37 
nmol/g) groups ( P  < 0.0001). The fetal brain folate content in 
the PD × MD (1.05  ± 0.06 nmol/g) group decreased the most, and 
PD × MS (1.19  ± 0.07 nmol/g) group has been signifi cantly lower 
than other groups (PS × MD; 1.36  ± 0.10 nmol/g, PS × MS; 1.37  ± 
0.10 nmol/g,  P  < 0.05). The placental global DNA methylation 
decreased in the PD × MS group, as compared to the PS × MS group. 
The placental global DNA methylation was decreased the most in 
the PD × MD ( P  < 0.0001), and there was no difference between 
PS × MD and PD × MS groups. The fetal brain global DNA methyla-
tion in the PD × MD group was decreased most, followed by PD × MS 
group and PS × MD group as compared to the PS × MS group ( P  < 
0.0001). In conclusion, paternal folate defi ciency led to decreased 
folate content and global DNA methylation in the placenta and fetal 
whole brain, as similar to maternal folate defi ciency and/or parents 
folate defi cient group. 
 This research was in part supported by The Basic Science Research 
Program through The National Research Foundation (2011-0003072) 
and by BK21. 
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Rapid Repletion for Preventing Birth Defects in Folate 
Defi cient Women 
 *S. Bailey 1 , J. Ayling 1 
 
1
 University of South Alabama, Pharmacology, Mobile, AL, United 
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 Initiation of neural fold closure occurs during Carnegie stage 
10 and is completed by stage 12 (i.e.,  ∼ days 22 to 28 after con-
ception). Examples of incipient human embryonic neural dysra-
phism have been reported only from Carnegie stage 11, or later. 
Currently, it is generally believed that women are not aware 
of being pregnant until it is too late to intervene with folate. 
However, many are now informed through home hCG test kits 
that can reveal the implanted state at about 14 days post concep-
tion or earlier. Typically, this would allow about a 7 day window 
of opportunity. AIM: To examine whether rapid folate repletion, 
which has heretofore been considered unachievable, might be 
accomplished with 5-methyl-6S-tetrahydrofolate (5-MTHF). 
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METHODS: Various dose regimes of 5-MTHF were studied using 
non-pregnant female volunteers, age 19-45 yr, screened to have 
lower than normal plasma folate levels. After 2 or 3 days (depend-
ing on the regime), subjects were switched to daily supplementa-
tion with folate in the amount of the RDA for prenatal vitamins. 
Levels of both total folate and 5-MTHF in plasma (the source 
of embryonic folate) were measured over the course of the treat-
ment. RESULTS: Starting from about 30 min after the fi rst dose 
of 5-MTHF, plasma folate could be elevated in a manner such 
that over the fi rst three days it stayed above a value likely to fully 
decrease the risk of neural tube defects. Moreover, by 3 days of 
treatment, subjects could be switched to a prenatal vitamin, and 
still be continuously maintained above the minimum necessary 
plasma level. CONCLUSION: Rapid repletion of folate within 
a few days is possible, and may represent an option for women 
who have detected pregnancy within the critical window of 
opportunity. 
 WS3 03
Umbilical Choline And Related Methylamines Betaine And 
Dimethylglycine In Relation To Birth Weight 
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 Question: Low birth weight (LBW) is associated with increased mor-
bidity and mortality for the newborn and increased risk on chronic 
diseases in adulthood. Choline has an essential role in the integrity 
of cell membranes, methylation reactions and memory development. 
We examined whether umbilical/maternal choline and related meth-
ylamines betaine and dimethylglycine (DMG) concentrations were 
associated with LBW in Dutch women. 
 Methods: Blood was sampled from umbilical cords at delivery 
(n = 1126). Maternal blood was sampled at 30-34 weeks of gestational 
age (n = 366). We calculated birth weights standardized for gestational 
age (SBW) and defi ned LBW as SBW  < 2500 grams. 
 Results: Maternal concentrations of all analytes were lower com-
pared to umbilical cord concentrations. Plasma betaine and DMG 
between mothers and newborns were strongly correlated. Higher 
umbilical cord choline and betaine were associated with lower birth 
weight ( β = -60[-89;-31] and  β = -65[-94;-36]). Odds ratio for LBW 
was 4.12 [1.15;14.78] and 5.68 [1.24;25.91] for the highest umbili-
cal choline and betaine quartile respectively compared to the lowest 
quartiles. 
 Conclusion: We observed an increased risk of lower birth weight 
with increased umbilical choline and betaine in venous umbilical 
cord blood. These results might refl ect a change in choline consump-
tion or metabolism or a disturbed placental function. 
 WS3 04
The activity and expression of enzymes of methionine 
synthesis are decreased in liver from foetuses with neural 
tube defects 
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 Background: Neural tube defects (NTD) are common malfor-
mations. Their pathogenic mechanisms are under the infl uence 
of genetic and nutritional risk factors. Maternal folate defi cit and 
genetic determinants of the one-carbon metabolism increase NTD 
risk. The re-methylation of homocysteine in methionine is cataly-
sed by two enzymes, methionine synthase (MTR) and betaine-Ho-
mocysteine MethylTransferase (BHMT). Methionine synthase uses 
vitamine B12 as coenzyme and methyl-folate as second substrate. 
Methionine is the precursor of S-adenosylmethionine (SAM), the 
universal methyl donor in transmethylation reactions. 
 Objective: To study the expression and activity of enzymes involve 
in the remethylation of homocysteine in methionine, methylenetetra-
hydrofolate reductase (MTHFR), MTR and BHMT and the concen-
tration of S-adenosylmethionine (SAM) and folate and vitamin B12 
in human liver tissue from NTD foetuses, compared with foetuses of 
spontaneous abortion. 
 Results: Decreased activities of MTHFR and MTR and decreased 
expression of MTR were observed in NTD tissues. BHMT activity 
was positively correlated with foetus age and MTR with SAM. The 
decreased concentration of SAM despite unchanged tissue concen-
tration of folate, vitamin B12 and holoTranscobalamin confi rmed the 
predominant role of decreased MTR in the decreased concentration 
of SAM. 
 Conclusion: Our results showed a decrease of activity and expres-
sion of enzymes of methionine synthesis, which may be a predis-
posing condition to NTD risk produced by maternal folate defi cit. 
They are also consistent with the increased NTD risk associ-
ated with MTHFR, MTR and MTRR polymorphisms in popula-
tion studies. The underlying mechanisms should deserve further 
attention. 
 WS3 05
MTHFR gene specifi c methyaltion in recurrent pregnancy 
losses 
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 Background: The etiology/ pathogenesis of recurrent pregnancy 
losses (RPL) via MTHFR C677T is still not clearly understood. 
Although studies suggest that the mutation results in the decrease in 
the enzyme activity by 40-70 % , thereby resulting in the increase in 
the homocysteine (Hyperhomocysteinemia). In addition to this, DNA 
methyaltion is also reported to silence the activity of the gene. Thus 
genetic and epigenetic mechanisms of MTHFR gene are expected to 
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play an important role in complex disorders like recurrent pregnancy 
loss. 
 Aim: The present study attempts to understand the role of MTHFR 
C677T gene polymorphism and its methylation status in the causa-
tion of RPL in North Indian population. 
 Methods: A Case-control study was performed in north Indian popu-
lation. Case group comprised of sixty-one (61) women with three (3) 
or more consecutive unexplained recurrent pregnancy losses before 
24 weeks of gestation. Control group comprised of eighty-fi ve (85) 
women with two (2) or more successful and uncomplicated pregnan-
cies. Both the groups were analyzed for MTHFR C677T polymor-
phism and for its methylation status by Methylation Specifi c PCR 
amplifi cation using primers that hybridize to the CpG island in the 
promoter region of MTHFR. 
 Results: Of all, number of individuals carrying methylated allele 
in promoter region of MTHFR among cases were found to be sig-
nifi cantly high (32.79 % ) as compared to only 9.41 % among controls 
(P < 0.0001). Moreover, methylation status of the individuals carrying 
CT and TT (MTHFR Mutation) among cases is found to be signifi -
cantly higher as compared to controls (p < 0.001). 
 Discussion and conclusion: The present study suggests that the 
methylation at the promoter region of MTHFR plays an important 
role in the causation of recurrent pregnancy loss. Further, a woman 
carrying methylated allele, if has CT or TT genotype, is found to be 
more prone to recurrent pregnancy loss. 
 WS3 06
Peri-Partum Thiamine Lack Compromises Gestation Outcome 
And The Onset Of Maternal Behavior 
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 Background: A growing body of work refers prohormonal activities 
to the molecule of thiamine: Its lack caused several disorders such us 
ovarian dysfunction, 1 disturbances of the fetoplacental insulin-like 
growth factor (IGF-I) regulation, 2 unsuccessful fetus implantation 
and stillbirths, 3,4 long-lasting impairment of brain weight and func-
tion in growing pups 5 and altered circadian rhythmicity.  6 Recent dis-
covery of thiaminylated adenine nucleotides 7 suggests its interactions 
with second messenger systems including cAMP (cyclic adenosine 
monophosphate), calcium mobilization and kinases activation. 8,9 
Thiamine defi ciency provokes also changes in behavior and induced 
either mouse-killing responses 10 (muricide) or disruption of mater-
nal behavior via alterations of dopaminergic systems (unpublished 
data). 
 Aim: This study attempts to determine whether thiamine defi -
ciency affects gestation outcome and maternal behavior towards 
pups. 
 Methods: Our investigations concern pregnant and lactating rats 
subjected to alternative different toxic effects of thiamine defi ciency. 
Experiments compare thiamine-defi cient diets-consuming females 
during pre, peri or postnatal periods with either controls or their 
respective pair-fed controls. Dams were observed for gestation out-
come (spontaneous abortion, fetal death, litter size and birth weight) 4 
and for apparent disorders of the maternal behavior related to the 
pups at parturition and within 48H after. 
 Results: Among the 7 experimental groups studied, only pre- 
and perinatal thiamine-defi cient dams exhibited respectively: 
Spontaneous abortion (33.36  % vs. 41.66  % ) and subsequent still 
births (43.3 % vs. 56.6 % ), reduced litter size (72.32 % vs. 76.16 
 % ) and lowered birth weight (7  % vs. 30.1 % ), followed by pups-
killing responses (57.14 % vs. 71.43  % ). These anomalies were not 
observed in the dams of any other experimental group and exacer-
bated signifi cantly from pre- to perinatal period (P  < 0.05 for any 
effect of thiamine defi ciency compared with control and its own 
pair-fed control). 
 Conclusion: Thiamine lack around parturition compromises ges-
tation outcome and the onset of maternal behavior. It may disturb 
both maternal and fetoplacental hormonal mechanisms perinatally 
induced. 
 References: [1] Greewood J, Love ER, Pratt OE.  Alcohol Alcohol 
1983; 18: 45-51. [2] Molina PE  et al .  J Nutri Biochem 1996; 7: 207-
213. [3] Subramanian S, Rao J, Adiga PR.  Indian J Exp Biol 1996; 
34: 302-306. [4] B â A.  J Matern Fetal Neonatal Med 2009; 22: 452-
457. [5] B â A.  Behav Brain Res 2011; 225: 235-242. [6] Bennett 
MR, Schwartz WJ.  J Neurol Sci 1999; 163: 6-10. [7] Fr é d é rich M.  et 
al .  FEBS J 2009; 276: 3256-3268. [8] Neher R, Milani A.  J Steroid 
Biochem 1983; 18: 1-6. [9] Lazarov Y, Bohorov O.  Comp Biochem 
Physiol Part A: Physiol 1981; 70: 643-647. [10] Onodera K.  Arch Int 
Pharmacodyn Ther 1987; 285: 263-276. 
 B-vitamins and choline in thrombosis & vascular 
diseases 
 WS4 01
Plasma homocysteine and the risk of venous 
thromboembolism: insights from the FIELD study 
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 Background: The lipid-lowering effect of fenofi brate is accom-
panied by a rise in plasma homocysteine, a potential risk factor 
for venous thromboembolism (VTE). This study investigated 
the relationship between homocysteine and the risk of VTE in 
patients treated with fenofi brate. Methods and results. The rela-
tionship between homocysteine and deep-vein thrombosis or pul-
monary embolism was investigated in 9522 participants of the 
5-year Fenofi brate Intervention and Event Lowering in Diabetes 
(FIELD) trial. All subjects received fenofi brate during a 6-week 
active run-in phase before randomization. A Cox proportional-
hazards model was used to assess the effect of homocysteine on 
risk of venous thromboembolic events. During active-drug run-in, 
homocysteine rose on average by 6.5  μ mol/L, accompanied by a 
substantial rise in plasma creatinine ( + 12 % ). Fenofi brate-induced 
changes in homocysteine and creatinine were fully reversible in 
the placebo group but persisted in the treatment group until the 
end of therapy. During follow-up, 1.7 % had at least one episode 
of deep-vein thrombosis or pulmonary embolism: 103 on feno-
fi brate and 68 on placebo (log-rank P = 0.006). In multivariate 
analysis, every 5  μ mol/L higher baseline homocysteine was asso-
ciated with 18.3  % higher risk of VTE. Fenofi brate treatment was 
associated with 51.6 % higher risk, but the change in homocysteine 
with fenofi brate was not signifi cantly associated with VTE after 
adjustment for baseline homocysteine. Baseline homocysteine 
and fenofi brate treatment interacted signifi cantly. Conclusions 
Hyperhomocysteinemia is prospectively associated with VTE. 
Fenofi brate may predispose individuals with a high pretreatment 
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homocysteine towards VTE. The fenofi brate-induced increase in 
homocysteine did not completely explain the higher risk associ-
ated with fenofi brate therapy. 
 WS4 02
Hyperhomocysteinemia is associated with microvascular 
rarefaction in men, not in women. A population-based 
study 
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 Background: Homocysteine (Hcy) is an independent predictor of 
cardiovascular risk. The pathophysiological mechanisms under-
lying this link are not fully elucidated. Whereas the association 
between Hcy and vascular dysfunction in conduit arteries is exten-
sively studied, the potential role of the microcirculation is largely 
unknown. 
 Aim: To assess the relationship of Hcy levels and microvascular 
structure and function in a population-based study in healthy, young 
adults. 
 Methods: We cross-sectionally studied 260 participants (aged 42 
years, 47  % men) of the Amsterdam Growth and Health Longitudinal 
Study (AGAHLS). Nailfold videocapillaroscopy (100x) was used 
to assess capillary density (number of perfused capillaries/mm 2 ) at 
baseline, during venous congestion and during reactive hyperaemia 
(after 4 minutes of arterial occlusion). The relationship between fast-
ing plasma Hcy and microvascular outcomes was evaluated using 
regression analyses with a dichotomous variable comparing the high-
est tertile with the two lowest tertiles of homocysteine with adjust-
ment for BMI and blood pressure. 
 Results: Stratifi ed analyses were performed for gender. In men, 
we observed an inverse, non-lineair relationship between Hcy and 
capillary density at baseline as well as during reactive hyperaemia, 
showing lower microvascular counts in the highest two tertiles of 
Hcy ( β of -7.3 (c.i. -13.6 to -1.1) and -9.1 (c.i. -17.5 to -0.8) capil-
laries/mm 2 respectively (p < 0.05)). In women, no such association 
was apparent. 
 Conclusions: In men, but not in women, elevated Hcy levels are 
associated with microvascular rarefaction, i.e. a decrease in the num-
ber of perfused capillaries at rest and during reactive hyperaemia. 
 WS4 03
Folate and B12 defi ciency and high blood lead increase risk 
of hyperhomocysteinemia in individuals with  MTHFR C677T 
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 Background: Genetic, nutritional and environmental factors could be 
contributing to highly prevalent hyperhomocysteinemia ( > 15 μ mol/l) 
in Pakistani population. 
 Aim: To unravel the underlying mechanism, we investigated the rela-
tionships of 6 SNPs in genes of enzymes involved in homocysteine 
metabolism - methylenetetrahydrofolate reductase ( MTHFR ; C677T, 
A1298C), methionine synthase ( MS A2756G) and cystathionine  β 
synthase ( CBS , T833C/844ins68, G919A) with plasma homocysteine 
in an urban population in Pakistan and also studied the role of folate 
and vitamin B12 status and blood lead (Pb) levels in infl uencing 
homocysteine levels. 
 Methods: In a cross-sectional study, 872 healthy adults were 
recruited from a population in Karachi. Fasting venous blood was 
obtained and assessed for plasma/serum homocysteine, folate, vita-
min B12, pyridoxal phosphate and blood Pb. DNA was isolated and 
genotyping was performed by PCR-RFLP based assays. 
 Results:  MTHFR C677T transition was found to increase the risk of 
hyperhomocysteinemia [OR(95 % CI); 10.17(3.6-28.67) for  MTHFR 
677TT genotype vs. 677CC genotype]. Protective effect towards 
hyperhomocysteinemia was observed with heterozygous (wild/
insertion) genotype of  CBS 844ins68 compared to homozygous wild 
type [OR(95 % CI); 0.58(0.34-0.99].  MS A2756G,  CBS G919A and 
 MTHFR A1298C had no signifi cant effect on plasma homocysteine. 
Individuals with  MTHFR 677CT or TT genotypes were at a greater 
risk of hyperhomocysteinemia in folate and vitamin B12 defi ciencies 
and high blood Pb level (p < 0.05). 
 Conclusion:  MTHFR C677T transition, folate and vitamin B12 
defi ciencies, male gender and high blood Pb level contribute 
towards the development of hyperhomocysteinemia in Pakistani 
population. 
 WS4 04
The correction of hyperhomocysteinemia and hyposelenemia 
in elderly patients with a stable stenocardia 
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 Background: The previous researches of the authors showed a com-
bination of moderated hyperhomo-cysteinemia (HHCY) and severe 
hyposelenemia together with manifestation of endothelium dysfunction 
in patients with myocardial infarction. We showed the correction of 
specifi ed disturbances and effi cacy of standard therapy supplemented 
by the complex of vitamins, containing folic acid (FA), and Se as 
Se-methionine on the endothelial function and carotid artery stiffness. 
 Aim: To develop the given direction of research we examined 62 
elderly patients (28 men and 34 women) at the age of 67,3 [62,6; 
71,6] with stable stenocardia (functional class II) and grade II arterial 
hypertension, FC I-II (NYHA). 
 Methods: Plasma folate (SimulTRAC-SNB), HCY (HPLC), Se 
(EAAS) and vascular functional parameters (endothelium-dependent 
vasodilatation, arterial stiffness) were measured. All investigations 
were performed before and after 3 months of complex therapy, 
including perindopril, aspirin, bisoprolol, atorvastatin, 500 mg FA 
and original drug  « SELENOBEL » , containing 0,4 g diacetofeno-
nilselenid (0,1 g Se). 
 Results: The target correction of HHCY and hyposelenemia 
together with standard therapy resulted in change of plasma folate 
concentrations from 7,4 [4,5;11,6] to 10,5 [8,5;12,6] nmol/l in men 
and from 6,9 [4,8;9,3] to 13,4 [9,6;15,7] nmol/l in women; HCY  – 
from 16,5 [11,1;18,5] to 15,8 [11,1;17,0] mkmol/l in men and from 
16,8 [10,8;20,4] to 11,8 [8,5;15,3] mkmol/l in women; Se - from 
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56,4 [44,3;70,2] to 70,3 [65,2;82,8] mkg/l in men and from 64,2 
[50,6;71,5] to 81,3 [72,2;91,5] mkg/l in women. 
 Conclusion: Improvement of the biochemical status correlated with 
positive dynamics of vessels functional properties (mainly in elderly 
women). 
 WS4 05
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patients with type II diabets mellitus: possible correlation 
with endothelial dysfunction 
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 Background: Increased blood homocysteine (Hcy) is a risk factor 
for cardiovascular disease (CVD), which is a major complication 
and the main cause of death in patients with type 2 diabetes mel-
litus (DM). Endothelial dysfunction (ED), an established mechanism 
of CVD, is in essence the reduced bioavailability of endothelium-
derived nitric oxide (NO). 
 Aim: We aimed to evaluate the relation, in DM patients with and 
without atherosclerosis (ATS), between ED and the concentrations 
of Hcy, folate, and vitamin B12 in blood serum. 
 Methods: 80 healthy subjects and 118 patients with DM were 
included in this study: 40 patients in the DM group had established 
ATS and the rest of 78 had no evidence of ATS. We used ELISA to 
measure blood serum concentrations of Hcy, B12, folate and nitric 
oxide (NO), as well as blood plasma concentrations of endothelin-1 
(ET1). 
 Results: Hcy was higher in DM patients with ATS compared to DM 
without ATS and this correlated well with ED markers (ET-1, NO 
and Hcy were positively correlated). Correlation between serum NO 
and serum Hcy was stronger in DM patients with ATS (r = 0.40) vs. 
control (r = 0.10). In DM patients there was a negative correlation 
between Hcy and either B12 (r = -0.37) or folate (r = -0.43), compared 
to the positive one in healthy subjects (r = 0.10 for Hcy and B12 ; 
r = 0.21 for Hcy and folic acid). 
 Disscussion and Conclusion: We discuss the multiple facets of the 
correlations observed, including a possible link with the insulin resis-
tance in type 2 DM. The correlation between serum NO and Hcy 
observed in our DM group with ATS could be important for ATS evo-
lution and coronary events in DM. An early manifestation of vascular 
disease progressing to ATS in type 2 DM patients is ED and this may 
be related to hyperhomocysteinaemia. 
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Vitamin B 12 level in peripheral arterial disease 
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 Objective: Hyperhomocysteinemia is considered a risk factor for 
atherosclerosis. Methyltetrahydrofolate reductase (MTHFR) gene 
mutation and low level of plasma vitamin B 12 and folic acid could 
take part in the etiology of peripheral arterial disease (PAD). 
 Methods: We examined whether plasma vitamin B 12 and folic acid 
levels and MTHFR C677T polymorphism are associated with the 
risk of PAD. The study comprised 293 patients (107 females, 186 
males, mean age of 66 ± SEM0.7 years) and 293 sex matched con-
trols (mean age of 62 ± SEM0.8 years) subjects. MTHFR genotypes 
were assessed by real-time polymerase chain reaction assay. We also 
determined plasma hsCRP, creatinie, vitamin B 12 , folic acid and total 
homocysteine for all patients and controls. 
 Results: We adjusted all calculations for confounding param-
eters where it was appropriate. Accordingly, as determined by 
logistic regression analysis, no significant odds ratios for differ-
ent genotypes of these polymorphisms could be observed. There 
was a significant lower level of vitamin B 12 in PAD patients, and 
this was observed in males but not in females. 43 % and 25 % of 
patient and control populations, respectively, were in the lowest 
quartile of vitamin B 12 (12 in the lowest quartile at least 10 fold 
increases the risk of PAD and it was independent of plasma folic 
acid level. 
 Conclusion: Low level of plasma vitamin B 12 is an important deter-
minant of hyperhomocysteinemia in PAD patients. PAD was not 
associated with an increased prevalence of MTHFR C677T mutation 
in the population studied. 
 B-vitamins, choline and cancer 
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 Question: We investigated the associations between intakes of one-car-
bon nutrients and CRC in the Women ’ s Health Initiative Observational 
Study, stratifi ed by folic-acid fortifi cation era and alcohol intake. 
 Methods: 88,045 postmenopausal women were recruited across pre- 
(1993-95), peri- (1996-97), and post- (1998) fortifi cation periods, 
and incident CRC cases were ascertained as of 2009. Dietary intakes 
were assesed via a food frequency questionnaire and dietary supple-
ment inventory. Hazard ratios (HR) and 95 % confi dence intervals 
(95 % CI) were estimated by Cox proportional hazards models. 
 Results: High versus low dietary and total intakes of vitamin B 6 
(HR = 0.80, 95 % CI 0.66-0.97 and HR = 0.80, 95 % CI 0.66-0.99, respec-
tively) and total intakes of ribofl avin (HR = 0.81, 95 % CI 0.66-0.99) were 
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associated with reduced risk for CRC overall and regionally spread dis-
ease. In current drinkers who consumed less than one drink (13g alco-
hol) per week, but not non-drinkers or current drinkers who consumed 
one drink/week or more, folate, B 6 , B 12 , and ribofl avin intakes were 
inversely associated with CRC risk (p for differences in slopes 
 Conclusions: B-vitamin intakes from diet and supplements were 
associated with decreased risk for CRC in postmenopausal women. 
The associations were particularly strong for regional disease and 
among women who consumed less than 1 alcoholic drink per week. 
 Figure 1: Time sequence of the national program of folic-acid for-
tifi cation, WHI-OS recruitment and Food Frequency Questionnaire 
(FFQ) databases used for measuring folic acid intake. (Abbreviations: 
WHI-OS, Women ’ s Health Initiative-Observational Study; FA, folic 
acid; DFE, dietary folate equivalent) .
 WS5 02
Dietary Intake of Choline and Betaine in Relation to Incident 
Colorectal Cancer in the U.S. Multiethnic Cohort 
 *U. LIM 1 , S. Murphy 1 , L. Wilkens 1 , K. Yonemori 1 , K. Koga 1 , M. 
Tiirikainen 1 , K. Monroe 2 , B. Henderson 2 , L. Kolonel 1 , L. Le Marchand 1 
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2
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 Background: Epidemiologic evidence is limited and inconsistent 
for the association between dietary choline or betaine and the risk 
of colorectal neoplasia, possibly due to different effects of choline-
containing compounds and their food sources. 
 Aim: To investigate the association of dietary intake of choline com-
pounds and betaine with the risk of colorectal cancer (CRC) in a 
multiethnic population with diverse diets. 
 Methods: Baseline diet was assessed through a 180-item food frequency 
questionnaire in a population-based sample of 215,251 men and women 
in Hawaii and Los Angeles who were of Caucasian, African, Japanese, 
Latino, and Native Hawaiian ancestry, and aged 45-75 in 1993-1996. 
Choline and betaine intakes were estimated using the USDA food com-
position database. A total of 1,988 male and 1,691 female incident CRC 
cases identifi ed through 2007 were analyzed using proportional hazards 
regression, with adjustment for other risk factors. 
 Results: Comparing the highest to the lowest quintiles of the nutri-
ents, CRC was associated with total choline [adjusted relative risk 
(RR)  = 1.10, 95 % confi dence interval, 1.00-1.20] and betaine intake 
(RR  = 1.25, 1.13-1.38) among men only. In particular, intake of free 
choline and glycerophosphocholine among the fi ve choline com-
pounds was associated with CRC. The association of choline and 
betaine with CRC was signifi cantly modifi ed by the consumption of 
alcohol and also of folate in both men and women. No ethnic hetero-
geneity was observed. 
 Discussion and Conclusion: These fi ndings suggest that higher 
levels of certain choline-containing compounds and betaine may be 
associated with the risk of colorectal cancer, depending on the levels 
of alcohol and folate consumption. 
 WS5 03
Choline and betaine intake and risk of lethal prostate cancer: 
incidence and survival 
 *E. Richman 1 , S. Kenfi eld 2 , M. Stampfer 2 , E. Giovannucci 2 , J. Chan 1 
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2
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 Question: Choline is concentrated in prostate cancer cells and may 
affect prostate cancer through its roles in cell membranes and one-
carbon metabolism. Higher plasma choline was associated with 
increased prostate cancer risk. No study has examined dietary cho-
line and prostate cancer. 
 Methods: We examined choline and betaine intake and risk of lethal 
prostate cancer (e.g. metastases or death due to prostate cancer) 
among 47,896 men. Diet was assessed six times during 22 years 
of follow-up. In a case-only survival analysis, we examined post-
diagnostic intake of these nutrients and risk of lethal prostate cancer 
among 4,282 men diagnosed with non-metastatic prostate cancer. 
 Results: In the incidence analysis, we observed 695 events during 
879,696 person-years. Men in the highest quintile of total choline had 
a 70 % increased risk of lethal prostate cancer compared to the lowest 
quintile (hazard ratio (HR): 1.70; 95 % confi dence interval (CI): 1.18, 
2.45; p-trend: 0.005). In the case-only survival analysis, we observed 
271 events during 19,694 person-years. Men who consumed the most 
choline after diagnosis had a nearly 2-fold increased risk of lethal 
prostate cancer (HR Q5 v Q1: 1.97; 95 % CI: 1.05, 3.70; p-trend: 
0.08). Betaine was not associated with lethal prostate cancer. 
 Conclusion: Dietary choline may increase risk of developing a lethal 
form of prostate cancer, and post-diagnostic intake of choline may 
promote progression of localized prostate cancer to lethal disease. 
 WS5 04
Folate and vitamin B12, and related biomarkers of one-
carbon metabolism in association with prostate cancer risk 
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3
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4
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 Background: Recent epidemiological studies suggested that high 
folate and vitamin B12 concentrations may be associated with 
increased prostate cancer risk. Other factors of the one-carbon 
metabolism have not previously been studied in population-based 
studies in relation to prostate cancer. 
 Methods: Within JANUS, a prospective cohort in Norway 
(n = 317.000) with baseline serum samples, we conducted a nested 
case-control study among 3000 prostate cancer cases and 3000 con-
trols, matched on age at serum sampling, county of residence, and 
blood storage time. Subjects were screened for several different bio-
markers of the one-carbon metabolism. Prostate cancer risk was esti-
mated according to serum concentrations, using conditional logistic 
regression. To adjust for degradation during sample storage, folate 
concentration was measured as  p -aminobenzoylglutamate equiva-
lents following oxidation and acid hydrolysis. 
 Results: Neither folate nor vitamin B12 concentrations were asso-
ciated with prostate cancer risk in overall analyses, although high 
folate concentration was associated with increased risk among indi-
viduals  ≥ 50 years at serum sampling (highest vs. lowest quintile 
odds ratio (OR)): 1.37,  P trend = 0.04. Conversely, high glycine and 
sarcosine concentrations were associated with reduced risk (glycine: 
OR = 0.82,  P trend = 0.07; and sarcosine: OR = 0.87,  P trend = 0.04). No asso-
ciations were observed for homocysteine, methionine, betaine, or 
dimethylglycine. 
 Conclusion: This large-scale population-based study does not sug-
gest that high folate and vitamin B12 concentrations affect prostate 
cancer risk. However, high concentrations of the related amino acids 
glycine and sarcosine may decrease prostate cancer risk. 
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Cross-talk between genome and epigenome infl uencing 
molecular phenotype and grade of breast cancer 
 *S. M. Naushad 1 , C. Apoorva Reddy 1 , P. Shree Divyya 1 , S. Kotamraju 2 , 
S. R. Gottumukkala 1 , R. R. Digumarti 1 , V. K. Kutala 1 
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2
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 To explore the cross-talk between genome and epigenome, we have 
explored the expression of six genes i.e. RASSF1, RARb1, CCND1, 
BRCA1, p21 and BNIP3 in breast cancer cell lines treated with increas-
ing concentrations of homocysteine. Dose-dependent down-regulation 
of RASSF1 and BRCA1 with homocysteine was observed in MCF-7 
and MDA-MB-231 cells respectively. Using breast cancer tissues, we 
demonstrated down-regulation of RASSF1, RARb, CCND1 and p21; 
moderate expression of BRCA1; and increased expression of BNIP3. 
Breast cancer cases exhibited hypermethylation of RASSF1 (71.1  ± 
6.3 % vs. 30.0  ± 8.8 % ) and BRCA1 (95.0  ± 5.0 % vs. 62.0  ± 12.7 % ) 
promoters. RASSF1 and BRCA1 methylation showed positive asso-
ciation with tubule formation and mitotic index respectively indicating 
their association with disease severity. Hyperhomocysteinemia was 
associated with hypermethylation of RASSF1 in ER and PR negative 
tumors while BRCA1 showed hypermethylation in all molecular phe-
notypes. RASSF1 methylation showed positive association with RFC1 
G80A and SHMT C1420T; and inverse association with MTHFR 
C677T and MTRR A66G variants. BRCA1 methylation showed 
inverse association with GCPII C1561T variant while showing posi-
tive association with RFC1 G80A, cSHMT C1420T, TYMS 5 ’ -UTR 
28bp tandem repeat, TYMS 3 ’ -UTR ins6/del6, MTHFR C677T and 
MTR A2756G variants. To conclude, aberrations in one-carbon metab-
olism infl uence epigenetic profi le of two crucial genes i.e., RASSF1 
and BRCA1 thus directly infl uencing breast cancer progression. 
 WS5 06
Application of the Vitamin Folic Acid as a Targeting Agent for 
Radionuclide Therapy of Folate Receptor Positive Cancer 
 *C. Mueller 1 , H. Struthers 1 , N. Romano 1 , R. Schibli 1 
 
1
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 Background: The vitamin folic acid emerged as a valuable tumor 
targeting agent because of its specifi c accumulation in folate receptor 
(FR)-positive cancer. Thus, a number of folic acid radioconjugates 
have been developed for nuclear imaging purposes. However, due to 
undesired accumulation of folate-based radioconjugates in radiosen-
sitive kidneys a therapeutic application was not possible so far. 
 Aim: The aim of this study was to preclinically investigate a novel 
folate radioconjugate with an albumin binding entity for radiothera-
peutic purposes. 
 Methods: The folate conjugate was radiolabeled with the beta-parti-
cle emitting radioisotope  177 Lu. Cell uptake of the radioconjugate was 
studied in FR-positive KB tumor cells. An ultrafi ltration assay was 
used to investigate plasma binding properties. The  177 Lu-radioconju-
gate was investigated in KB tumor bearing nude mice with regard to 
its tissue distribution and therapeutic anticancer effi cacy. 
 Results: The  177 Lu-radioconjugate proved FR-specifi c uptake in cul-
tured KB cells and signifi cant binding to serum proteins. The tissue 
distribution of the  177 Lu-folate resulted in a high tumor uptake whereas 
accumulation in the kidney was signifi cantly lower than usually found 
with other radiofolates. Therapeutic studies (20 MBq/mouse) in mice 
showed signifi cant inhibition of tumor growth and a prolonged sur-
vival ( > 2-fold) of treated mice compared to untreated controls. 
 Discussion &  Conclusions: Installation of an albumin binding entity 
improves the tissue distribution of folate-based radioconjugates sig-
nifi cantly. This approach allowed for the fi rst time the performance 
of folate-based radionuclide therapy. The excellent preclinical results 
hold promise for future application of FR-targeted radionuclide ther-
apy in patients. 
 Vitamin defi ciency, supplementation, and clinical 
outcome 
 WS6 01
Lower homocysteine levels are associated with better 
quality of life scores in older people 
 *S. Gariballa 1,2 
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 Background: Although there is evidence of a strong link between 
B12/folate status and possibly high levels of plasma homocysteine 
(tHcy) and depression in older adults less is known of a relationship 
between B12, folate and quality of life  1 . The aim of this report is to 
examine the associations between elevated plasma tHcy and quality 
of life scores in older patients recovering from acute illness. 
 Methods: Two-hundred and thirty-six hospitalised acutely ill older 
patients, who were part of a randomised double-blind placebo-con-
trolled trial, were assigned to receive daily mixed oral nutritional 
supplements containing B-group vitamins or a placebo for 6 weeks. 
Outcome measures included quality of life measured using SF-36 
scale and plasma Hcy levels. 
 Results : The mean tHcy concentration fell by 22 % among patients 
given the supplements compared with the placebo group (mean dif-
ference 4.1  μ mol/L (95 % C.I, 0.14 - 8.03), p  = 0.043. tHcy concentra-
tions was divided into 4 quartiles and analysed against quality of life 
scores. tHcy concentrations in the fi rst relative to the fourth quartile of 
the distribution were associated with better quality of life scores at the 
end of the supplement period (SF-36 total score r  = 0.25, p  = 0.01). 
 Conclusions: Lower plasma tHcy concentrations were associated 
with better quality of life scores in older patients recovering from 
acute illness. 
 Reference: [1] Folstein M, Liu T, Peter I, Buel J, Arsenault L, Scott T, 
Qiu WW. Homocysteine hypothesis of depression. Am J Psychiatry 
2007; 164: 861-867 
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 WS6 03 
Urinary betaine excretion predicts excess loss of glomerular 
fi ltration rate in patients with diabetes mellitus 
 *H. Schartum-Hansen 1 , P. M. Ueland 2 , E. R. Pedersen 2 , M. Ebbing 1 , 
G. Svingen 2 , B. Vikse 3 , O. Nyg å rd 2 
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2
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3
 Haukeland University Hospital, Department of Medicine, Bergen, 
Norway 
 Question: We have recently shown that urinary excretion of betaine 
is increased in diabetes mellitus and may be a marker of tubular 
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dysfunction, which has been associated with progression of kidney 
dysfunction in previous studies among diabetic patients. We there-
fore assessed if baseline urinary betaine excretion is a predictor of 
future loss of estimated glomerular fi ltration rate (eGFR) in diabetic 
or non-diabetic patients. 
 Methods: We studied 2133 patients (81.3 % men) without macroal-
buminuria or moderate renal failure. The majority had stable angina 
pectoris, and 225 had established type 1 or 2 diabetes at baseline. 
All participated in the Western Norway B-vitamin Intervention Trial 
(WENBIT). eGFR was calculated at baseline, at follow-up visits after 
1 month and 1 year, and at the end of the study (mean 3.2 years). 
Multilevel linear modelling was used to calculate yearly change in 
eGFR. 
 Results: In patients with diabetes, urinary betaine excretion at 
baseline was a strong predictor of future loss of eGFR, p < 0.001. 
At the geometric mean (SD) of betaine excretion (21.5 (8.1, 58.1) 
mmol/mol creatinine), the estimated (95 % CI) yearly loss of eGFR 
was 1.39 (1.88, 0.91) mL/min/1.73 m 2 . For each standard deviation 
increase in betaine excretion, we observed an additional loss of 0.84 
(1.33, 0.34) mL/min/1.73 m 2 , p = 0.001 per year of follow-up. The 
result was not attenuated by adjustment for potential confounders, 
such as urinary albumin/creatinine ratio, baseline eGFR, age or 
gender. Betaine excretion did not predict loss of eGFR in patients 
without diabetes. 
 Conclusion: Urinary excretion of betaine is an independent predic-
tor of excess loss of eGFR in patients with type 1 or 2 diabetes and 
cardiovascular disease. 
 WS6 04 
Homocysteine in Older Adults: Association with Different 
Aspects of Physical Functioning 
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 Question: Growing evidence suggests that higher homocysteine lev-
els are associated with lower physical functioning in older persons. 
The current study aimed to examine homocysteine in relation to dif-
ferent aspects of physical functioning. 
 Methods: Data from the B-PROOF study (cross-sectional) and the 
Longitudinal Aging Study Amsterdam (LASA) (cross-sectional and 
3-year follow-up) were used. B-PROOF is a randomized controlled 
trial; LASA is an ongoing cohort study. The current study was per-
formed in persons aged  ≥ 65 years (N = 1221-2878 in B-PROOF and 
N = 321-1267 in LASA, depending on outcome). Different aspects of 
physical functioning, including physical performance, muscle mass, 
and grip strength were regarded as outcomes. Gender and serum 
creatinine were investigated as effect modifi ers. 
 Results: In both LASA and B-PROOF, higher homocysteine lev-
els were associated with lower physical performance, only in 
older women. Moreover, higher homocysteine was associated with 
decreased grip strength (B-PROOF) or loss of grip strength (LASA) 
in older women. The association with muscle mass was only found 
in LASA; in persons with serum creatinine levels below the median 
(classifi ed as normal creatinine), homocysteine in the highest quartile 
was associated with an increased odds to loose muscle mass as com-
pared with the fi rst quartile. 
 Conclusions: In both studies, higher homocysteine levels were asso-
ciated with lower physical performance and reduced muscle strength 
in older women. Minor differences might be explained by differences 
in the study populations ’ homocysteine range. 
 WS6 05 
Pyridoxine (vitamin B6) therapy for premenstrualsyndrome 
 *M. Kashanian 1 
 
1
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 Objective: A comparison between Pyridoxine (vitamin B6) and a 
placebo for the treatment of premenstrual syndrome (PMS). 
 Material and Methods: A double blind randomized clinical trial 
was performed on 160 university students who were suffering from 
PMS (according to the retrospective diagnostic criteria which had 
been recorded during the last 3 menstrual cycles). Then the patients 
were randomly assigned into two groups, and fi nally 94 patients who 
had fi nished the study were statistically analyzed. 
 In the Pyridoxine group (46 patients) vitamin B6 was prescribed at a 
dose of 40 mg twice daily (total 80 mg), and in the placebo group (48 
patients) a tablet similar to vitamin B6 tablets in size, smell, shape 
and taste was prescribed 1 tablet twice daily. In both groups the tab-
lets were started from the fi rst day of the fourth menstrual cycle and 
continued for the next two cycles, and during these two cycles the 
symptoms were recorded. 
 Results: The severity of PMS in the second cycle of the treatment 
(in both groups) showed a statistically signifi cant decrease (p  < 0.05, 
Pair T test) and the comparison between the two groups showed that 
the severity of PMS in the Pyridoxine group decreased more than the 
placebo group, which was statistically signifi cant (p  < 0.05, Student 
T Test) and this was because of the reduction in the psychiatric rather 
than somatic symptoms of PMS. 
 Conclusion: Regarding the effect of Pyridoxine in reducing the 
severity of PMS, it can be suggested as a treatment for PMS, at least 
for the psychiatric symptoms. 
 WS6 06 
Folic Acid Paradox: Retrospective Record Review of Psoriatics 
and related skin disease on 1-6 mg Folic acid, Vitamin B6 and 
Vitamin B12 
 *P. Aronson 1 
 
1
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 Background: A psoriasis susceptibility locus has been asociated 
with the nitric oxide synthase (NOS) gene 2. When it is expressed, 
it produces inducible NOS (iNOS), the expression of which can be 
inhibitied by folic acid. iNOS also modulates contact dermatitis. 
Endothelial nitric oxide synthase (eNOS), from the NOS3 gene, exists 
in monomeric and dimeric forms. Coronary artery disease subjects in 
a study by others received either 400 mcg or 5 mg folic acid. The 400 
mcg dose enhanced pro-infl ammatory monomeric eNOS. The 5 mg 
dose signifi ciantly enhanced anti-infl ammatory dimeric eNOS. 
 Aim: To report the effects of low and high doses of of folic acid 
plus 1 mg B12 and 100 mg B6 on psoriasis and psoriasiform contact 
dermatitis. 
 Methods: Retrospective case review of 4 patients Three patients had 
coronary artery disease (2/3 with elevated homocysteine). One of the 3 
had psoriasiform contact dermatitis with nail pitting. The fourth patient 
age 40 had psoriasis onset at age 35 with elevated homocysteine. 
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 Results: Two of the 4 psoriatics had their skin disease fl are on 1-2 
mg daily folic acid. All 4 showed reduction of their body surface 
rash area on 5-7 mg folic acid beginning at 4-10 weeks. Maximum 
percent reduction in body surface area rash were 22 for the 40 year 
old on 4 mg folic acid, 43 (5 mg folic acid), 51 (for a 109-112 kg man 
with psoriasiform contact dermatitis with atopic diathesis on 6 mg 
folic acid and 79 on 5-7 mg folic acid. 
 Discussion and Conclusion: There can be a parodoxical worsening 
effect of daily low dose folic acid (1-2 mg) and a benefi cial effect of 
4-6 mg on psoriasis and psoriasiform contact dermatitis. 
 P6 21 
Serum versus Red Cell Folate - What to do in Clinical 
Practice ? 
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 Background: Folate status can be assessed by serum or red cell folate 
analysis. While serum folate is easily measured on high throughput 
automated analysers red cell folate requires an extra haemolysis step, 
which makes this test more labour intensive and subject to error. It is 
not well established how these two tests compare and if one of them 
should be preferred. 
 Aim: This study sought to compare the ability of serum and red cell 
folate to assess folate status using homocysteine as a functional marker 
of intracellular folate availability. In addition we looked at the responses 
of both parameters to therapeutic folate supplementation and to the 
introduction of mandatory fortifi cation of fl our in Australia in 2009. 
 Methods: Data was collated from 648 patients who had had mea-
surement of folate and homocysteine at a network of hospitals across 
northern Sydney, Australia. Serum vitamin B12 and creatinine were 
also measured and the estimated GFR (eGFR) calculated. All mea-
surements were made on a Roche Modular analyser. Longitudinal 
analysis of a series of folate defi cient patients commenced on supple-
mentation was performed. In addition, all folate results from a 12 
month period before and after the introduction of mandatory fortifi -
cation were evaluated from a total of 12713 subjects. 
 Results: Serum and red cell folate both demonstrated a signifi cant 
independent association with homocysteine on multivariate analy-
sis. Among patients with normal eGFR and vitamin B12, there was 
no difference in correlation coeffi cient with homocysteine between 
serum folate (-0.35; 95 % CI -0.45 to -0.24) and red cell folate (-0.34; 
95 % CI-0.45 to -0.21). Comparison of area under the ROC curve 
for predicting elevated homocysteine showed a signifi cantly better 
performance of serum folate (AUC 0.67) over red cell folate (AUC 
0.58), p < 0.01. Therapeutic folate supplementation of defi cient 
individuals consistently normalised both parameters into the high-
normal range without showing a relevant difference between the 
two. The introduction of mandatory folate fortifi cation in Australia 
increased mean serum (31.2 to 38.5nmol/L) but not red cell folate 
levels (2564nmol/L pre-fortifi cation, 2537nmol/L post- fortifi cation) 
and reduced plasma homocysteine (11.0 to 10.3 μ mol/L). The preva-
lence of abnormally low folate levels was seen to decrease with both 
parameters (decrease of 68 % for serum and 45 % for red cell folate). 
Lastly, red cell, but not serum, folate was seen to demonstrate an 
unexpected negative correlation with haemoglobin. This appears to 
be an artefactual increase in patients with low haematocrit. 
 Discussion and Conclusion: Our results show that serum and red 
cell folate are both useful to assess folate status in humans and to 
monitor the response to supplementation. However, serum folate 
may better identify folate defi cient patients. Given that serum folate 
also has analytical advantages over red cell folate, it may be the pref-
erable test for high throughput laboratories without compromising 
diagnostic performance. 
 B-vitamins and choline in child development 
 WS7 01 
Folate Receptor antibodies (FRAbs) in neurodevelopmental 
disorders 
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 Background: FRAbs are associated with neural tube defect preg-
nancies and cerebral folate defi ciency in developmental disorders 
including Rett syndrome and autism spectrum disorders. 
 Aim: To determine mechanisms by which FRAbs affect neurodevel-
opment  in utero and during weaning in a rat model. 
 Methods: We determined the distribution of FRAbs administered 
IP to dams on GD14 and its effect on  3 HPGA uptake in the fetus. 
Similarly, the localization of Abs administered on PND10, 11 and 
12 in weaning pups and its effect on folate uptake in the brain was 
determined. Additional pups were reared and underwent behavioral 
testing to determine functional defi cits. 
 Results: FRAbs administered to pregnant dams showed most of the 
Ab localization to uterine and placental tissue with associated reduc-
tion in folate uptake in the fetus. FR Abs administered during wean-
ing accumulated in the hippocampus, cerebral cortex, and midbrain 
(20 % each) with highest accumulation in the cerebellum (40 % ). 
Consistent with this, folate uptake was signifi cantly reduced in the 
cerebral cortex, cerebellum and midbrain. 
 Discussion and Conclusion: The results suggest that in addition to 
antibody mediated infl ammation, blocking of folate transport to the 
fetus or to specifi c areas of the brain as the likely primary mecha-
nism by which the antibody exerts its effect. These results offer an 
explanation as to how pharmacologic folate alleviates the symptoms 
associated with FRAb autoimmune disorders. This has major impli-
cations in the prevention and treatment of developmental disorders. 
 WS7 02 
Neurobehavioural effects of neonatal choline supplementation 
in mecp2-308 mouse model of Rett syndrome 
 *L. Ricceri 1 , B. De Filippis 1 , A. Fuso 2 , G. Laviola 1,2 
 
1
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 Rett syndrome is a pervasive developmental disorder, primarily 
affecting girls, that causes a wide variety of debilitating symptoms 
and for which and no cure currently exists. Mutations in the gene 
encoding methyl-CpG-binding protein 2 (MeCP2, a transcriptional 
repressor and activator) have been found to be responsible for about 
90 % of classical RTT cases. Although several MeCP2-target genes 
have been proposed, mechanisms leading to the severe, progressive 
and specifi c neuronal dysfunctions when MeCP2 gene is mutated 
remain to be elucidated. We wanted to investigate long-term effects 
of postnatal choline supplementation (from birth till weaning) in the 
truncated MeCP2-308 mouse model of Rett syndrome. 
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 We exposed from birth till weaning male hemizygous (hz) mutant 
mice to choline supplementation (through dietary dam exposure) and 
evaluate neurobehavioural effects (locomotr activity, emotional pro-
fi le, brain Nerve Growth Factor and Brain Derived Growth Factor 
levels, SAM/SAH ratios). 
 Adult male mutant hz mice showed a reduction of locomotor activ-
ity compared to wild type (wt) littermates. Early choline treatment 
restored wt-like locomotor activity levels in hz mice. Decreased 
levels of cortical mRNA NGF were also found in hz mice. Choline 
supplementation enhanced NGF and BDNF expression in cortical 
and hippocampal regions. 
 In agreement with previous reports on MeCP2 null mice, postnatal 
choline supplementation attenuates some of the behavioural and neu-
robiological abnormalities of the Mecp2-308 phenotype. 
 WS7 03 
Choline requirements, nutritional intake and plasma 
concentrations in extremely preterm infants: retrospective 
analysis and fi rst biochemical data 
 *W. Bernhard 1 , A. Full 1 , R. Kunze 1 , V. Koch 1 , J. Arand 1 , C. Maas 1 , C. 
F. Poets 1 , A. Franz 1 
 
1
 Children ’ s Hospital, Univ. of T ü bingen, Neonatology, T ü bingen, 
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 Question: While accepted as an essential nutrient, the role of choline 
in preterm infant nutrition is unclear. 
 Methods: Estimation of the adequate choline intake (AI) of preterm 
infants from dietary recommendations for term infants, children, and 
adults. Retrospective analysis of the choline intake in inborn infants 
with  < 1000g birth weight or  < 28 weeks gestational age in 2006 and 
2007 (n = 93). Mass spectrometric analysis of choline in blood plasma 
from hospitalized preterm infants (n = 55) compared to age-matched 
cord blood at delivery (n = 35). 
 Results: Estimated AI was 25mg/kg/d. Day by day variability of cho-
line supply was high and reached a plateau at d11 (median: 21.7mg/
kg/d; 25 th percentile: 19.6; 75 th percentile: 23.9). Whereas individual 
supply at d0-3 was  < 10mg/kg/d in 85 % , such values were frequently 
found even from d11 onwards. Intakes  ≥ 25mg/kg/d were only 
achieved in 2-18 % of infants. Whereas at delivery preterm infants 
had median plasma choline of 38 μ mol/L (25 th perc.:27; 75 th perc. 54) 
during neonatal intensive care routine blood suctions only comprized 
18 (13; 22) μ mol/L. 7 out of 55 samples were below 10 μ mol/L. 
 Conclusions: Choline intake does not meet requirements in hospital-
ized preterm infants, with frequent critical shortage until postnatal d10 
and insuffi cient supply in the majority of infants later on. This results 
in decreased choline concentrations, even below adult values. The 
defi cient intake and plasma concentrations demonstrated in this study 
may contribute to the neuro-developmental impairment often observed 
in extremely preterm infants. Future studies need to investigate the 
effects of improved choline supply on neuro-cognitive development. 
 WS7 04 
Maternal Homocysteine In Association With Small For 
Gestational Age Offspring: Systematic Review And 
Meta-Analysis 
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 Question: Growth retardation in utero leading to small for gesta-
tional age (SGA) newborns, is associated with increased neonatal 
morbidity and mortality and with life-long consequences such as 
poor cognitive function and cardiovascular diseases. Maternal total 
homocysteine concentrations (tHcy) have been linked to a wide 
range of adverse pregnancy outcomes and could possibly infl uence 
birth weight. We performed a systematic review and meta-analysis 
on the association of maternal tHcy and birth weight. 
 Methods: A literature search of English, German and French publi-
cations using Pubmed database (January 1966-July 2010) revealed 
78 abstracts. Search terms were: homocysteine AND (birth weight 
OR small for gestational age OR intrauterine growth retardation). 
Studies were eligible if information on maternal tHcy, birth weight 
and the possible association between maternal tHcy and birth weight 
was available. Effect size estimates were converted to odds ratios as 
estimate of the relative risk for a woman to deliver SGA offspring 
when maternal tHcy exceeds the 90 th percentile. 
 Results: The search yielded 19 studies for analysis, consist-
ing of 21,326 individuals. Pooled analysis resulted in a crude OR 
of 1.25[1.09;1.44]. If this estimate is expressed as a linear effect, 
it corresponds to -31[-13;-51]g for 1sd increase in maternal tHcy. 
Adjustment for known confounders was not possible but a tendency 
to decreased strength of association was observed in studies after 
adjustment for strong determinants. 
 Conclusion: Higher maternal tHcy concentrations are associated 
with a small increased risk for SGA offspring. The small estimated 
birth weight difference might be of little clinical relevance for the 
individual newborn, however, it could be of greater importance on 
a population level. 
 WS7 05 
Vitamin B12 defi ciency induce alteration in DNA methylation 
and protein expression in rats: A proteo-epigenetic study 
 *S. Sengupta 1 , S. Sati 1 , A. Kumar K 2 , V. Singh Tanwar 1 , S. Ahmad 1 , A. 
Lalitha 2 , A. Patowary 1 , G. Chandak 3 , M. Raghunath 2 , S. Sivasubbu 1 , 
V. Scaria 1 
 
1
 Institute of Genomics and Integrative Biology, Genomics and 
Molecular Medicine, Delhi, India 
 
2
 National Institute of Nutrition, Hyderabad, India 
 
3
 Center for Cellular and Molecular Biology, Hyderabad, India 
 Background: Vitamin B 12 (B 12 ) is an important micronutrient, defi -
ciency of which is associated with several disorders. Micronutrient 
defi ciency  in-utero is proposed to predict risk of complex disorders 
as DNA methylome is particularly vulnerable to B 12 and folate defi -
ciencies, as these are primary sources of methyl groups. 
 Aim: The aim was to ascertain if maternal B 12 defi ciency affects 
epigenetic reprogramming and thus forms a basis of complex dis-
eases in adults. 
 Methods: We used methylated DNA immunoprecipitation assay, fol-
lowed by high throughput sequencing on Illumina ’ s Solexa platform, 
to identify differentially methylated regions and 2D-differential in gel 
electrophoresis followed by mass spectrometry to identify differentially 
expressed proteins in pups born to B 12 restricted and control mothers. 
 Results: We identifi ed about 1400 DMRs (at 5 % FDR) in the liver 
tissue of B 12 defi cient pups compared to controls. At the proteome 
level, several proteins involved in lipid, carbohydrate and amino acid 
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metabolism were differentially expressed between the two groups 
and the expression of many of these were restored to control levels 
after rehabilitation with B 12 . We also identifi ed a transcription factor 
that affects these pathways and western blot analysis revealed that 
the transcription factor expression is altered in B 12 defi cient group. 
 Discussion and Conclusion: This study is fi rst of its kind as correla-
tion of the effects of maternal nutrition on genome methylation and 
the corresponding proteome profi le of the offspring would help us 
understand the potential mechanisms by which nutritional defi ciency 
during early developmental stages, leads to changes in methylome 
and manifest diseases in adults. 
 WS7 06 
Infantile Thiamine Defi ciency And Its Role In Language 
Impairment In Children 
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 Background: Thiamine plays a central role in cerebral metabolism 
and is essential for brain development in infants. In November 2003, 
twenty infants with encephalopathy were hospitalized in pediatric 
intensive care units in Israel, due to feeding with a non-dairy thiamine-
defi cient infant formula. Two of them died from cardiomyopathy and 
the rest remained with severe neurological sequela. It was estimated 
that 600-1000 infants had been fed with the thiamine defi cient formula. 
These infants were considered as high-risk and their development was 
subsequently monitored. A previous study followed 20 children from 
this group aged 2-3 years and found signifi cant language delay. 
 Aim: To assess the linguistic function of children aged 5-6 years who 
had been exposed to thiamine defi ciency in infancy but had not dis-
played any neurological signs at the time. 
 Methods: 59 children aged 5-6 years, fed with a thiamine defi cient for-
mula for at least one month, were compared with 35 healthy children, 
fed with a different milk substitute, matched for age and residential area. 
All children underwent standardized tests for language assessment that 
are sensitive to lexical and syntactic impairments in this age group. 
 Results: All mean scores of the language assessments were signif-
icantly lower for the thiamine defi cient group. The 3 tests assess-
ing syntactic movement ( p  < .0001), as well as the lexical retrieval 
test ( p  < .0001), indicated syntactic and/or lexical specifi c language 
impairment for  > 90 % in the thiamine defi cient group as compared to 
8 % in the controls. 
 Discussion &  Conclusions: The results indicate that thiamine defi -
ciency in infancy causes severe language disorders, and that dietary 
factors may be one of the causes for language impairment. 
 Molecular mechanisms 
 WS8 01 
N-methyl D-aspartate receptors (NMDARs) in human red 
blood cell membrane as targets for homocysteine and 
homocysteic acid 
 *A. Bogdanova 1 , A. Makhro 1 , P. Haenggi 1 , O. Speer 1 , J. Goede 1 , L. 
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1
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 Background: Recently expression of NMDARs was reported in 
bone marrow and in circulating leucocytes, platelets and in rodent red 
blood cells (RBCs). Activation of these receptors by glutamate, homo-
cysteine (HC) or homocysteic acid (HCA) results in Ca 2 +  uptake. 
 Aim: We have explored expression of NMDAR subunits during 
erythroid precursor differentiation and abundance and function of 
these receptors in circulating RBCs of healthy humans and patients 
with sickle cell disease (SCD). 
 Methods: We have used ex vivo erythropoietic maturation of mono-
nuclear cells, and circulating RBCs from peripheral blood of healthy 
humans and SCD patients. Receptor subunits ’ expression was mea-
sured using qPCR, immunoblotting and fl ow cytometry. NMDAR 
function was assessed using live imaging, patch clamping and associ-
ated changes in cell volume, density and activation of Ca 2 +  -sensitive 
K  +  channels. 
 Results: Functional NMDARs are expressed in erythroid precur-
sor cells and present in circulating RBCs. Receptor abundance and 
activity is signifi cantly enhanced in SCD-RBCs compared to cells of 
healthy subjects. Activation of NMDARs by treatment with agonists 
in vitro or during hemolytic crises in vivo triggers Ca 2 +  uptake, dehy-
dration and  “ sickling ” of SCD-RBCs. Treatment of SCD-RBCs with 
antagonists of NMDARs reversed these effects and reduced Ca 2 +  
uptake and HbS polymerisation. 
Discussion and Conclusion: Our data raise signifi cant concern 
regarding the consequences of up-regulated plasma HC and HCA 
levels in SCD patients. Hyperactivation of NMDARs in circulating 
SCD-RBCs causes dehydration, increase in aggregability of RBCs, 
activation of Ca 2 +  -sensitive proteases contributing to vaso-occlusive 
crises in this group of patients. 
 WS8 02 
Analysis Of The Enzymatic Activity Of Mutant Cbs Proteins 
Reveals A Strong Association With The Localization Of The 
Affected Residue In The Protein Primary Structure 
 *M. Mendes 1,2 , H. Cola ç o 1 , R. Ramos 1 , D. Smith 2 , I. Tavares de 
Almeida 1 , I. Rivera 1 , G. Salomons 2 , H. Blom 2 , P. Leandro 1 
 
1
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2
 VUmc, Clinical Chemistry, Amsterdam, Netherlands 
 Background/Aim: The key regulatory point of transsulfuration is 
catalyzed by cystathionine beta-synthase (CBS), a homotetrameric 
PLP-dependent enzyme activated by S-adenosyl methionine (SAM). 
Each CBS monomer comprises three domains, an N-terminal domain, 
a catalytic core and a C-terminal regulatory domain. Previously we 
characterized the genotypic background of a group of CBS defi cient 
patients and developed a prokaryotic expression system to study the 
identifi ed mutant proteins. Here we present the enzymatic activity, 
SAM activation ratio and oligomeric profi le in crude  E. coli extracts 
of this group of mutant CBS proteins. 
 Methods: CBS cDNA was cloned into pET28b expression vector. 
The mutations P49L, G151R, G153R, K269del, I278T, R336C, 
R336H, G351R, P227L, D444N, S500L and L540Q were introduced 
by site-directed mutagenesis. Enzyme activity was determined in 
crude  E. coli extracts in the absence and presence of SAM (SAM 
activation ratio). Oligomeric profi le was determined by Western blot 
analysis of native-gels. 
 Results/Discussion: We found a strong association between the 
enzymatic activity of the mutant protein and location of the affected 
residue. Mutations in the catalytic domain lead to inactive or lowly 
active proteins, whereas C-terminal domain mutations display a near 
normal activity and mutations within the N-terminal domain present 
an intermediate activity. Interestingly, no link between SAM stimu-
lation and the location of the mutation was found. Further compara-
tive analysis of the recombinant expression results with homozygous 
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patients ’ fi broblast data showed an identical behaviour, therefore 
validating our system. 
 WS8 03 
Cystathionine gamma-lyase-defi cient mice as an animal 
model of cystathioninuria/-emia; the comparison with 
cystathionine beta-synthase-defi cient mice 
 *I. Ishii 1 
 
1
 Keio University Graduate School of Pharmaceutical Sciences, 
Biochemistry, Japan 
 Cysteine is considered as one of the non-essential amino acids in 
mammals because it is synthesized from methionine via methionine 
cycle/transsulfuration. Cystathionine beta-synthase (CBS) and cys-
tathionine gamma-lyase (CSE) are the transsulfuration enzymes 
essential for homocysteine metabolism/cysteine biosynthesis, and 
are currently attracting much attention as the major H 2 S-producing 
enzymes. Although CBS-defi cient mice had been generated as an 
animal model of homocystinuria, most of them die within 4 weeks 
after birth probably due to severe hepatic dysfunction, hampering the 
detailed analyses of these mice. We succeeded to obtain more viable 
CBS-defi cient mice by altering its genetic background to C3H/HeJ; 
the mice appeared normal in general behavioral tests but showed cer-
ebellar malformation and impaired learning ability. We also gener-
ated CSE-defi cient mice as animal model of cystathioninuria/-emia; 
they appeared normal but displayed hypercystathioninemia/hyper-
homocysteinemia though not hypermethioninemia. They displayed 
vulnerability to oxidative injury, acute lethal myopathy in cases 
of dietary cysteine defi ciency, or acute lethal hepatitis in cases of 
dietary methionine excess. Because current newborn screening for 
homocystinuria detects methioninemia but not homocysteinemia 
via either simple Guthrie ’ s method or tandem mass spectrometry, 
CSE-defi cient patients may pass the screening but may suffer homo-
cysteinemia and display severe pathological conditions upon amino 
acid-imbalanced diets. 
 References: Akahoshi et al., Hum Mol Genet 17:1994-2005 (2008); 
Ishii et al., J Biol Chem 285:26358-26368 (2010). 
 WS8 04 
Cystathionine- β synthase defi ciency increases collagen  N -
Homocysteinylation in mice 
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 Background: Clinical manifestations of severe hyperhomocysteine-
mia due to cystathionine- β synthase ( CBS ) defi ciency include con-
nective tissue abnormalities affecting skin, bone, lung, eye, and 
vasculature (Mudd et al.  Am J Hum Genet 1985;37:1). Similar abnor-
malities are observed in  Cbs -/- mice (Hamelet et al.  Exp Mol Pathol 
2007;83:249), but molecular mechanisms underlying these abnor-
malities remain obscure. 
 Aim: We predict that  N -homocysteinylation of collagen lysine resi-
dues will prevent the formation of essential cross-links and cause 
connective tissue abnormalities. Because connective tissues are 
supramolecular assemblies, even low levels of  N -Hcy-lysine in col-
lagen can result in a structural defect. 
 Methods: We studied  Tg - I278T Cbs  -/-  mice (tHcy = 272 ± 50  μ M), 
which have elevated  N -Hcy-protein (16.6 ± 4.1  μ M), and  Tg - I278T 
Cbs  + / +  mice (tHcy = 1.9 ± 1.6  μ M), which have normal and  N -Hcy-
protein (1.6 ± 0.3  μ M) (Jakubowski et al.  Faseb J 2009;23:1721). 
We prepared collagen from skin of these mice using the acetic acid 
extraction method, confi rmed its purity by SDS-PAGE, and analyzed 
its  N -Hcy-collagen content. 
 Results: We found that  N -Hcy-collagen was elevated 18-fold in  Tg -
 I278T Cbs  -/-  mice, compared with  Tg - I278T Cbs  + / +  animals (89.9 ± 25.1 
 vs. 5.0 ± 2.4 pmol/mg skin). 
 Discussion and Conclusion: These fi ndings demonstrate that 
collagen is a target for  N -homocysteinylation  in vivo in mice and 
can account for connective tissues defi ciencies observed in severe 
hyperhomocysteinemia. 
 WS8 05
A novel function for an old folate enzyme 
 *N. Krupenko 1 , I. Kramarenko 1 , S. Krupenko 1 
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 Glycine N-methyltransferase (GNMT), an abundant cytosolic 
enzyme and a major folate binding protein, transfers the methyl 
group from S-adenosylmethionine (SAM) to glycine producing 
S-adenosylhomocysteine and sarcosine. It functions as a metabolic 
regulator of the availability of activated methyl groups. Importantly, 
mouse knockout studies and epidemiological data pointed toward 
GNMT as a cancer susceptibility gene. 
 We studied the role of GNMT in regulation of cellular proliferation. 
 We expressed the protein and its mutants, defi cient in catalysis, folate 
binding or cytoplasmic targeting, in several GNMT-defi cient cell 
lines and evaluated proliferation, apoptosis, and distribution of cells 
between cell cycle phases. Using fl uorescence-based techniques we 
also monitored intracellular compartmentalization of the enzyme. 
 This study demonstrated that GNMT is strongly down regulated in 
various human cancers while the re-expression of GNMT in cancer 
cell lines inhibits proliferation and induces apoptosis. Antiproliferative 
effects of either the catalytically defi cient or folate binding defi cient 
mutants of GNMT were the same as the wild-type enzyme. The 
growth-suppressor effects of GNMT were not rescued by high folate 
or methionine supplementation. We also showed that the enzyme is 
localized in both cytoplasm and nuclei. Furthermore, GNMT engi-
neered to localize to nuclei only still evokes antiproliferative effects. 
 Our fi ndings indicate that the suppressor effects of GNMT were 
not caused by the depletion of SAM or restriction of availability of 
intracellular folates. We suggest that GNMT localized in the nucleus 
is responsible for the proliferation regulatory effects and that these 
effects require interaction of GNMT with specifi c nuclear proteins. 
 WS8 06
Formate and one-carbon metabolism 
 *S. Lamarre 1 , G. Morrow 1 , M. Brosnan 1 , J. Brosnan 1 
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 Background: Impairments of the one-carbon metabolism (1C), due 
to vitamin B-defi ciencies or defects in genes that encode enzymes, 
are associated with numerous pathologies and developmental anom-
alies. We have recently discovered that plasma formate concentration 
is elevated during vitamin B12 and folate defi ciencies (1). 
 Aim: Our objective is to establish a robust assay for formate and to 
use this assay to determine its response to B-vitamin defi ciencies, 
as well as to determine rates of whole-body formate metabolism in 
rats. 
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 Methods: Vitamin B defi ciencies were generated in rats by feeding 
defi cient diets. Plasma formate was measured by GC-MS and homo-
cysteine by HPLC. The whole-body kinetics of formate were deter-
mined by means of a constant infusion of 13C-formate. 
 Results: Formate determination by GC-MS was superior to that by 
formate dehydrogenase, particularly at low formate levels. Plasma 
formate was markedly elevated during folate- and vitamin B12-
defi ciencies but was unaffected by vitamin B6-defi ciency. The entry 
of new formate into the formate pool is estimated to be approximately 
 ∼ 10  μ mol/hr in  ∼ 200 g chow fed rats. 
 Discussion &  Conclusion: Plasma formate concentration is very 
sensitive to disturbances in remethylation but not in transmethylation. 
Thus, it conveys information complementary to that obtained from 
Hcy and methylmalonic acid. Determination of formate kinetics in 
vitamin-B12- and folate-defi cient animals will permit us to establish 
whether a defect in formate production or removal is responsible for 
the hyperformatemia of these conditions. 
 Reference: [1] Lamarre SG, AM. Molloy, SN Reinke, BD Sykes, ME 
Brosnan and JT Brosnan (in press) Formate can differentiate between 
hyperhomocysteinemia due to impaired remethylation and impaired 
transsulfuration. American Journal of Physiology; Endocrinology 
and Metabolism. doi:10.1152/ajpendo.00345.2011 
 Clinical outcome & metabolom after vitamin 
treatment 
 WS9 01
Reduced remethylation in patients with chronic kidney 
disease (CKD) induces vitamin B6 defi ciency by enhanced 
trans-sulfuration activity 
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 Background: Hyperhomocysteinemia and vitamin B6 defi ciency 
reduce bone quality in patients with chronic kidney disease (CKD). 
 Aim: To assess the link between hyperhomo-cysteinemia and vita-
min B6 defi ciency in CKD. 
 Methods: Ten hemodialysis (HD) patients were randomized to 
receive methylcobalamin 500  μ g iv after HD and oral folic acid (FA) 
15 mg/day po (Group A, n = 5) or methylcobalamin and FA plus vita-
min B6 (B6) 60 mg/day po (Group B, n = 5) for 3 weeks. A methi-
onine (Met) loading test was conducted before and after treatment 
and plasma levels of amino acids, such as homocysteine (Hcy), Met 
and cysteine (Cys), were measured. Serum levels of S-adenosyl-
methionine (SAM) and S-adenosylhomocysteine (SAH) were also 
measured in 20 HD patients receiving the Group B regimen. 
 Results: B6 levels were signifi cantly lower in HD patients than con-
trols (2.9 ± 1.1 ng/mL vs 20.1 ± 10.8 ng/mL, p < 0.01). Hcy levels were 
higher when fasting (30.3 ± 10 nmol/mL vs 12.3 ± 5.8 nmol/mL in con-
trols, p < 0.01) and demonstrated a greater increase on Met loading. 
Both treatments normalized the Hcy profi le. The Cys level was also 
signifi cantly elevated. The Met/Hcy ratio (representing remethylation 
activity) was lower in HD patients, but was increased by both treat-
ments. The Cys/Hcy ratio (represents trans-sulfuration activity) was 
unaffected in HD patients, and was also increased by both treatments. 
Serum SAM (441.1 ± 101.8 nmol/L) and SAH (340.1 ± 91.1 nmol/L) 
levels were very high and increased after vitamin supplementation. 
 Conclusion: In CKD, the trans-sulfuration pathway was not attenu-
ated, but was accelerated by Hcy-lowering therapy. Reduced rem-
ethylation induces B6 defi ciency by enhancing trans-sulfuration, 
possibly due to an accumulation of SAM. 
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 Background: Biomarkers and metabolites related to B-vitamin func-
tion and one-carbon metabolism have been studied as predictors of 
chronic diseases in studies based on samples stored in biobanks. For 
most biomarkers, stability data are lacking or fragmentary. 
 Methods: Degradation and accumulation kinetics of 32 biomarkers 
were determined at 23 o C in serum and plasma (EDTA, heparin and 
citrate) collected from 16 individuals and stored for up to 8 days. In 
frozen serum (-25 o C), stability was studied cross-sectionally in 650 
archival samples stored for up to 29 years. Concentration versus time 
curves were fi tted to mono-exponential, bi-exponential, linear, and 
non-linear models. 
 Results: For many biomarkers, stability was highest in EDTA 
plasma. Storage effects were similar at room temperature and at 
-25 o C; notable exceptions were methionine, which could be recov-
ered as methionine sulfoxide, and cystathionine, which decreased 
in frozen samples. Cobalamin, betaine, dimethylglycine, sarcosine, 
total homocysteine, total cysteine, asymetric and symmetric dim-
ethyl arginine, creatinine and methylmalonic acid were essentially 
stable under all conditions. Most B-vitamins (folate, vitamin B 2 and 
B 6 ) were unstable; choline increased markedly, and some amino 
acids also increased, particularly in serum. The kynurenines showed 
variable stability. For many biomarkers, degradation (folate and fl a-
vin mononucleotide) or accumulation (pyridoxal, ribofl avin, choline, 
amino acids) kinetics at room temperature were non-fi rst order. 
 Conclusion:  Data on stability and deterioration kinetics for indi-
vidual biomarkers are required to optimize procedures for handling 
serum and plasma, and for addressing preanalytical bias in epidemio-
logical and clinical studies. 
 WS9 03
Effect of One Year D- and B-vitamins Supplementation on 
Bone Metabolism 
 W. Herrmann1, V. Kruse1, *S. H. Kirsch1, S. Gräber2, R. Eckert3, 
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 Introduction: Vitamins D andB defi ciencies and hyperhomo-
cysteinemia are risk factors for osteoporosis. The benefi t of B-vitamin 
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supplementation onbone metabolism is not well studied and is 
thought to be dependent on vitamin D status. This study investigates 
the effect of 1 year combined oral supplementation of the vitamins B 
and D on bone markers. 
 Methods: 111 subjects (mean age 69 years) were recruited from a 
rehabilitation program. The study was randomized and double blind. 
The treatment arms were: group A recieved 50 mg B 6 , 500  μ g B 12 , 
456 mg calcium, and 1200 IE vitamin D; group B received 1200 IE 
vitamin D and 456 mg calcium. Homocysteine (Hcy), metabolites, 
vitamins,parathormon (PTH), lipids, and bone markers [osteocalcin, 
bone alkaline phosphatase (BAP), tartratresistent acid phosphatase 
(TRAP), desoxypyridoniline (DPD), sclerostin] were determined in 
serum, plasma, or urine. 
 Results: At baseline, high Hcy, low vitamin D3 but elevated plasma 
PTH had been observed. A marked increase of 25-hydroxy vitamin 
D3 was observed in both groups in group A (16 to 32 ng/ml), in 
group B (16 to 29 ng/ml). As a consequence, high baseline PTH 
dropped to normal. Baseline Hcy was elevated ( > 12  μ mol/L) in 
50 % of the people and was normalized only in the group A receiving 
the B-vitamins. The bone metabolism was lowered after the treat-
ment, markers of bone formation (BAP, osteocalcin) as well degra-
dation markers (DPD, TRAP) decreased. Furthermore, the decline 
of osteocalcin in-group A was somewhat less than in group B. The 
changes in bone markers were not remarkable after 6 months of vita-
min treatment. 
 Conclusion: Supplementation with vitamin B and D in elderly sub-
jects had a benefi cial effect in lowering risk factors of osteoporosis 
like Hcy and PTH, which affect bone degradation. There was a ten-
dency that the bone turnover by combination of D and B-vitamins 
was not as high as by using of vitamin D alone. Because of the slow 
bone metabolism, longer duration of D and B-vitamin treatment 
should be tested. 
 WS9 04
Folic acid supplementation may disturb the 
regulatory effect of S-adenosylmethionine on 
methylenetetrahydrofolatereductase activity. 
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 Background: Elevated plasma levels of homocysteine (Hcy) 
are associated with an increased risk of cardiovascular disease. 
Supplementation with folic acid lowered plasma homocysteine, but 
failed to reduce the risk on cardiovascular disease. 
 Aim: Determine the effect of folic acid supplementation on the intra-
cellular levels of one-carbon (1C) metabolites. 
 Method: Fifty healthy volunteers received either 500  μ g folic 
acid daily for 8 weeks, or a placebo. Plasma and peripheral blood 
mononuclear cells (PBMC) levels of S-adenosylmethionine (SAM), 
S-adenosyl-homocysteine, Hcy, methionine, cystathionine and 
5-methyltetrahydrofolate levels were measured by LC-MS/MS. 
 Results: At baseline, plasma levels are a poor refl ection of intracel-
lular levels of most 1C metabolites. Only cystathionine (R = 0.445, 
P = 0.001), 5-methyltetrahydrofolate (R = 0.329, P = 0.024) and Hcy 
(R = 0.350, P = 0.014) showed a signifi cant correlation between plasma 
and intracellular levels. Folic acid supplementation did not signifi -
cantly alter the PBMC levels of any of the 1C metabolites. Multiple 
regression analysis showed that baseline PBMC Hcy levels are cor-
related to PBMC SAM, PBMC methionine, PBMC 5-methyltetrahy-
drofolate and plasma Hcy levels. After folic acid supplementation, 
PBMC Hcy was correlated to PBMC SAH and plasma Hcy, sug-
gesting a loss of SAM ’ s regulatory function. In-vitro experiments 
confi rmed that at higher folate substrate levels, physiological levels 
of SAM no longer inhibit MTHFr. 
 Conclusion: The effect of administration of folic acid is much dif-
ferent intracellularly than in plasma. In fact, intracellular 1C metabo-
lism may become perturbed after folic acid supplementation 
 WS9 05
Supplementation With Cyanocobalamin In Stable Angina: A 
Novel Pathway For Asymmetric Dimethylarginine Breakdown ? 
 *I. Bondarenko 1 
 
1
 North West Research Centre for Hygiene and Public Health, 
Laboratory Medicine, St. Petersburg, Russian Federation 
 Background: Asymmetric dimethylarginine (ADMA) is a naturally 
occurring amino acid and a component of the blood. ADMA is an 
endogenous inhibitor of nitric oxide synthesis, and its plasma level 
(P-ADMA) is elevated in patients with stable angina (SA), being a 
marker and a mediator of endothelial dysfunction in those patients. 
 ADMA is believed to be eliminated mostly via degradation by dime-
thylarginine dimethylaminohydrolases. We suggested that an alterna-
tive, namely, demethylation, pathway may exist for ADMA disrup-
tion, with cyanocobalamin (Cbl) being a methyl group acceptor. 
 Aim: To check if Cbl intake may lead to P-ADMA decrease and 
associated elevation of plasma methylcobalamin (P-MetCbl) in SA 
patients different from controls. 
 Methods: 24 SA patients (P-ADMA:) and 25 age- and gender-
matched controls were given Cbl per os at 500  μ g 2x a day for 2 weeks. 
P-ADMA and P-MetCbl were re-measured on the day 15 by HPLC. 
 Results: In the control subjects, the intake of Cbl has lowered 
P-ADMA from 0,51 ± 0,07  μ M/L to 0,40 ± 0,05  μ M/L (by 18 % , 
p < 0,05) and increased P-MetCbl from 295 ± 68 ng/L to 580 ± 89 
ng/L (by 97 % ; p < 0,05). In SA patients, P-ADMA decreased from 
0,70 ± 0,09  μ M/L to 0,42 ± 0,08  μ M/L (by 40 % ; p < 0,05) and P-MetCbl 
rose from 204 ± 87 ng/L to 760 ± 107 ng/L (by 273 % ; p < 0,05). 
 Discussion and conclusion: Administration of Cbl results in a decline 
of P-ADMA in both control and SA groups (more pronounced in SA). 
This was associated with a substantial increase of P-MetCbl (more pro-
nounced in SA), while the elevation of plasma level of 5 ’ -deoxyade-
nosylcobalamine was less marked. The fi ndings indirectly support the 
possibility of existence of a demethylation pathway for the degradation 
of ADMA that is more active in SA patients compared to controls. 
 WS9 06
Dietary folate, vitamin B 12 and vitamin B 6 affect both plasma 
choline and plasma DHA concentrations in rats 
 *N. van Wijk 1 , C. J. Watkins 2 , R. J. J. Hageman 1 , J. W. C. Sijben 1 , P. 
J. Kamphuis 1,3 , R. J. Wurtman 2 , L. M. Broersen 1 
 
1
 Danone Research, Centre for Specialised Nutrition, Disease Targeted 
Nutrition, Wageningen, Netherlands 
 
2
 Massachusetts Institute of Technology, Dept. of Brain and Cognitive 
Sciences, Cambridge, MA, USA, United States 
 
3
 Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 
Utrecht, Netherlands 
 Background: Folate, vitamins B 12 and B 6 are essential nutritional 
components to support transfer of one-carbon units and therefore 
could support methylation of phosphatidylethanolamine (PE) to 
phosphatidylcholine (PC) by PE- N -methyltransferase (PEMT) in 
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the liver. It has been suggested that PC synthesis by PEMT cannot 
only affect choline availability but also infl uence circulating levels 
of polyunsaturated fatty acids, like docosahexaenoic acid (DHA) 
(Watkins  et al. , 2003). 
 Aim: To investigate whether dietary enrichment with the three 
B-vitamins could increase plasma choline and DHA levels in rats. 
 Methods: Exp1: Plasma free choline, total DHA and total homo-
cysteine (tHcy) were measured in rats that consumed a B-vitamin-
poor diet for 4 weeks after which they were either continued on the 
B-vitamin-poor diet or switched to a B-vitamin-enriched diet for 
another 4 weeks. 
 Exp2: Plasma total DHA and tHcy were measured in rats after feeding 
them one of 4 diets with increasing levels of B-vitamins for 4 weeks. 
 Results: The results demonstrate for the fi rst time that rats supple-
mented with B-vitamins show higher plasma choline and DHA 
concentrations. Moreover, plasma DHA was found to be dose-de-
pendently increased by dietary B-vitamins. 
 Conclusion: The current data demonstrate the interdependence between 
B-vitamin intake and plasma choline and DHA, possibly mediated by 
enhancing PC synthesis by PEMT. Details on this mechanism, clinical 
implications, and pending additional results will be presented. 
 Folate physiology and methods 
 WS10 01
Clinical Recognition and Aspects of the Cerebral Folate 
Defi ciency Syndromes 
 *V. Ramaekers 1 , J. M. Sequeira 2 , E. V. Quadros 2 
 
1
 University of Li è ge, Department of Pediatric Neurology and Center 
of Autism, Li è ge, Belgium 
 
2
 SUNY-Downstate Medical Center, Departments of Medicine/Cell 
Biology, Brooklyn, United States 
 Cerebral Folate Defi ciency Syndrome (CFDS) represents a group 
of neuro-psychiatric disorders associated with low spinal fl uid  5 N-
methyltetrahydrofolate (MTHF) in the presence of normal folate and 
B 12 status outside the nervous system. The most compelling underly-
ing cause of CFDS is the presence of serum autoantibodies of the 
blocking and binding type directed against and forming complexes 
with the folate receptor (FR) antigen attached to the plasma-side of 
choroid plexus epithelial cells, which normally mediates the trans-
port of MTHF to the CNS. Alternative causes of CFDS are FOLR-1 
mutations and mitochondrial disorders. 
 Two important clinically recognizable syndromes of FR-antibody 
mediated CFDS have been detected in young children, being the 
infantile-onset CFD syndrome presenting 4 to 6 months after birth 
and a spastic ataxic syndrome which may present from the age of 1 
year. In addition, serum FR autoantibodies and CFDS have also been 
reported in a proportion of children affected by a variant of the Aicardi-
Gouti è res syndrome, Asperger syndrome, PDD.NOS, Rett syndrome 
and childhood disintegrative disorder (Heller ’ s dementia). Moreover, 
we have identifi ed within the autism spectrum disorders, CFDS due to 
FR auto antibodies as an important neurobiological marker for infan-
tile autism associated with or without neurological defi cits. 
 The heterogeneity of the clinical phenotype associated with 
FR-autoantibody mediated CFDS might be explained by differences 
in the time of onset and period during which these FR autoantibod-
ies are generated and lead to folate defi ciency within the nervous 
system. Folate defi ciency during various critical stages of fetal devel-
opment and infancy could have profound effects on the structural 
and functional refi nement of the brain. Public awareness of CFDS in 
association with FR autoimmunity should lead to early detection and 
diagnosis with improved prognosis of these potentially treatable new 
group of neuro-psychiatric disorders. 
 WS10 02
Folate receptor alpha is crucial for folate transport across the 
blood-CSF barrier 
 *R. Steinfeld 1 , M. Grapp 1 
 
1
 University of Goettingen, Pediatrics, Goettingen, Germany 
 Background: Folates are essential nutrients and necessary cofac-
tors for important metabolic pathways such as synthesis of amino 
acids, DNA and lipophilic substances. The major biological active 
metabolite 5-methyltetrahydrofolate (MTHF) is distributed by the 
blood stream. Active MTHF transport into the brain occurs at the 
choroid plexus and results in a twofold higher MTHF concentration 
in cerebrospinal fl uid (CSF) than in plasma. 
 Aim: Reduced MTHF concentrations in the human CSF are associ-
ated with various neurological symptoms such as epileptic seizures, 
developmental delay and movement disorders. We aimed to disclose 
the interrelation between the clinical picture associated with reduced 
MTHF concentration and genetic alterations in MTHF transporting 
proteins. 
 Methods: We studied a group of pediatric patients with progres-
sive neurological symptoms as well as severely reduced folate con-
centrations in the CSF. We assessed brain myelination by MRI and 
metabolic state by in vivo MR spectroscopy. Patients with brain 
abnormalities were screened for mutation in theFOLR1gene coding 
for folate receptor alpha (FRalpha). 
 Results: In 11 patients we identifi ed mutations in the FOLR1 gene. 
The identifi ed mutations either resulted in loss of FRalpha expres-
sion or in intracellular mistargeting of mutant FRalpha. Folinic acid 
therapy could restore CSF MTHF concentrations, reverse white mat-
ter alterations and consecutively improve clinical symptoms. 
 Discussion and conclusions: Mutations in the FOLR1 gene coding 
for FRalpha are responsible for inherited cerebral folate transport 
defi ciency, a treatable childhood neurodegenerative disorder. 
 WS10 03
Regulatory mechanisms of folate transport in a rat model of 
folate oversupplementation. 
 *J. Kaur 1 , S. Dev 1 , N. A. Wani 1 , S. Thakur 1 
 
1
 Postgraduate Institute of Medical Education and research 
(PGIMER), Biochemistry, Chandigarh, India 
 Background: Folic acid is key one-carbon donor required for 
numerous biological function, the defi ciency of which is associated 
with the risk of various diseases. Countries with obligatory folate 
fortifi cation of food have documented a signifi cant decrease in neural 
tube defects. Food fortifi cation along with nutritional supplements 
creates a state of folate oversupplementation, the effect of which on 
the folate absorption and regulation has not been studied. 
 Aim: To examine the effects of folate oversupplementation on the 
intestinal and renal folate transport in rats. 
 Methods: Male Wistar rats in group I were given semisynthetic diets 
containing 2mg folic acid/kg diet (control) and those in group II were 
given folate oversupplemented rat diet (20mg folic acid/ kg diet) for 10 
days (short-term treatment) and for 60 days (long-term treatment). 
 Results: Folate uptake in intestine and kidney was signifi cantly 
reduced in short-term folate oversupplemented rats as compared to 
control rats which was associated with a signifi cant decrease in the 
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expression of the reduced-folate carrier (RFC) and proton coupled 
folate transporter (PCFT). Long-term oversupplementation, how-
ever, did not affect the transport. 
 Discussion and conclusion: Short-term folate oversupplementation 
leads to a signifi cant decrease in intestinal absorption and renal reab-
sorption of folate in association with down-regulation of RFC and 
PCFT via some post-transcriptional mechanisms. 
 WS10 04
Factors Affecting 5-Methyltetrahydrofolate (5MTHF) Stability: 
Implications for 5MTHF Defi ciency Observed in Inherited 
Metabolic Disorders 
 *S.-B. Aylett 1 , V. Neergheen 2 , S. Eaton 3 , J. Land 2 , S. Rahman 1 , S. 
Heales 1,2,4 
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 Background: Defi ciency of 5MTHF in CSF has been documented 
in a range of inherited metabolic disorders, including those where 
mitochondrial function is impaired. 
 Aim: The aim of this study was to gain further insight into the fac-
tors that infl uence 5MTHF stability in CSF by utilising a range of 
experimental model systems. 
 Methods: 5MTHF was quantifi ed by reverse-phase HPLC with fl uo-
rescence detection. The stability of 5MTHF was determined in, (i) 
phosphate buffer (pH 7.4), (ii) pooled human CSF, (iii) phosphate 
buffer in the presence of ascorbate, (iv) phosphate buffer and (v) 
pooled human CSF in the presence of a hydroxyl radical generat-
ing system utilising Fenton chemistry (Fe 2 +   + H 2 O 2  → Fe 3 +   + OH  •   + 
OH - ). All experiments were carried out in air saturated conditions at 
37 ° C under timed incubations. 
 Results: 5MTHF (500 nM and 150 nM) degraded in buffer, with 
approximately 46 % and 27 % disappearing over time periods of 150 
and 210 minutes, respectively. In contrast, endogenous 5MTHF pre-
sent in CSF remained relatively stable. Addition of ascorbate (150 
 μ M) stabilised 5MTHF in buffer. In both buffer and CSF, hydroxyl 
radical generation led to the rapid degradation of 5MTHF. 
 Discussion and conclusion: The relative stability of 5MTHF in CSF, 
in contrast to buffer, infers the presence of a protective factor counter-
acting degradation. The observation that ascorbate, which is present 
in CSF, confers 5MTHF stability, suggests that this is a biologically 
relevant protective factor. The presence of a hydroxyl radical gen-
erating system markedly increased degradation in CSF, indicating 
that any protective mechanism present may be overwhelmed. These 
fi ndings suggest that oxidative stress within the CNS can lead to 
decreased 5-MTHF availability. 
 WS10 05
Folate-dependent regulation of cellular motility 
 *S. Krupenko 1 , N. Oleinik 1 , N. Krupenko 1 
 
1
 Medical University of South Carolina, Biochemistry and Molecular 
Biology, Charleston, United States 
 Cell motility is regulated by a complex network of extracellu-
lar signals including essential nutrients. One of such nutrients 
is folate, a vitamin serving as a coenzyme for the fundamental 
metabolic reactions of one-carbon transfer. Folate abundance is 
benefi cial for cellular proliferation, which require effi cient folate 
pathways to support de novo nucleotide biosynthesis and methy-
lation processes. Not much is known about the role of folate in 
motility regulation. 
 We studied the role of folate in regulating cancer cell motility. 
 We evaluated effects of media folate on motility and actin dynam-
ics in a cell culture model by several invasion/migration assays and 
fl uorescence-based techniques. Using bioluminescent imaging upon 
tail vein injection of A549 cells stably expressing fi refl y luciferase, 
we monitored colonization of cancer cells in the lung of SCID mice 
kept on normal  vs. folate defi cient diet. 
 We have shown that folate deprivation strongly inhibits migration 
and invasion of cancer cells through a mechanism associated with 
robust dephosphorylation of the actin depolymerizing factor cofi lin 
by two major cellular phosphatases, PP1 and PP2A, followed by the 
alterations in actin cytoskeleton. Upon folate withdrawal we observed 
F-actin stabilization, re-distribution of cytoplasmic actin toward strong 
preponderance of fi lamentous actin and formation of actin stress 
fi bers. We have further demonstrated that the dietary folate restriction 
prevents colonization of cancer cells in lung of SCID mice. 
 We have demonstrated distinct intracellular pathways regulating 
motility in response to folate status. Our data further suggest that 
these mechanisms underlay folate effects in enhancing cancer-related 
metastatic processes. 
 WS10 06
Stable isotope dilution assays as tools for determining folate 
contents and bioavailability 
 *M. Rychlik 1 
 
1
 Lehrstuhl f ü r Analytische Lebensmittelchemie, Technische 
Universit ä t M ü nchen, Freising, Germany 
 Introduction: Folates play a crucial role as coenzymes in the 
metabolism of one-carbon groups. Therefore, folate defi ciency is 
considered to increase the risk of neural tube defects and is sus-
pected of being associated with the development of several wide-
spread diseases. 
 For examining folate concentrations, one of the most accurate quan-
titation method is the stable isotope dilution assay (SIDA), which is 
based on the use of isotopically labelled analogues of the analytes as 
internal standards. The merits of SIDA include the ideal compensa-
tion for losses and superior specifi city. 
 Objective: To establish accurate dietary recommendations and to 
evaluate folate bioavailability, different approaches can be pursued. 
Of these, two short-term designs were applied. 
 Methods: In the fi rst investigation, we examined bioavailability in a 
large-scale human study with application of 3 model foods and folic 
acid as the reference dose. Folates were quantifi ed in the test foods 
and in the plasma of the volunteers by newly developed SIDAs. A 
second approach was a double label isotope study, in which deute-
rium and 13C-labels were used to differentiate oral doses from ana-
lytical internal standards. 
 Results: Calculation of area under the curve data of the post-dose 
plasma folate levels revealed a folate bioavailability of 20 % , 73 % 
and 33 % in Camembert cheese, Spinach and wheat germs, respec-
tively, relative to folic acid. 
 Using the double label technique, we were able to detect the signals 
of all folate isotopologues in blood plasma and to show that folate 
vitamers show different absorption behaviours. 
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 Conclusion: As folate bioavalability widely varies for different 
foods and different vitamers, further human studies are necessary to 
compile valid dietary recommendations. Differently labelled folates 
are perfect tools for this task. 
 Advanced experimental models in vitamin 
research 
 WS11 01
New Focus on Pyridoxamine effects in Experimental Diabetic 
Nephropathy 
 *M. Elseweidy 1 
 
1
 Faculty of Pharmacy, Zagazig University, Biochemistry, Zagazig, 
Egypt 
 Diabetic nephropathy is a clinical syndrome characterized by marked 
decline in glomerular fi ltration rate (GFR),persistent Albuminuria 
and arterial hypertension in the absence of clinical or laboratory evi-
dence of any other disease. It has become the main cause of end-
stage renal failure (ESRF). Pyridoxamine is a vitamer in the vitamin 
B6 family which have certain metabolic effects. It can inhibits the 
maillard reaction and can block the formation of advanced glyca-
tion end products. Present work aimed mainly to study the metabolic 
effect of pyridoxamine in Diabetic nephropathy. 
 Method: Male Albino rats were rendered diabetics by alloxan 
admini stration 90 mg/kg body weight, Later division into 2 main 
groups. The fi rst one has received pyridoxamine orally (180 mg/kg 
bw) daily for 6 weeks, the other one was kept as diabetic control. 
certain biomarkers were selected for evaluation of pyridoxamine 
effect. 
 Results: pyridoxamine induced signifi cant decrease in serum glu-
cose, fructosamine, urea, creatinine, CRP, urinary microalbumin, 
protein, renal MDA, expression of TNF- α , TGF- β -1 joined with 
increased GSH as compared to diabetic control group > 
 Histopathological examination of renal tissues illustrated certain 
regeneration attempts, dilated peritubular capillaries and normal 
appearance of renal tubules with focal interstitial lymphocytic 
aggregation 
 Conclusion: Marked improvements were observedin renal functions, 
antioxidant status, glycemic control. This may deserve the presenta-
tion of pyridoxamine as a new therapeutic candidates for diabetic 
nephropathy. 
 WS11 02
Dietary betaine supplementation enhances growth 
performance, carcass and immune response of New Zealand 
White rabbits under high ambient temperature 
 *T. Ebeid 1 , R. Hassan 1 
 
1
 Faculty of Agriculture, Kafrelsheikh University, Department of 
Poultry Production, Kafr El-Sheikh, Egypt 
 A total of 120 weaned New Zealand White male rabbits, 6 weeks 
old, were randomly divided into fi ve experimental treatments (24 
each). Animals were fed  ad libitum the basal diet supplemented 
with 0 (control), 250, 500, 750 and 1000 mg betaine /kg diet from 
6 to 12 weeks of age. Animals were provided with water freely. 
The average daily temperature and relative humidity inside the rab-
bitry were 30.3 ± 0.9  ° C and 76.2 ± 2.5  % , respectively. Under heat 
stress conditions, diet signifi cantly increased the body weight and 
hot carcass weight and signifi cantly reduced the feed conversion. 
Dietary 1000 and 750 mg betaine/kg increased (P < 0.05) fi nal body 
weights (2529.1 and 2418.5 g, respectively) compared with the 
control (2110.3 g). Betaine supplementation ameliorated some of 
the adverse effects of heat stress on immune responsiveness, rectal 
temperature and respiration rate. Dietary 250, 500, 750 and 1000 
mg betaine/kg led to a decrease in rectal temperature (40.03, 39.85, 
39.63 and 39.53  ° C, respectively) compared with the control (40.20 
 ° C). The inclusion of 1000 mg betaine/kg in the growing rabbits ’ 
diets nearly doubled the humoral and immune responses compared 
to the controls (P < 0.05) and signifi cantly reduced rectal temperature 
and respiration rate. Serum T3, T4, total protein, globulin and total 
lipids were signifi cantly increased while serum glucose concentra-
tion was signifi cantly decreased due to dietary betaine. In conclu-
sion, supplemental dietary betaine enhanced growth performance 
and humoral and cell-mediated immunity as well as reduced rectal 
temperature and respiration rate in growing rabbits subjected to heat 
stress. From an economic point of view, high levels of betaine are 
not recommended because betaine is reasonably effective at lower, 
less expensive, doses. 
 WS11 03
Ameliorative Effects Of Beta Vulgaris (L.) On Ethanol  – 
Mediated Hepatotoxicity And Oxidative Stress: In Vitro And 
In Vivo Studies 
 *N. K. Jain 1,2 , A. K. Singhai 1,2 
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 Background: The roots of  Beta vulgaris Linn. (Family - 
Chenopodiaceae) are widely used in Indian traditional medicine for 
various ailments including hepatic disorders 1,2 . 
 Objective: The aim of present study was to investigate the protec-
tive effect of  Beta vulgaris root (BV) on ethanol induced hepato-
toxicity and oxidative stress using  in vitro and  in vivo screening 
models. 
 Methods: In the  in vitro evaluation, primary cultures of rat hepato-
cytes were exposed to ethanol with or without various plant samples 
or silymarin for 2 h. The cell viability and the levels of serum marker 
enzymes were determined. In the  in vivo evaluation, rats were treated 
with BV or silymarin once daily for 7 days and a single oral dose of 
ethanol. Histopathological changes and the levels of serum marker 
enzymes and antioxidants were assayed. 
 Result: In the  in vitro evaluation, butanol fraction of BV (BVBF) 
was found to be more potent than others as evident from marked 
increase in cell viability and decrease in serum marker enzymes. 
In the  in vivo evaluation, BVBF and silymarin elicited a signifi cant 
hepatoprotective and antioxidant activity as evident by lowering the 
serum marker levels and elevation of antioxidants in a dose depen-
dent manner. The biochemical observations were supplemented with 
histopathological results. 
 Discussion and conclusion: The present study demonstrates that 
butanol fraction of  Beta vulgaris roots has signifi cant hepatoprotec-
tive activity against ethanol induced hepatotoxicity, which could be 
attributed to the antioxidant effect of the constituents and enhanced 
antioxidant defenses. 
 References: [1] Diehl AM.: Alcohol 27, 7-11(2002). [2] Kirtikar KR, 
Basu BD.: Indian Medicinal Plants, Lalit Mohan Basu, Allahabad 
2005. 
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 WS11 04
Methyl Donor Defi ciency infl uences development, mucosal 
barrier, infl ammation, and innate immunity in the Small 
Intestine of New Born Rats 
 *S. Pooya 1 , A. Bressenot 1 , A. Germain 1 , C. Bossenmeyer-Pouri é 1 , 
J.-L. Gu é ant 1 , L. Peyrin-Biroulet 1 
 
1
 Inserm U954, Facult é de M é decine, Vandoeuvre les Nancy, France 
 Background: Infl ammatory bowel diseases (IBD) are a major public 
health problem. The potential link between methyl donors and IBD 
is supported by population studies. Methyl donor defi ciency (MDD) 
aggravates experimental colitis in rats. 
 Aims: We investigated whether a diet lacking methyl donors (folate, 
vitamin B12 and choline) may affect development and functions of 
small intestine in rat pups from dams subjected to the defi ciency dur-
ing gestation and lactation. 
 Methods: Pathways related to development, mucosal barrier and innate 
immunity were studied in both proximal and distal intestine of rat pups. 
 Results: A global wall hypotrophy was observed in distal small 
bowel with increased crypt apoptosis, loss of enterocyte differentia-
tion in villous and reduction of intestinal phosphatase alkaline pro-
duction. Cleaved caspase-3 immunostaining and Apostain labelling 
index showed increased crypt apoptosis. Decreased proliferation was 
observed in crypts of the proximal small bowel with a reduced number 
of MCM-6 and PCNA-positive cells. This lack of enterocyte differ-
entiation in distal small bowel was associated to impaired expres-
sion of  β -catenin and decreased  β -catenin/E-cadherin interaction. 
Low Protein Phosphatase 2A expression levels may trigger increased 
 β -catenin degradation. MDD also affected proximal small bowel by 
decreasing Paneth cells number after immunostaining for lysosyme 
and by reducing goblet cells number and mucus production after 
immunostaining for mucin-2. Decreased expression of PPARgamma 
and hypomethylation of PGCalpha were consistent with the decreased 
expression of beta-Defensin1, a target of PPAR gamma. 
 Conclusion: The MDD produces dramatic effects on enterocytes, 
which may predispose to IBD 
 WS11 05
Creatine supplementation and homocysteine metabolism in 
rats fed choline-defi cient diet 
 *R. Deminice 1 , L. Vieira Francicco 1 , L. E. Costa Mendes da Silva 1 , F. 
Trevisan Franjacomo 2 , S. Britto Garcia 2 , A. Afonso Jordao 1 
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 Background: Choline-defi cient diet (CDD) impairs methionine 
metabolism and increases homocysteine (Hcy) levels. Studies have 
shown that creatine supplementation modulates the fl ux of transmethy-
lation reactions and decreases blood (Hcy) levels. However, the effects 
of creatine supplementation on CDD have been poorly explored. 
 Aim: To examine the effects of creatine supplementation on Hcy 
metabolism in rats fed choline-defi cient diet. 
 Methods: Twenty four rats were divided into 3 groups of 8 rats each: 
control diet (C), choline-defi cient diet (CDD), choline-defi cient diet 
supplemented with creatine (Cr). The CDD diet was AIN-93 without 
the choline recommended content. Creatine was supplemented by the 
inclusion of 2 % in the diet. The rats received the diets for 4 weeks. 
 Results: The CDD diet signifi cantly increased Hcy concentration 
(50 % ) and decreased hepatic S-adenosylmethionine concentration 
(SAM) (25 % ). Creatine supplementation signifi cantly increased 
plasma (303 % ) and liver (478 % ) creatine concentration and greatly 
down-regulated endogenous creatine synthesis, as evident from a 
 ∼ 80 % decrease in renal arginine:glycine amidinotransferase activ-
ity. This mechanism caused reduction in plasma Hcy (C 11.2 ± 0.7, 
CDD 16.9 ± 1.3, Cr 10.1 ± 0.6, umol/L). However, it did not returned 
hepatic SAM levels to normal. In addition, there were not changes 
in plasma cysteine, methionine, vitamin B12 and folate. It was also 
found increased plasma MDA (25 % ) and ALT (30 % ) levels. Creatine 
supplementation partially normalized these perturbations. 
 Conclusion: Creatine supplementation prevents increased Hcy induced 
by choline-defi cient diet probably by methyl fl ux modulation. 
 Supported by Prodoc-Capes, Brazil. 
 WS11 06
Homocysteine-lowering therapy: a novel non vitamin drug 
 *D. Giustarini 1 , P. Del Soldato 2 , *R. Rossi 1 
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 We recently observed that new chemical entities, obtained by 
grafting DG1 (a dithiolethione moiety) onto existing drugs, not-
withstanding their deep chemical differences, shared a particular 
characteristic, affecting aminothiol metabolism in several tissues. 
We also found that a similar effect was obtained in animals treated 
with DG1 alone. Starting from these observations we had the idea 
to test the parent compound DG2 (DG1 is one of its metabolites) 
as possible lowering Hcys therapy. Our data obtained on rats essen-
tially show that: 
oral administration of DG2 signifi cantly decreases total Hcys in i) 
normal rats; 
 oral administration of DG2 signifi cantly decrease total Hcys in ii) 
hyperomocysteinemic rats; 
 oral treatments with DG2 increase glutathione (GSH) and iii) 
Cysteine (Cys) levels not only in blood but also in most of analy-
sed tissues (in particular in liver and kidney): 
 GSH (and Cys) increase were paralleled by their enhanced iv) 
export in particular by liver and kidney; this, in turn, evokes a 
higher thiol to disulfi de ratio in plasma and the consequent trans-
formation of the majority of circulating homocysteine (protein 
bound) into low molecular weight form(s) that are more easily 
excretable or metabolizable to Cys. 
 It is noteworthy that GSH increase and Hcys decrease may have syn-
ergic action on preventing the detrimental actions of hHcys: GSH 
is a antioxidant compound and its increase may help to balance the 
damaging effects of Hcys according to oxidative stress hypothesis. 
 DG2 is a potent drug able to decrease circulating homocystene and 
warrants soon a study in humans in alternative to the classic vitamin 
therapy. 
 POSTER PRESENTATIONS 
P1  – B12, biochemistry, transport, metabolism 
and disorders 
 P1 01
Metabolism and Disorders of Vitamin B 12 
 *T. Gruner 1 
 
1
 Southern Cross University, School of Health & Human Sciences, 
Lismore, Australia 
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 Background: Vitamin B 12 is not commonly thought of as causing 
defi ciency as it is abundant in most people ’ s diet in the form of ani-
mal proteins. 
 However, factors affecting its uptake, transport in the blood and stor-
age in tissues include the presence and effi cacy of hydrochloric acid, 
Intrinsic Factor, plasma transport and tissue storage proteins. 
 The conversion of homocysteine to methionine, important for methy-
lation reactions, requires vitamin B 12 and folic acid as co-factors. If 
either of these vitamins is lacking, homocysteine will accumulate in 
tissues. 
 Discussion: Other than pernicious anaemia health issues leading 
to lowered B 12 status include cystic fi brosis, hydro- or achlorhydia 
and atrophic gastritis, gastric or ileal resection, and liver pathology. 
Defi ciency symptoms usually develop over several years and can be 
diffi cult to diagnose initially. 
 As a result, homocysteine can accumulate and lead not only to heart 
disease but also to Down syndrome, spina bifi da, neuropsychiatric 
disorders, osteoporosis and DNA damage. 
 Serum vitamin B 12 , the most commonly employed blood test, fails to 
diagnose the defi ciency accurately, leading to underdiagnosis of vita-
min B 12 defi ciency. Measuring the metabolic intermediates methyl-
malonic acid and homocysteine, or holo-transobalamin II, are more 
accurate markers. 
 The best treatment option (other than for lack of B 12 in the diet) is 
regular intramuscular vitamin B 12 injections. 
 Conclusion: Vitamin B 12 -related health disorders are often over-
looked due to non-specifi c symptoms and lack of (accurate) testing. 
Treatment should be implemented in GIT pathologies to avoid the 
fl ow-on effects with major repercussions to life quality and costs to 
the health care system. 
 P1 02
Vitamin B 12  – The Missing Link in Mental Health ? 
 *T. Gruner 1 
 
1
 Southern Cross University, School of Health & Human Sciences, 
Lismore, Australia 
 Background: Nutritional repletion and optimization of nutrient sta-
tus can avert or at least improve many health problems including 
mental health, thus reducing the burden on the national health care 
system. One such nutrient is vitamin B 12 - a commonly overlooked 
factor. A literature search was conducted on the link between low 
vitamin B 12 (with or without folate) status and neurological and psy-
chological health problems. 
 Discussion: Both vitamin B 12 and folate are required to lower homo-
cysteine and are thus cofactors in methylation reactions. Low status 
of either of these vitamins can compromise methylation, potentially 
leading to a range of health problems, including psychological and 
neurological symptoms, and dementia. 
 Apart from lack in the diet (as in vegans) low vitamin B 12 status is 
encountered frequently in people with gastrointestinal and liver pathol-
ogy as this compromises the absorption and utilization of the vitamin. 
This may provide the missing link to the above-mentioned pathologies. 
 The most commonly employed test for vitamin B 12 status is serum B 12 , 
an unreliable marker of vitamin B 12 status. Therefore, some people with 
low vitamin B 12 status may go undiagnosed. Once symptoms appear, 
especially regarding dementia, repletion with the vitamin is unlikely to 
reverse existing neurocellular damage; hence it is prudent to identify 
and treat those at risk well before signs and symptoms develop. 
 Conclusion: As vitamin B 12 is safe, affordable and non-toxic it should 
be provided to those at risk either orally on a daily basis, or admin-
istered intramuscularly in cases of compromised gastrointestinal or 
liver function, in order to maintain adequate body stores and reduce 
the risk of methylation-related pathology. 
 P1 03
Vitamin B12 Prodrugs for Chemotherapy 
 *M. T. Q. Tran 1 , R. Alberto 1 
 
1
 Institute of Inorganic Chemistry, University of Zurich, Zurich, 
Switzerland 
 Background: Vitamin B12 is an attractive molecule for chemotherapy 
for 2 reasons, its essential role in the growth of fast-growing cells and 
its ability to release the axial ligands inside the cells. The latter guar-
antees the liberation of anticancer drugs at tumor sites, if introduced at 
the axial position of B12. As a proof, the crystal structure of vitamin 
B12-{PtCl(NH3)2} conjugate (1), its physio-logical stability[1a] , bio-
logical activity[1b] and cytotoxicity[1c] were previously reported. 
 Aim: This work studies the delivery capability of vitamin B12 to 
other non-metal chemotherapeutic agents including cytarabine, dac-
arbazine, and anastrazole. 
 Methods: HPLC, NMR, IR, and MS (characterization); MTT and 
Resazurin assays (IC50). 
 Results: All three compounds, B12-cytarabine (2), B12-dacarbazine 
(3) and B12-anastrazole (4) were stable in a mixture with human 
serum albumin for at least 3 days. IC50,  μ M = 0.2 (2 on leukemia 
cancer K562 cells). Both anastrazole and (4) do not show IC50 (on 
breast cancer MCF7 cells). IC50 of (3) is under investigation. 
 Discussion and conclusion: The stability of B12-prodrugs in 
human serum albumin guarantees the availability of the compounds 
for tumor uptake. The in-vitro experiments were performed with 
no addition of B12 transport proteins. As B12-prodrugs enter the 
cells through receptor-mediated uptake, the prodrugs are expected 
to have higher cytotoxicity than the reported values in living organ-
isms with suffi cient expression of transport proteins. These results 
show that B12 is suitable to deliver different types of chemothera-
peutic agents, metal-based (cisplatin) and non-metal (cytarabine, 
dacarbazine, and anastrazole), with different types of cancer (cytar-
abine for leukemia, dacarbazine for melanoma, and anastrazole for 
breast cancer). As anastrazole is effi cient for breast cancer after 
surgery and for metastasis in pre- and post-menopausal women, it 
is not surprising that (4) and anastrazole show no IC50 in in-vitro 
assay for MCF7 cells. Therefore, it is interesting for a future in-vivo 
experiment with (4). 
 [1] a) S. Mundwiler et al., Chem. Eur. J., 2005, 11, 4089. b) P. R. 
Sanch é z et al., J. Biol. Inorg. Chem., 2008, 13, 335. c) P. R. Sanch é z 
et al., J. Biol. Inorg. Chem., 2011, 16, 33. 
 P1 04
The Utility of Holotranscobalamin II as a Marker of Vitamin 
B12 Balance 
 *M. L. Diaz 1 , C. Shanley 2 , V. Linares 1 , L. Dicroce 1 , G. Stemmelin 2 , 
J. Ceresetto 2 , O. Rabinovich 2 , S. Palmer 2 , S. Prieto 2 , A. Ruades 2 , R. 
Peressin 2 , D. Sutovsky 2 , D. Martin 1 , E. Bullorsky 2 
 
1
 Hospital Britanico, Medicina Nuclear, Buenos Aires, Argentina 
 
2
 Hospital Britanico, Haematology, Buenos Aires, Argentina 
 Question: Holotranscobalamin II (holo-TC II) is the complex bind-
ing of cobalamin or vitamin B12 (Cbl) with transcobalamin II, which 
carries Cbl into cells. A decrease in holo-TC II is the fi rst sign of poor 
absorption and is the earliest marker of Cbl defi ciency. 
 The question of the study was to highlight the value of testing 
holo-TC II as an early marker of B12 defi ciency. 
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 Methods: 119 adult patients with anaemia and neurological diseases 
were studied. 
 Fifty normal blood donors were used as controls. 
 Holo-TC II and Cbl serums were measured using MEIA and RA. 
 Results: In accordance with the results the patients were divided 
into 3 groups: Group A) 27 / 119 patients (22.69 % ) with decreased 
holo-TC II ( < 50 pmol / L) and decreased Cbl ( < 300pg/mL), Group 
B) 36/119 patients (30.24 % ) with decreased holo-TC II and normal 
Cbl and Group C) 56 / 119 patients (47.06 % ) with normal holo-TC 
II and normal Cbl. 
 Early detection of B12 defi ciency is crucial to the prevention of neuro-
logical complications that may develop even in the absence of macro-
cytic anaemia. Holo-TC II measurement refl ects the level of Cbl tissue. 
In the patients studied 30.25 % showed decreased levels of holo-TC II 
with normal Cbl serum, which would be considered normal using only 
B12 doping. Depletion of holo-TC II is the fi rst sign of B12 defi ciency. 
 Conclusions: When vitamin B12 defi ciency is suspected, holo-TC II 
should also be tested. Measuring holo-TC II is useful for predicting 
early B12 depletion. 
 Testing holo-TC II refl ects B12 absorption and partially replaces the 
Schilling test. 
 P1 05 – WITHDRAWN 
 P1 06
Plasma 25-(OH) vitamin D levels in the patients with 
Parkinson syndrome 
 *H. Takigawa 1 , H. Kowa 1 , K. Nakashima 1 
 
1
 Tottori University, Faculty of Medicine, Division of Neurology, 
Department of Brain and Neurosciences, Yonago, Japan 
 Background: There is some evidence suggesting that patients with 
Parkinson syndrome (PS) fall and break a bone easily when com-
pared to age-matched healthy subjects. It is unclear what the patients 
with PS affected. 
 Aim: The aim of this study was to investigate the association with 
plasma 25-(OH) vitamin D (VitD) levels and neurological symptoms 
in the patients with PS. 
 Methods: The subjects constructed 36 patients with Parkinson ’ s dis-
ease/dementia with lewy bodies (PD/DLB; 20 females, average age 
72.2 years), 25 patients progressive supranuclear palsy/corticobasal 
degeneration (PSP/CBD; 10 females, average age 75.2 years) admit-
ted to our hospital. Twenty one normal healthy volunteers (CTL) 
composed the control group (13 females, average age 76.1 years). 
We evaluated gender, age, period of illness, stage of the Hoehn-
Yahr stage (H-Y), orthostatic dysregulation, dementia, hallucination, 
wearing-off, serum albumin and hemoglobin, 123I-MIBG cardiac 
uptake and levodopa equivalent dose. We examined a statistical anal-
ysis by the multiple linear regression. 
 Results: VitD levels in plasma were 16.3  + /- 5.0 ng/mL (mean 
 + /- S.D.) in the patients with PD/DLB, 14.3  + /- 5.9 ng/mL in the 
patients with PSP/CBD and 25.5  + /- 6.8 ng/mL in CTL. VitD lev-
els in the patients with PD/DLB and PSP/CBD were signifi cantly 
lower than in the CTL (p  < 0.0001). The fi nal linear registration 
model included not only H-Y (regression coeffi cient -0.384; p  = 
0.0024) but also serum albumin (regression coeffi cient 0.358; p  = 
0.0043) as signifi cant variable infl uencing the VitD (R  = 0.659, p  < 
0.0001). 
 Discussion and Conclusion: VitD is one of vitamins associated with 
the metabolism of a calcium. Our results suggest that the falling and 
fracture easily in the patients with PS associate with not only motor 
dysfunction with illness but also the subjects of nutrition include 
VitD. 
 P2  – B-Vitamin supplementation 
 P2 01
More Dietary Biotin Is Needed When Diet of Quails Contains 
Soybean Oil 
 *O. Kucuk 1 
 
1
 Erciyes University, Veterinary Med, Animal Nutrition, Kayseri, 
Turkey 
 Background: Biotin is involved in fatty acid synthesis and is also 
associated with certain diseases such as diabetes mellitus, liver dis-
orders, and immunological abnormalities. 
 Aim: The objective of this study was to evaluate the effects of 
dietary biotin supplementation with different fat sources (soybean 
oil or beef tallow) on live performance, carcass characteristics, organ 
weights, and plasma concentrations of some minerals and metabo-
lites in Japanese quails. 
 Methods: One hundred and twenty 10-day-old healthy Japanese 
quails were assigned to 4 treatment groups. The experiment was 
designed in a 2 X 2 factorial arrangement using two types of fat 
source (5 % soybean oil or 5 % tallow) and two levels of biotin sup-
plements (0 or 300 mcg/kg diet). 
 Results: Feed intake was not infl uenced by either fat source or biotin 
supplementation in the diet ( P  > 0.05). Final body weights and feed 
effi ciency were greater when the diet of quails contained soybean oil 
compared with that of tallow ( P  ≤ 0.012). Liver weights ( P  = 0.017) 
and abdominal fat accumulation (although not signifi cantly,  P  = 0.17) 
were greater in quails fed tallow. Plasma cholesterol and triglyceride 
concentrations decreased with soybean oil feeding, but cholesterol 
concentrations increased with biotin supplementation. Biotin supple-
mentation increased plasma glucose concentrations ( P  = 0.01). 
 Discussion and Conclusion: It was concluded that biotin can be 
supplemented at 300 mcg/kg diet to the quail diets containing  % 5 
soybean oil. 
 P2 02
Supplementation with zeolite and vitamins B 1 , B 2 and B 6  –  in 
vitro experiment 
 *Z. Basic 1 , V. Kilibarda 2 
 
1
 Institute of Hygiene, MMA, Belgrade, Serbia 
 
2
 Centre for poisoning control, MMA, Belgrade, Serbia 
 Preparations on the basis of the zeolites are used for adsorption of 
toxic substances of organic and nonorganic background and they 
fi nd more and more use in the veterinary and human medicine and 
pharmacy. 
 The aim was to estimate possibilities of zeolite to adsorB-vitamins 
B 1 , B 2 and B 6 in acid and neutral solution, as well as the nature of the 
process (saturability and reversibility). 
 For vitamins B 1 , B 2 and B 6 detection the HPLC method with fl uorescent 
detector was used as a specifi c and sensitive enough. Analite separa-
tion and detection were carried out by applying reverse-phase method 
on the C18 column, and fl uorescent detector with variable wavelength, 
respectively. Examination of vitamin solutions in concentrations 
1, 2 and 5 mg / L, were carried out at pH = 2 and pH = 7, at 37  ° C, 
and the determination of vitamine content in the presence of zeolite 
was done before and 10, 30, 60 and 180 minutes after adding zeolite 
in the vitamine solution. Ion competitiveness was examined by adding 
commercial feed mixture (grower) which contained defi ned content of 
examined vitamines in the pH = 2 and pH = 7 zeolite solution. 
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 Zeolite signifi cantly adsorbs vitamins B 1 , B 2 and B 6 in the acid and 
neutral solution at 37  ° C already in the fi rst ten minutes of the con-
tact. Adsorption is irreversible in single solution, and reversible after 
changing of solution pH from acid to neutral. In neutral solution sig-
nifi cant ions competition for zeolite adsorption exists, so there no 
statistically signifi cant vitamins B 1 , B 2 and B 6 
 Adsorption occurs, while in an acid solution competition is smaller 
and zeolite signifi cantly adsorbs these vitamins, although in less 
degree than under concurent ions absence conditions. 
 P2 03
Vitamin B(12) with folic acid ameliorates arsenic-induced 
liver damage via DNA protection by antioxidant systems 
 *S. Maiti 1 , S. Chattopadhyay 1 , B. Deb 1 
 
1
 Oriental Institute of Science and Technology, Biochemistry, 
Midnapore, India 
 The present study elucidated the protective role of vitamin B(12) 
with folic acid against arsenic-induced hepatotoxicity in female rats. 
Ingestion of sodium-arsenite- contaminated water [0.4 ppm/100 g 
body weight (b.w.)/day] in combination with vitamin B(12) plus 
folic acid (0.07 and 4.0  μ g, respectively/100 g b.w./day) for 24 days 
to Wistar rats offered a signifi cant protection against alone arsenic-
induced distorted liver function, damaged histoarchitecture, elevated 
oxidative stress and DNA fragmentation. Arsenic only exposure 
decreased hepatic superoxide dismutase (SOD), catalase activities 
and the level of nonprotein-soluble thiol (NPSH) with a concomitant 
increase in thiobarbituric acid reactive substances (TBARS) and con-
jugated dienes (CDs) in the liver. Our earlier studies on human blood 
samples from individuals (exposed to  ≥ 100  μ g/L As,  ≥ 10 years) 
from few affected villages in Eastern India explore that more than 
70 % developed pigmentation and palmoplantar hyperkeratosis with 
many of those developing carcinomas. A signifi cant decrease in anti-
oxidant component like catalase, soluble thiol and recently recognized 
uric acid worsen the situation by generating free radicals as observed 
in signifi cant rise in malondialdehyde ending up with increase in 
DNA fragmentation in WBC and arsenic associated mutagenesis car-
cinogenesis. To search for a therapeutic agent, in our rat experiment, 
it was observed that vitamin supplementation restrained the increase 
of TBARS and CDs by restoring catalase, SOD, and NPSH levels. 
Restricted generation of free radicals may be correlated to the protec-
tion of DNA stability and tissue morphology. This study explains the 
decisive role of vitamin B(12) with folic acid in amelioration of arse-
nic-mediated liver injuries.   #   Correspondence: Dr Smarajit Maiti, 
Associate Professor and Head, email: maitism@rediffmail.com 
 P2 04
Evaluation of the impact of a lipoic acid - based nutritional 
supplement on the serum paraoxonase activities in post-
acute stroke patients undergoing rehabilitation 
 *B. N. Manolescu 1 , M. Berteanu 2 , D. Cinteza 2 , D. Poenaru 2 , E. 
Oprea 3 , V. Marcu 2 , S. Popescu 4 , G. Galbeaza 4 , S. Diaconescu 4 
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Bucharest, Romania 
 
3
 University of Bucharest, Faculty of Chemistry, Departament of 
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4
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Balneoclimatology, Bucharest, Romania 
 Background: Paraoxonase 1 (PON1) is a high density lipoprotein 
(HDL)-associated protein responsible for the antioxidant properties 
of these particles. 
 Aim: To evaluate the dynamic of serum paraoxonase activities in 
post-acute stroke patients treated with a lipoic acid - based nutritional 
supplement. 
 Methods: We enrolled 28 post-acute stroke patients hospitalized for 
a period of two weeks for specifi c rehabilitation procedures. They 
were organized in two groups: group 1 (14 patients, 7 females/7 
males, mean age 67.07  ± 2.90 y.o.) and group 2 (14 patients, 7 
females/7 males, mean age 67.14  ± 2.85 y.o.). There was no statis-
tical difference between these groups in respect to the medication. 
Patients from group 2 received a dose of 2 tablets/day of the nutri-
tional supplement (ALAnerv  ®  ). Blood samples were taken at the 
hospitalization and at the discharge moments. We evaluated serum 
PON1 activities with three different substrates paraoxon, phenyl ace-
tate and dihydrocoumarin, using previously described methods. In 
both groups we assessed the percentage of variation of the enzymatic 
activity between the hospitalization and the discharge moments. The 
non-parametric test Mann-Whitney was used for statistical analysis 
( P  < 0.05). 
 Results: The percentages of variation for the enzymatic activities 
were compared between group 1 versus group 2: (i) paraoxon (9.73  ± 
6.07 vs. -8,07  ± 5.84,  P  = 0,019), (ii) phenyl acetate (147.60  ± 121.04 
vs. 18.39  ± 9.34,  P  > 0.05) and (iii) dihydrocoumarin (111.00  ± 
122.85 vs. 118.70  ± 28.75,  P  < 0.001). 
 Discussion and Conclusion: The results of this pilot study suggest 
that administration of ALAnerv  ®  was associated with signifi cant 
variation of the enzymatic activities in respect to paraoxon and 
dihydrocoumarin. The data point the need to evaluate the effects 
of this nutritional supplement over a longer period of time. 
 P2 05
Evaluation of the effect of a lipoic acid - based nutritional 
supplement on the dynamic of the blood redox status in 
post-acute stroke patients undergoing rehabilitation 
 *B. N. Manolescu 1 , M. Berteanu 2 , D. Cinteza 2 , D. Poenaru 2 , E. 
Oprea 3 , V. Marcu 2 , S. Popescu 4 , G. Galbeaza 4 , S. Diaconescu 4 
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Nenitescu ” , Bucharest, Romania 
 
2
 University of Medicine and Pharmacy  “ Carol Davila ” , Faculty of 
Medicine, Department of Rehabilitation and Physical Medicine, 
Bucharest, Romania 
 
3
 University of Bucharest, Faculty of Chemistry, Departament of 
Organic Chemistry, Biochemistry and Catalysis, Bucharest, Romania 
 
4
 National Institute of Rehabilitation, Physical Medicine and 
Balneoclimatology, Bucharest, Romania 
 Background: Oxidative and nitrosative stress are key elements in 
stroke etiology. 
 Aim: To evaluate the dynamic of the blood redox status in post-
acute stroke patients treated with a lipoic acid-based nutritional 
supplement. 
 Methods: 28 post-acute stroke patients were hospitalized for specifi c 
rehabilitation procedures for a period of two weeks. The patients were 
organized in two groups: group 1 (14 patients, 7 females/7 males, 
mean age 67.07 ± 2.90 y.o.) and group 2 (14 patients, 7 females/7 
males, mean age 67.14 ± 2.85 y.o.). There was no statistical differ-
ence between these groups in respect to the medication. Patients from 
group 2 received a dose of 2 tablets/day of the nutritional supplement 
(ALAnerv  ®  ). Blood samples were taken at the hospitalization and at 
the discharge moments. The following markers of oxidative stress 
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were assessed, according to previously described methods: total anti-
oxidant capacity, total thiols, non-proteic thiols, protein carbonyls, 
oxidized low-density lipoprotein (LDL) particles (LDLox), lipid 
hydroperoxides and the activity of g-glutamyltranspeptidase. We 
calculated the percentage of variation for these markers between the 
hospitalization and the discharge moments. The non-parametric test 
Mann-Whitney was used for statistical analysis ( P  < 0.05). 
 Results: When comparing the percentages of variation between the 
two groups, statistically signifi cant differences were obtained only 
for LDLox (-4.00  ± 6.08 vs. -78.31  ± 1.89,  P  < 0.001) and lipid 
hydroperoxides (36.52  ± 31.60 vs. -33.82  ± 12.20,  P  = 0.029). 
 Discussion and Conclusion: These preliminary results suggest that 
administration of ALAnerv  ®  would contribute to the improvement 
of some oxidative stress parameters during the rehabilitation period. 
This study points the need to evaluate the effects of this nutritional 
supplement over longer time periods and in high dosages. 
 P2 06
Folic acid supplementation Effects in Patients with Type 2 
Diabetes Mellitus 
 *B. Pourghassem Gargari 1 , V. Aghamohammadi Khiavi 1 , A. 
Aliasgharzadeh 1 , M. Hamed Behzad 1 
 
1
 Faculty of Health and Nutrition, Biochemistry and Nutrition, Tabriz, 
Iran, Islamic Republic of Iran 
 Introduction: This study performed to determine the effects of sup-
plementation of folate on indices of glycemic control, insulin resis-
tance and lipid profi le in men with type 2 diabetes under metformin 
(at least 1500mg daily) treatment. 
 Materials and Methods: This was a double-blind randomized con-
trolled clinical trial. 68 men with type 2 diabetes participated with 
written consents. Patients were randomly divided in two groups; 
folic acid 5mg/day and placebo. All the patients received the tablets 
for 8 weeks. Anthropometric and nutrient intakes data obtained from 
each patient. Baseline and 8th week fasting blood glucose, HbA1C, 
serum insulin, insulin resistance, serum total cholestrol, TG, LDL-C, 
HDL-C, serum folate and plasma homocysteine were measured. 
 Results: Supplementation with folic acid for 8 weeks led to decrease 
HbA1C (P = 0.019) and fasting blood glucose (P = 0.006), serum 
insulin (P = 0.028), insulin resistance (P = 0.043) and plasma homo-
cysteine (P < 0.001), increase serum folate (P < 0.001) of folic acid 
group. Conclusion: Pharmacological dose of folic acid supplemen-
tation for patients with type 2 diabetes decreased plasma level of 
homocysteine and improved glycemic control, insulin resistance and 
serum folate levels. 
 Key Words: Folic acid, Glycemic control, Insulin resistance, met-
formin, type 2 diabetes 
 P2 07
B-vitamins, Homocysteine And Anemia In Dialysis Patients 
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1
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Urology Department, Cernusco s/N (Milan), Italy 
 Introduction: Many years ago it has been discovered that vita-
min B therapy improved anemia in vitamin B depleted patients. 
Hemodialysis patients often show vitamin B defi ciency. Vitamin 
B therapy should improve anemia in these patients, but until now 
there are contrasting data. Hyperhomocysteinemia, a risk factor of 
vascular and bone disease, is frequently detected in vitamin B poor 
hemodialysis patients. Animal models hypothesize that high homo-
cysteine levels, giving a low methylation potential, may lower eryth-
ropoietin synthesis. Actually, we do not know whether homocysteine 
may interact with erythropoiesis. 
 Aim and Methods: In view of these considerations, we studied the 
effects of vitamin B therapy on homocysteine, hemoglobin, erythro-
poiesis stimulating agents (ESA) doses and erythropoiesis stimulat-
ing agents resistivity index (ESA RI) of hemodialysis patients. We 
performed a long, retrospective study. Hemoglobin values and ESA 
doses were assessed every month; homocysteine, folate and vitamin 
B12 values were measured every 4 months. We considered suitable 
for the study vitamin B treated patients without residual renal func-
tion, hemorrhagic accidents and blood transfusions during 2-years 
follow up. 33 patients were split by 3 groups, according to the mean 
homocysteine level: group A with normal homocysteine level (below 
15 micromoles/litre), group B with moderate hyperhomocysteinemia 
(mean homocysteine level between 15 and 30 micromoles/litre) and 
group C with severe hyperhomocysteinemia (mean homocysteine 
level higher than 30 micromoles/litre). 
 Results: Group C patients had both higher hemoglobin levels and 
lower ESA RI than patients of group A and B (respectively for hemo-
globin and ESA RI: 12,0 vs.10,9 vs. 11,4 g/dl - p < 0,05; and 4,2 vs. 
13,3 vs. 11,6 - p < 0,05). Furthermore ESA RI was inversely associ-
ated to vitamin B12 levels (r  = 0,44  – F = 7,5  – p < 0,05), suggesting 
a low consumption of ESA in B12 replete patients. 
 Conclusions: Hemodialysis patients with severe hyperhomo-
cysteinemia had lower ESA RI than patients with normal or mod-
erately high homocysteine levels. We think that homocysteinilation 
may up-regulate erythropoietin receptor stimulated by ESA. Severe 
hyperhomocysteinemia seems also to increase platelet count. High 
B12 levels are also associated to low ESA RI. 
P2 08 – WITHDRAWN
 P2 09
Cardiovascular Risk Of An Elderly, Black South African 
Population In Sharpeville, South Africa 
 *C. Grobler 1 , W. Oldewage-Theron 1 
 
1
 Vaal University of Technology, Biosciences, Vanderbijlpark, South 
Africa 
 Cardiovascular disease exists in epidemic proportions in developed 
countries and is an increasing problem in the developing world. 
Black elderly people in South Africa live under poor living condi-
tions, this often results in house hold food insecurity and malnutri-
tion, which has negative effects on the health status of the elderly 
including chronic disease of lifestyle. 
 The aim of this part of the study is to evaluate the baseline status 
of the cardiovascular risk markers as part of a multi-micronutrient 
programme to address malnutrition among elderly attending a day 
care centre. 
 This is an ethically approved, experimental study in 350 purposively 
selected samples of all the elders attending a day-care centre in 
Sharpeville, Gauteng, South Africa. Blood collection and analysis 
parameters were performed according to standard laboratory proto-
col in order to comply with SANAS accreditation requirement. 
 A prevalence of 68 % hypertension and 27.9 % obesity were identifi ed 
as health risk markers. Biochemical blood markers indicated 32.5 % 
females and 20.8 % respondents had a decreased serum folate level, 
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vitamin B12 defi ciency was detected in 29.2 % males and 10.5 % 
females. A very high fi brinogen level (5.3 ± 2.2g/l) indicated a risk for 
cardiovascular disease. 
 It is concluded that this population is at high risk for cardiovascu-
lar disease. It is necessary to design an acute intervention to reduce 
the risk in this vulnerable population. It is proposed that a homo-
cysteine lowering strategy (vitamin B6, B12 and folate supplemen-
tation) should be implemented and evaluated for its effect on the 
homocysteine metabolism, coagulation, fi brinolysis, infl ammatory 
response and hypertension. 
 P3  – B-vitamins and choline in age associated 
diseases 
 P3 01
The relationship between serum biotin and oxidant/
antioxidant activities in bovinelameness 
 *K. Al-Qudah 1 
 
1
 Jordan University of Science and Technology, Veterinary Clinical 
Sciences, Irbid, Jordan 
 Serum biotin concentrations, erythrocyte superoxide dismutase 
(SOD), catalase (CAT), glutathione peroxidase (GSH-Px), reduced 
glutathione (GSH) and plasma thiobarbituric acid reactive substances 
(TBARS) were measured in 36 dairy cows, 18 of them were healthy 
and served as control. In the 18 cows with lameness problems, there 
were 5 cows with interdigital necrobacillosis, 5 cows with subsolar 
abscessation, 2 cows with solar ulcers, 2 cows with white line dis-
ease, 2 cows with chronic laminitis and 2 cows with septic arthri-
tis. The degree of lameness was estimated to be slight in 3 cows, 
moderate in 11 cows and severe in 4 cows. Plasma fi brinogen levels 
and TBARS concentrations were increased signifi cantly (P < 0.05) 
in lame cows compared to control group. The antioxidant enzymes 
GSH-Px, and CAT concentrations were increased signifi cantly (P  < 
0.05) in lame cows. The level of reduced glutathione and the activity 
of SOD were signifi cantly decreased in affected cows compared to 
healthy ones. Serum biotin levels in healthy cows ranged from 2.25 
to 3.5 ng/ml while in lame cows, biotin levels ranged from 1.17 to 
2.3 ng/ml. Biotin levels correlated positively with blood GSH (r  = 
0.870, P  < 0.05), (r  = 0.735, P  < 0.05) and with GSH-Px (r  = 0.539, 
P  < 0.05) and with SOD (r  = 0.637, P  < 0.05), (r  = 0.449, P  < 0.05), 
(r  = 0.585, P  < 0.05) in both healthy and lameness affected subjects, 
respectively. 
 P3 02
Effect of folic acid injestion on homocysteine related patient 
comorbidities in U.S. Veterans 
 *S. Herman 1,2 , P. Aronson 1,2 , C. Young 2,3 
 
1
 John D. Dingell Veterans Administration Medical Center, 11M-
DERM, Detroit, United States 
 
2
 Wayne State University, Detroit, MI USA, United States 
 
3
 John D. Dingell Veterans Administration Medical Center, Research 
11R, Detroit, MI, United States 
 Background: Exposure of vascular smooth muscle cells to 
homocysteine prior to cytokine stimulation ultimately leads to 
infl ammation. 
 Aim: We aim to investigate comorbidities asspociated with vascul-
opathy in veterans with homocysteine above and below 13 umol/L 
on and off folic acid. 
 Methods: Relative risk calculations comapring homocysteine asso-
ciated comorbidities on and off vitamins in a population of 278 vet-
erans whose homocusteine levels were taken between 6/16/2009 and 
8/06/2010. 
 Results: For patients with homocuysteine  > 13, those taking folic 
acid supplementation had a signifi cantly higher rate of diabetes than 
patients not takingfolic acid, RR = 2.34 (95 % CI: 1.12-4.89). For 
patients with homocysteine  > 13, those taking folic acid supple-
ments had a signifi cantly higher rate of hyperlipidemia compared to 
patients with homocysteine  > 13 not taking folic acid in this period, 
RR - 1.52 (95 % CI: 1.06-2.16).Among patients not taking folic acid 
supplements, only those with low homocysteine levels had signifi -
cantly lower incidence of CVAs, RR  = 0.217 (95 % CI: 0.063-0.749), 
kidney disease, RR = 0.217 (95 % CI: 0.085-0.558), anemia, RR - 
0.406 (95 % CI: 0.172-0.955), and hypertension, RR = 0.780, (95 % 
CI: 0.627-0.97). Among psoriatics, those taking folic acid supple-
ments had a higher incidence of diabetes mellitus, RR = 2.353 (95 % 
CI: 1.14-7.02). 
 Discussion and Conclusions: Taking folic acid doses of up to 1 mg 
daily may sometimes be associated with an increases risk of mul-
tiple disorders associated with vascular pathology, especially when a 
patient has elevated homocysteine. 
 P3 03
Postnatal Effects Of An Early Methyl Donor Defi ciency On 
The Rat Brain: Specifi c Sensitivities According To Brain 
Structures 
 *N. Martin 1 , G. Pouri é 1 , C. Bossenmeyer-Pouri é 1 , J.-L. Gu é ant 1 , 
J.-L. Daval 1 
 
1
 Inserm U954, Facult é de M é decine, Vandoeuvre les Nancy, 
France 
 Background: Folate and vitamin B12 are methyl donor precursors 
for the production of S-adenosylmethionine which plays a modulat-
ing role in disease occurrence. In particular they are involved in epi-
genetic/epigenomic mechanisms. Gestational and perinatal methyl 
donor defi ciency (MDD) has early and late consequences yet incom-
pletely elucidated. 
 Aim: We studied the effects of an early methyl donor defi ciency on 
brain maturation and plasticity in rat pups. 
 Methods: Dams received a standard diet or a MDD diet (B12, folate, 
and choline) one month before mating. The regimen was maintained 
until weaning of the offspring (21 days), and replaced subsequently 
by a normal diet. 
 Results: At 21 days of age, the MDD diet produced an accumula-
tion of homocysteine (hcy) in specifi c brain structures but results 
differed according to the concerned brain areas. The MDD diet 
was associated with histological impairments. Hcy accumulation 
in the hippocampus and the cerebellum was produced in part by 
a decreased expression of cystathionine beta-synthase (CBS) and 
methionine synthase (MS) only in the hippocampus. Neuroplasticity 
Proteins expressions were decreased in both brain structures. In par-
allel, behavioral tests showed an impaired maturation of functions 
related to cerebellum and hippocampus in case of defi ciency. At 450 
days of age, in spite of the return to normal nutritional conditions 
at weaning and recovery of metabolic markers, the deleterious tis-
sular consequences of early exposure to defi ciency lead to persistent 
functional disorders. 
 Discussion and Conclusion: The key mechanisms involved would 
occur at critical periods during the maturation of the various brain 
structures, thus highlighting the role of fetal programming. 
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 P3 04
Perinatal Choline Supplementation Increases Neurotrophin 
Levels and Expression of Cholinergic Markers in the 
Hippocampus and Septum of an Alzheimer ’ s Disease Model 
 *T. Mellott 1 , O. Huleatt 1 , S. McCarthy 1 , B. Liu 1 , J. Blusztajn 1 
 
1
 Boston University School of Medicine, Pathology, Boston, United 
States 
 Background: Progressive synaptic dysfunction and neurodegenera-
tion may be the result of accumulating levels of  ß -amyloid protein 
(A ß ) in Alzheimer ’ s disease (AD). Overproduction of A ß has been 
shown to disrupt adult neurogenesis, reduce survival of newborn 
neurons, alter neurotrophin availability, and impair signaling path-
ways associated with learning and memory. Choline is an essential 
nutrient critical for brain development. In rats, supplementation of 
the maternal diet with choline has been shown to improve memory 
and cause biochemical changes in the brains of the offspring. 
 Aim: We propose to use perinatal dietary manipulation of choline as 
a means to elevate neurotrophin expression, improve rates of neuro-
genesis, and augment cholinergic neurotransmission in an AD mouse 
model. 
 Methods: Wildtype (WT) female mice were placed on either a con-
trol or choline supplemented diet then crossed with APPswe/PS1dE9 
transgenic male mice. All pups were weaned to a control diet. 
 Results: We found that perinatal choline supplementation alters the 
expression of several trophic factors including nerve growth factor 
(NGF) in the hippocampus of both WT and APPswe/PS1dE9 mice, 
suggesting that choline supplementation enhances the trophic microen-
vironment in the brain that may protect against AD-associated neuronal 
insults. Moreover, protein levels of tyrosine kinase receptor A and the 
low-affi nity NGF receptor p75 were signifi cantly higher in choline-
supplemented mice, which may render the cholinergic neurons more 
responsive to NGF signaling. Choline supplementation also prevented 
a decrease in CHAT protein in 9-month old APPswe/PS1dE9 mice. 
 Conclusion: This study may help develop a potential means of pre-
venting or slowing the progression of AD. 
 P3 05
Perinatal Choline Supplementation Improves Social 
Behavioral Defi cits in an Animal Model of Autism 
 *T. Mellott 1 , B. Liu 1 , E. Langley 1 , J. Blusztajn 1 
 
1
 Boston University School of Medicine, Pathology, Boston, United 
States 
 Background: Autism is a developmental disorder characterized by 
severe defi cits in social interaction skills, impairments in verbal and 
nonverbal communication, and stereotyped, repetitive patterns of 
behaviors and interests. Prenatal exposure of rats to valproic acid 
(VPA) causes many anatomical and behavioral abnormalities simi-
lar to those seen in autistic patients. Choline is an essential nutrient 
critical for brain development. When rat maternal diets were supple-
mented with choline during embryonic day (E) 11-17, the offspring 
had improved memory and attention. 
 Aim: The purpose of this study was to evaluate the effectiveness of 
perinatal choline supplementation on ameliorating social behavioral 
defi cits in an animal model of autism. 
 Methods: On E11, pregnant Wistar dams were given either a control 
or choline supplemented diet. On E12.5, rats received an ip injection 
of either saline or VPA (550 mg/kg). 
 Results: As expected, VPA delayed eye opening and decreased post-
natal body and brain weights. Choline supplementation prevented 
the delay in eye opening and reduction in brain weight. Perinatal 
choline supplementation dramatically improved behavioral defi cits 
in social interaction in both adolescence and adulthood. Control ani-
mals exposed to VPA displayed reduced time spent engaged in social 
interaction with either a familiar or unfamiliar rat and signifi cantly 
more time in the center of the testing area, whereas choline supple-
mentation increased time engaged in social interaction. 
 Conclusions: The results suggest that the perinatal nutritional 
manipulation of choline can counteract the behavioral alterations in 
VPA rats and reveal an important discovery for the treatment or pos-
sibly prevention of autism spectrum disorders. 
 P3 06
 In vitro and  in vivo inhibition of acetylcholinesterase by 
some anaesthetic drugs 
 *H. As¸kin 1 , D. Ekinci 1 , M.  S¸ ent ü rk 1 
 
1
 Ataturk University, Department of Molecular Biology and Genetics, 
Erzurum, Turkey 
 Acetylcholinesterase (AChE; EC 3.1.1.7) activities are usually mea-
sured in whole blood and the most commonly used substrate is acetyl-
thiocholine. Acetylcholine is critical for an adequately functioning 
memory, and it is the subject of the majority of research looking for 
treatments for memory defects, like those found in Alzheimer ’ s disease. 
Any mental health issue that involves memory or lack thereof, directly 
or indirectly relates to acetylcholine [1]. Current therapeutic strategies 
for the symptomatic treatment of Alzheimer ’ s disease and other related 
disorders such as vascular dementia and dementia with Lewy bodies are 
aimed at enhancing the associated cholinergic defi cit by inhibiting ace-
tylcholinesterase (AChE) [2] resulting in a boost in endogenous level 
of acetylcholine (ACh) in the brain and an improvement of the cogni-
tive function [1-3]. We report here the inhibitory capacities of lidocaine, 
articaine, bupivacaine against the AChE ezymes from human and the 
arthropod ( Drosophila melanogaster ) (AChE). The ezymes showed 
quite diverse inhibition profi les with these drugs. Inhibitory capacities 
of lidocaine, articaine, bupivacaine on hAChE and  Dm AChE activity 
were determined using DTNB under  in vitro conditions. IC 50 values 
were determined to be in low micromolar ranges indicating that these 
drugs inhibit the enzymes quite effectively. 
 [1]. Rosler, M.; Anand, R.; Cicin-Sain, A.; Gauthier, S.; Agid, Y.; 
Dal-Bianco, P.; St ä helin, H. B.; Hartman. R.; Gharabawi, M.; Bayer, 
T.  British Medicinal Journal,  318 , 633-640, 1999. [2]. Ekinci, D.; 
Ceyhun, S. B.; Senturk, M.; Erdem, D.; Kufrevioglu, O. I.; Supuran, 
C. T.  Bioorganic &  Medicinal Chemistry ,  19 , 744-748, 2011. [3]. 
Giacobini, R.; Spiegel, E.; Enz, A.; Veroff, A. E.; Cutler, N. R. 
 Journal of Neural Transm  109 , 1053-1065, 2002. 
 P3 07
Motor function of 5-6 year old children who were exposed to 
Thiamine defi ciency during infancy 
 *Y. Harel 1 , M. Guindy  1 , L. Zuk 1 , A. Fattel-Valevski 1 
 
1
  “ Dana ” Children Hospital, Pediatric Neurology Unit, Tel Aviv, 
Israel 
 Background: Nutrient insuffi ciency can have irreversible effects on 
the rapidly developing brain, depending on the timing, dosage and 
duration of exposure. Towards the end of2003 agroup of infants were 
hospitalized, after being fed with a soy-based formula lacking in thia-
mine. Knowledge of the effects and long term implications in children 
exposed to thiamine defi ciency is rare. This study aimed to investigate 
Brought to you by | University of Queensland - UQ Library
Authenticated
Download Date | 9/21/15 2:40 AM
A44  Advances and Controversies in B-Vitamins and Choline, Leipzig, Germany, March 2012
whether children who had been exposed to thiamine defi ciency during 
infancy, display motor diffi culties at the age of 5-6 years. 
 Methods: In this case-control study, 39 children aged 5-6 years, who 
had been exposed to a thiamine defi cient formula during infancy, 
were compared with 30 children matched for age and gender who 
had been fed with other substitute formulae. The motor function 
of the participants was evaluated by two known motor skill assess-
ments: The Movement Assessment Battery for Children (M-ABC) 
and the Zuk Assessment for Motor Function and Movement Skills. 
 Results: Both assessments showed signifi cant differences between 
the study and the control groups for gross and fi ne motor function 
(p < 0.001, except for ball skillsp = 0.01) and grapho-motor function 
(p = 0.004). The most signifi cant difference was noted in balance 
control functioning (p < 0.001). In the study group, both assessments 
(M-ABC, Zuk) concurred on the high rate of children suffering from 
Developmental Coordination Disorder (DCD) in comparison to the 
control group (M-ABC: 56 % vs. 10 % , Zuk: 59 % vs. 3 % ,p < 0.001). 
 Conclusions: Thiamine defi ciency in infancy affects gross and fi ne 
motor function in childhood. The current study emphasizes the cru-
cial role thiamine takes in normal motor development and it ’ s pos-
sible effect on formation of brain structures. 
 P3 08
B-vitamin defi ciency and the Blood Brain Barrier in a mouse 
model of Alzheimer ’ s Disease 
 *A. Fuso 1,2 , M. Leopizzi 3 , M. Corsi 3 , L. Capriotti 3 , V. Nicolia 1 , S. 
Scarpa 1 , R. Businaro 3 
 
1
 Sapienza University of Rome, Dept. of Surgery  “ P. Valdoni ” , Rome, 
Italy 
 
2
 Sapienza University of Rome, Dept. of Psychology, Section of 
Neuroscience, Rome, Italy 
 
3
 Sapienza University of Rome, Dept. of Medico-Surgical Sciences 
and Biotechnologies, Rome, Italy 
 The role of B-vitamins and high homocysteine (HCY) levels in the 
Late Onset Alzheimer ’ s Disease (LOAD) is a controversial topic. 
We previously applied a nutritional model of B-vitamin defi ciency to 
a transgenic mouse model of Alzheimer ’ s Disease to study the infl u-
ence on Alzheimer-like features. The defi ciency of Folate, vitamin 
B12 and vitamin B6 primarily resulted in increased plasma HCY. 
Consequently, tg mice under B-vitamin defi ciency showed increased 
A β overproduction due to the impairment of DNA methylation and 
PSEN1 and BACE1 overexpression. 
 We hypothesized that A β scavenging and transportation could also be 
deregulated by B-vitamin defi ciency and decided to investigate A β 
passage through the Blood Brain Barrier (BBB). The idea of study-
ing the role of B-vitamins in the BBB functions fi nds a rationale also 
in the theories postulating a common basis for LOAD and dementia 
of vascular origin (Vascular Dementia: VaD), since B-vitamins and 
HCY are common risk factors. 
 A β transport across the BBB was analyzed through the study of the 
levels of its receptors RAGE, which is responsible for the passage 
of A β from the bloodstream to the brain tissue, and LRP1, which 
is responsible for the inverse passage. Endothelial dysfunction was 
studied by immunohistochemistry. 
 Our results indicated that RAGE is more expressed and LRP1 less 
expressed in tg mice. B-vitamin defi ciency induces RAGE increase 
in the frontal and parietal microvasculature and intracellular RAGE 
decrease and LRP1 increase both in Tg and wt mice within fron-
totemporal, parietal cortex and hippocampus. Preliminary analysis 
revealed different response of cerebral and systemic vasculature to 
B-vitamin defi ciency. 
 These results evidence that B-vitamin defi ciency can modulate 
RAGE and LRP1 expression and endothelial function with possible 
consequences for A β transport across the BBB and for its clearance 
at the level of CNS cells. 
 P3 09
Dietary intake does not predict vitamin B12 status in Chilean 
elderly 
 *A. Brito 1,2 , L. H. Allen 3 , D. L ó pez de Roma ñ a 2 , E. Hertrampf 2 , H. 
S á nchez 2 , C. Albala 2 , L. Lera 2 , M. Mujica 2 , D. Masferrer 2 , S. Shahab-
Ferdows 3 , R. Uauy 2,4 
 
1
 University of California, Davis, United States 
 
2
 Institute of Nutrition and Food Technology (INTA), University of 
Chile, Santiago, Chile 
 
3
 USDA, ARS Western Human Nutrition Research Center, University 
of California, Davis, United States 
 
4
 London School of Hygiene & Tropical Medicine, London, United 
Kingdom 
 Background: Low vitamin B12 (B12) status is prevalent among 
elderly and usually attributed to its poor absorption from food, but 
few studies have examined the extent to which it is predicted by low 
intake of the vitamin in this age group. 
 Aim: To evaluate the relationship between B12 intake and status 
biomarkers in free-living, healthy Chilean elderly recruited from the 
community. 
 Methods: Serum B12, total homocysteine (tHcy), methyl malonic 
acid (MMA), holo-transcobalamin (holo-TC), serum folate (SF) and 
B12 intakes were assessed at baseline (n = 282) in a RCT of B12 sup-
plementation in Chilean elderly. 
 Results: 48 % of subjects were B12 defi cient (serum B12  < 148 
pmol/L). The main sources of B12 were meat (44 % ), dairy products 
(22 % ) and B12-fortifi ed milk delivered by Chile ’ s Ministry of Health 
(18 % ). Total B12 intake was 2.9 ± 1.2  μ g with 66 % reaching the EAR 
(2.0  μ g/d). Serum B12 was 152 (94-255) pmol/L, tHcy 12 (10-15) 
nmol/L, MMA 228 (147-392) nmol/L, holo-TC 48.1 (34.7-67.4) 
pmol/L and SF 12.0 (8.0-17.0) ng/mL. Neither total dietary B12 nor 
tertiles of intake were correlated with any biomarker. 
 Conclusions: Meat, dairy products and milk fortifi ed with B-12 were 
the main sources of B12, but providing fortifi ed milk (1.4  μ g/d B12) 
was insuffi cient to achieve normal status. The high prevalence of 
vitamin B12 defi ciency and depletion in this elderly population was 
not predicted by dietary vitaminB12 intake. 
 Funded by FONDECYT  # 10700592 
 P3 10 presented as oral presentation WS2 02 
 P3 11
Low holotranscobalamin and cobalamins predict incident 
fractures in elderly men  – The MrOS Sweden study 
 *C. Lewerin 1 , H. Nilsson-Ehle 1 , S. Jacobsson 2 , H. Johansson 2,3 ,  î 
Ljunggren 4 , M. K. Karlsson 5 , C. Ohlsson 3 , D. Mellstr ö m 3 
 
1
 Section of Hematology and Coagulation, Department of Internal 
Medicine at the Institute of Medicine, Sahlgrenska Academy at the 
University of Gothenburg, Gothenburg, Sweden 
 
2
 Department of Clinical Chemistry and Transfusion Medicine, Sahlg-
renska Academy at the University of Gothenburg, Gothenburg, Sweden 
 
3
 Center for Bone and Arthritis Research (CBR), Department of 
Geriatrics and Internal Medicine, Sahlgrenska Academy at the 
University of Gothenburg, Gothenburg, Sweden 
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4
 Department of Medical Sciences, University of Uppsala, Uppsala, 
Sweden 
 
5
 Clinical and Molecular Osteoporosis Research Unit, Department of 
Clinical Sciences, Lund, Sweden 
 Question: Whether cobalamins, serum holotranscobalamin, serum 
folate and plasma total homocysteine are associated with risk of inci-
dental fracture in older men. 
 Methods: The MrOS study is a population based study of 790 elderly 
men in the Gothenburg, (median age of 75.3), without ongoing 
B-vitamin medication. Baseline data included physical performance, 
falls, BMI, BMD, cobalamins, holotranscobalamin, folate and homo-
cysteine and incidental fractures were registered. Men were followed 
for up to 7.4 years (average 5.9 years). 
 Results: During follow up 110 men sustained one or more fracture. 
Overall, the risk of fracture multivariable adjusted increased by 39 % 
and 26 % for each SD increase in cobalamins and holotranscobala-
min, respectively (HR 1.39; 95 % confi dence interval 1.12-1.73 and 
HR 1.26; 95 % confi dence interval 1.03-1.55). Men in the lowest 
quartile of cobalamins and holotranscobalamin, had an increased 
risk of fracture, (HR = 1.70, 95 % CI 1.13-2.56 and HR = 1.70, 95 % CI 
1.14-2.54, respectively) than did those in quartile 2-4. Corresponding 
fi gures for vertebral fractures were HR 2.47 (1.304-4.57) and 2.49 
(1.36-4.57) respectively. Poisson regression models demonstrated 
that both cobalamins and holotranscobalamin below the median 
(310 pmol/L and 51.8 pmol/L, respectively) was inversely related to 
yearly incidence of fractures. No associations between folate, homo-
cysteine and incident fractures were seen. 
 Conclusions: Older men with low holotranscobalamin and cobala-
mins have an increased risk of incident fractures. This association 
does not seem to be mediated via BMD and other known risk factors 
for fracture. 
 P4 - B-vitamins and choline in birth defects 
 P4 01
Folic acid and Grape Seed Extract Prevent Azathioprine 
induced- fetal malformations and Renal Toxicity in Rats 
 *I. El-Ashmawy 1 , A. Bayad 1 
 
1
 Faculty of Vet. Medicine, Pharmacology, Behera, Egypt 
 Azathioprine (Aza) is an important drug commonly used in the ther-
apy of the autoimmune system disorders . It induces many hazard 
effects that restrict its use. The effects of administration of grape seed 
extract (GSE) and folic acid on Aza toxicity by gavage simultane-
ously for 4 weeks were studied by determining the changes in kidney 
histology,the glutathione level (GSH), and lipid peroxidation con-
tent as malondialdehyde (MDA) in the kidney tissue were measured. 
Additionally, their effects on the fetal development were investi-
gated. Aza induced a renal damage as indicated from the pronounced 
changes in histological structure, a signifi cant increase in serum urea 
and creatinine, and MDA content in the kidney tissue. Meanwhile, 
the GSH activity was signifi cantly decreased. Co-treatment with 
GSE signifi cantly minimised the previously mentioned the hazard 
effects of Aza by ameliorating the antioxidant activity. At this point 
folic acid induced a non signifi cant protective activity. The results 
also revealed that administration of folic acid and GSE at 6th through 
15th day of gestation did not altered fetal development. While, Aza 
administration clearly disturbed fetal development as indicated from 
abnormal feto-maternal attachement and a signifi cant decrease in 
fetal weights and numbers. Furthermore, co-administration of both 
drugs signifi cantly minimised simillary the hazards of Aza on the 
fetal development. It may be concluded that GSE and folic acid are a 
useful herbal remedies, especially for controlling oxidative damages 
and are considered as a protective agent against Aza toxicity. 
 P5  – Choline & Betaine 
 P5 01
Linear and logistic model in meta-analysis of milk yield 
responses to rumen protected choline supplementation 
 *L. Pinotti 1 , C. Polidori 2 , A. Campagnoli 2 , V. Dell ’ Orto 1 , A. Baldi 1 
 
1
 University of Milan, VSA, Milan, Italy 
 
2
 UNITEL, Milan, Italy 
 Choline requirements for lactating dairy cows have not been estab-
lished. In spite of that, higher choline availability (by feeding rumen-
protected choline, RPC) can improve milk production, suggesting 
that this nutrient may be limiting either for lactating dairy cow, or for 
the transition cows in the late gestation and in early lactation. Based 
on these assumptions, we investigated the effects of rumen protected 
choline administration on milk yield in 12 different studies, carried 
out between 1991 and 2008. Accordingly, 42 experimental groups for 
milk yield, have been considered in the dataset. Mean and standard 
error data have been tested with both linear and logistic regression 
models and milk yield response to RPC supplementation has been 
investigated. Dataset analysis indicated that although most of vari-
ability among experiments was related to treatments schedule, dry 
matter intake and dietary composition, these factors were also highly 
correlated. For this reason, and in order to avoid any redundancy, our 
regression analysis included only RPC supplementation (control/
treated) as fi xed effect, while all other variables have been considered 
as experimental effects and treated as random components in both 
considered models, in order to take into account the difference among 
experimental conditions. The results of this analysis indicate that the 
linear model that assume a constant RPC response and utilization effi -
ciency appears less appropriate, if compared to the logistic one, espe-
cially when high choline ( > 20g/d) supplementation is considered. 
 P5 02
New substrates for the transporters of the CTL (choline 
transporter like) gene family 
 *S. O ’ Regan 1 
 
1
 CNRS/Universit é Paris Descartes, UMR 8192, Paris, France 
 The fi rst CTL family members to be characterized were CTL1 
and CTL2, and the expression of both of these proteins correlates 
with changes in the level of choline uptake. However, other mem-
bers of the family such as the yeast and C. elegans CTLs neither 
transport choline nor are required for membrane synthesis, since 
other mechanisms of choline transport exist in these organisms. 
Even CTL1, which comes the closest to fulfi lling the role of a cho-
line transporter dedicated to phosphatidylcholine synthesis, has 
recently been found in mitochondria as well as the plasma mem-
brane. Together, these fi ndings indicate that both other substrates 
and other roles than providing choline for phospholipid synthesis 
need to be examined to better understand the physiological contri-
bution of these proteins. 
 Question: Do CTL family proteins increase uptake of other amines ? 
 Methods: Recombinant CTL proteins (hCTL1 and hCTL2, CeCTL) 
were expressed in Xenopus oocytes and uptake of several radioactive 
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substrates was measured and compared to that of water injected 
oocytes. 
 Results: As well as choline, CTL1 and CTL2 also increase uptake of 
betaine and spermine but not glucosamine. The  C. elegans ortholog 
CeCTL/chtl-1 did not transport choline or spermine, but did increase 
uptake of the amino acid aspartate by cRNA-injected oocytes. 
 Conclusions: The CTL proteins appear to have a more complex bio-
logical role than originally reported. CTL proteins that are known 
to transport choline have a broader substrate profi les that include 
spermine, which is known to affect mitochondrial calcium levels and 
glucose metabolism. 
 P5 03
A splicing variant leads to complete loss of function of 
 Betaine-homocysteine methyltransferase ( BHMT ) gene in 
hepatocellular carcinoma 
 *H. Pellanda 1 , F. Namour 1 , M. Fofou-Caillierez 1 , A. Bressenot 1 , 
J.-M. Alberto 1 , C. Chery 1 , A. Ayav 1 , J.-P. Bronowicki 1 , J.-L. Gu é ant 1 , 
T. Forges 1 
 
1
 INSERM U954, Facult é de M é decine, Vandoeuvre les Nancy, 
France 
 Background: The remethylation of homocyteine into methionine is 
catalyzed either by methionine synthase (MTR) or by betaine-ho-
mocysteine methyltransferase (BHMT), in the liver. Choline/betaine 
defi ciency and impaired BHMT pathway have been associated with 
hepatocellular carcinogenesis, in animal models. The molecular 
mechanisms that impair the BHMT pathway are unknown. 
 Aim: We aimed to investigate  BHMT ,  BHMT2, and  MTR expression 
in HepG2 cells and human hepatocarcinoma tissues. 
 Methods: Transcripts were quantifi ed by RT-qPCR and splicing 
was assessed by analysis of exon junctions and sequencing of vari-
ants. Protein expression was studied by Western Blot, immunohis-
tochemistry and enzyme activity. Tumor tissue was compared with 
surrounding healthy tissue. 
 Results: RT-qPCR of HepG2 cells and of tumor samples showed 
a strong decrease of transcripts of  BHMT and  BHMT2 , compared 
to normal.  MTR transcript levels were not different. The decreased 
 BHMT expression resulted from the transcription of a splicing vari-
ant that produced a frameshift in exon 4, with a premature termina-
tion codon in exon 5 and a loss of function of the gene. This splicing 
variant did not fi t with any mechanism resulting from known splic-
ing consensus sequences and was not detected in normal adult and 
fetal liver. BHMT protein and enzyme activity were not detectable in 
HepG2 and tumor tissues, compared to normal tissues. 
 Conclusion and Discussion: A transcription variant of exon 4 produces 
a loss of function of  BHMT in human hepatocarcinoma. This opens 
new insights for targeting MTR in chemotherapy of hepatocarcinoma. 
Whether this abnormal transcription of  BHMT is part or consequence 
of liver carcinogenesis should deserve further investigations. 
 P5 04
Methionine-Homocysteine Metabolism and Methrotexate 
Toxicity 
 *R. Perez 1 , N. Brauer 1 , T. Imschweiler 1 , T. Niehues 1 
 
1
 HELIOS Klinikum Krefeld, Zentrum f ü r Kinder und Jugendmedizin, 
Krefeld, Germany 
 Background: Methrotexate (MTX) is a drug widely used in pediat-
ric oncology. Like other chemotherapeutic drugs it can cause severe 
adverse reactions. It is currently not possible to predict how severe 
the adverse reactions will be in a particular patient. 
 Aim: We are conducting a pilot study to identify polymorphisms 
related to the betaine, homocysteine and methionine metabolism, 
as well as their metabolites that could predict the occurrence of 
adverse reactions in patients receiving MTX. This could lead to an 
improvement of chemotherapeutic protocols, eg with the admin-
istration of betaine in patients at high risk of presenting toxicity 
from MTX. 
 Methods: We included 5 Patients (3 with ALL, 1 with AT/TR 
and 1 with medulloblastoma) that were treated with intravenous 
and intrathecal MTX, according to the COALL, HIT and Eu 
Rhab chemotherapeutic protocols. During the protocols we col-
lected serial samples of cerebrospinal fl uid and blood. We intend 
to analyze the samples by mass spectrometry and compare the 
results with MTX serum levels, as well as with the adverse reac-
tions presented by the patients and changes found in the cerebral 
imaging. 
 Results: Up to now we have collected 114 blood serum and 79 cere-
brospinal fl uid samples. Preliminary results show that patients with 
betaine and homocysteine defi ciency o are at increased risk for pre-
senting MTX toxicity. 
 Discussion and Conclusion: By analyzing polymorphisms and 
metabolites of betaine, homocysteine and methionine in patients 
receiving MTX we hope to fi nd a correlation that might improve che-
motherapeutic protocols in the future. 
 P5 05 – WITHDRAWN
P5 06
Choline and methyl metabolism in the liver of the laboratory 
rat fed a high fat diet 
 *W. Rees 1 , S. Hay 1 
 
1
 University of Aberdeen, Rowett Institiute of Health and Nutrition, 
Aberdeen, United Kingdom 
 Background: Phosphatidylcholine (PC) is a component of very low 
density lipoprotein (VLDL) which is critical for lipid secretion from 
the liver. High fat diets increase VLDL secretion by the liver. PC is 
synthesised either directly from dietary choline or via the enzyme 
phosphatidylethanolamine N-methyl transferase (PEMT). The rela-
tive activity of these two pathways is unknown in animals fed high 
fat diets. 
 Aim: To evaluate the impact of a high fat diet on the expression 
of genes associated with choline metabolism in the liver of the 
rat. 
 Methods: Male Sprague Dawley rats were fed low or high fat diets 
(Dyets Inc.) for 2 weeks. Livers were removed and levels of key 
mRNAs were measured by Q-RT-PCR (Applied Biosystems). Data 
were normalised to the 18S ribosomal RNA. 
 Results: High fat intake increased liver fat content. The mRNAs 
for betaine hydroxymethyl transferase (Bhmt), PEMT and PPAR- α 
were induced by the high fat diet. There was no change in choline 
dehydrogenase (Chdh), phosphocholine cytidyltransferase (Pcyt), 
gadd153 or Srebp-1c.  
 Conclusion: These results suggest high fat diets increase the produc-
tion of PC via PEMT. Furthermore, the data suggest that the animals 
are using betaine as methyl source. 
Brought to you by | University of Queensland - UQ Library
Authenticated
Download Date | 9/21/15 2:40 AM
Advances and Controversies in B-Vitamins and Choline, Leipzig, Germany, March 2012  A47
 P5 07
Citicholine ameliorates regresive age-related changes in the 
mouse hippocampus 
 *D. Crespo 1 , C. Fernandez Viadero 1 , R. Verduga 1,2 , M. Meg í as 1,2 
 
1
 University of Cantabria, Anatomy and Cell Biology, Santander, Spain 
 
2
 University of Cantabria, Anatomy & Cell Biology, Santander, Spain 
 Our goal was to analyze the effects of chronic administration of 
citicoline (cytidine-5 ′ -diphosphate-choline) on the morphology and 
features of several hippocampal cell populations such as; granule 
cells, hiliar neurons, and astrocytes. Three groups (N = 60) of male 
mice (CFW cobs) were used in this study. A group of 12-month-old 
mice (Adult Control Group -ACG), a group of 24-month-old mice 
(Old Control Group -OCG), and a third group of mice administered 
a solution of Citicholine from 12-month of age up to 24 month (Old 
Experimental Group -OEG). The histological techniques used in this 
study were; NADPH-diaphorase to evaluate those neurons that syn-
thesize nitric oxide (NO). The features of astrocytes were evaluated 
using GFAP. Electron microscopy (EM) was used to analyze the mor-
phological features of the hippocampal cells. The cognitive study was 
performed in a radial maze. The hippocampus of the OCG animals 
presented some characteristics of ageing when compared to ACG ani-
mals. These main features were a signifi cant decrease in the number 
of NADPH-diaphorase positive neurons in the dentate gyrus (DG) 
and a signifi cant increase in the number of astrocytes in the OCG 
animal. When we compared the results of these two groups with those 
of the OEG, we observed a signifi cant improvement in these ageing 
effects. The morphological characteristics of neurons and astrocytes 
were similar to those of the ACG animals. We may conclude that the 
chronic treatment of these mice with citicoline ameliorates some of 
the deleterious effects of ageing in some hippocampal cell popula-
tions. The citicholine (Somazina) used in these experiments was 
kindly provided by FERRER-INTERNACIONAL Spain. 
 P5 08
Hepatoprotective effect of betaine against alcoholic liver 
injury via improvement of impaired hepatic transsulfuration 
reactions 
 *Y. C. Kim 1 , S. J. Kim 1 , Y. S. Jung 1 , J. W. Lee 1 , D. Y. Kwon 1 , H. K. Park 1 
 
1
 Seoul National University, Pharmacy, Seoul, Korea, Republic of 
Korea 
 Background and Aims: It has been accepted that alcoholic liver 
injury involves an impairment of hepatic metabolism of sulfur-con-
taining amino acids. We studied the effects of dietary betaine on the 
disturbance of transsulfuration reactions in liver injury induced by 
chronic ethanol intake. 
 Methods: Rats were fed a liquid diet containing ethanol (5  % ) for 6 
wk. Betaine (1  % ) was supplemented for the entire period or for the 
fi nal 2 wk of ethanol intake. 
 Results: Ethanol intake resulted in hepatic lipid accumulation 
and elevation of serum ALT and AST activities. The resistance of 
liver tissue to oxidative stress was also reduced signifi cantly. The 
ethanol-induced changes were all inhibited by betaine supplementa-
tion. Ethanol intake reduced hepatic levels of S-adenosylmethionine 
(SAM), cysteine, glutathione, and taurine. Methionine adenosyl-
transferase (MAT) and cysteine dioxygenase (CDO) activities were 
depressed, whereas cystathionine  γ -lyase (C γ L) was induced. Betaine 
supplementation increased MAT and C γ L, but inhibited CDO further. 
The ethanol-induced decrease in hepatic SAM and glutathione was 
reversed by betaine, which may account for the enhancement of anti-
oxidant defense. Increases in hepatic mRNA expression of CD14, 
TNF α , COX-2, and iNOS were all prevented when supplemented 
with betaine. A similar degree of hepatoprotection was provided by 
betaine administered for the fi nal 2 wk of ethanol intake, revealing its 
potential therapeutic value in alcoholic liver. 
 Conclusions: Betaine supplementation attenuates the liver injury 
and infl ammatory response induced by chronic ethanol intake. It is 
suggested that hepatoprotective effect of betaine is associated with 
improvement of impaired transsulfuration reactions. 
 P5 09
Associations of folate, vitamin B12, choline, and betaine with 
homocysteine in a Bangladeshi population 
 *M. Hall 1 , V. Ilievski 2 , V. Slavkovich 2 , J. Graziano 2 , M. Gamble 2 
 
1
 Columbia University, Epidemiology, New York, United States 
 
2
 Columbia University, Environmental Health Sciences, New York, 
United States 
 Background: For reasons that are unclear, Araihazar, Bangladeshis 
an area with a high prevalence of folate defi ciency (FD) and hyperho-
mocysteinemia (HHcys). Folate and betaine are two interdependent 
methyl donors used in the remethylation of homocysteine (Hcys) to 
methionine. Betaine can be obtained from diet or produced from the 
oxidation of choline. 
 Aim: To evaluate the relationships of plasma folate, vitamin B12, 
choline, and betaine with Hcys in this unique population. 
 Methods: We conducted a cross-sectional study of 379 Bangladeshi 
adults and measured plasma concentrations of folate, vitamin B12, 
choline, betaine,SAH, and Hcys. 
 Results: As previously observed, moderate FD and HHcys were 
common (FD: males-39 % , females-21 % ; HHcys: males-37 % , 
females-20 % ). In the total sample, a multiple linear regression 
model including age, sex, smoking, folate, B12, betaine,SAH, 
and body mass index accounted for 37.5 % of the variability in 
Hcys (folate: 15.8 % , B12: 3.1 % , betaine: 1.1 % ); folate, B12, and 
betaine were all signifi cantly inversely associated with Hcys. In 
those with FD (n = 111), the same regression model accounted for 
42 % of the variability in Hcys and the associations of betaine and 
folate with Hcys were stronger than in the total sample. Among 
 Table 1  Gene expression in the liver of rats fed high fat diets (P5 06)
Bhmtr Chdh Pcyt PEMT gadd153 Srebp-1c PPAR  α 
Mean LF 3.47 3.68 2.59 3.62 3.28 5.23 3.72
HF 5.29 3.95 2.99 4.60 3.00 4.60 5.41
sd LF 1.01 0.93 1.51 0.61 0.79 2.05 0.67
HF 0.65 0.36 1.11 0.46 1.85 1.97 1.37
P 0.003 0.512 0.593 0.008 0.704 0.570 0.010
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the folate suffi cient (n = 268), choline was signifi cantly positively 
associated with Hcys and the association between betaine and 
Hcys was not signifi cant. 
 Discussion and Conclusion: In this Bangladeshi population, 
nutrients have a strong infl uence on Hcys concentrations and the 
associations of choline and betaine with Hcys differ by folate 
status. 
 P6  – Folate and Homocysteine 
 P6 01
Factors associated with vitamin B12, folate and 
homocysteine levels in persons with type 2 diabetes 
 *M. S. Farvid 1 , F. Homayouni 1 
 
1
 Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti 
University of Medical Sciences, Community Nutrition Department, 
Tehran, Iran, Islamic Republic of Iran 
 Objective: The purpose of this study was to evaluate the extent of 
vitamin B12 and folate defi ciencies and the levels of homocysteine 
in type 2 diabetic patients in respect to the metformin exposure and 
dietary habits. 
 Research Design and Methods: A cross-sectional study was con-
ducted on 298 type 2 diabetic patients. Fasting serum vitamin B12, 
folic acid and homocysteine were measured. Demographic charac-
teristics and dietary intake were assessed. 
 Results: 27.2 % of type 2 diabetes had serum vitamin B12 defi -
ciency ( < 200 pg/ml), 27.2 % had folic acid defi ciency ( < 4.43 ng/
ml) and 62.8 % had serum homocysteine  > 15  μ mol/l. Metformin, 
serum folic acid, low-fat dairy product, high-fat dairy product and 
vitamin supplementation were signifi cantly associated with the 
vitamin B12 defi ciency [OR: 1.70 (1.38-2.11); OR: 0.86 (0.78-
0.95); OR: 0.53 (0.34-0.81); OR: 2.04 (1.05-3.97); OR: 0.38 
(0.17-0.83), respectively] in a logistic regression. Male sex, serum 
vitamin B12, vitamin supplementations and blood pressure lower-
ing drug were inversely associated with low folic acid levels [OR: 
3.77 (1.88-7.57); OR: 0.997 (0.996-0.999); OR: 0.26 (0.13-0.59) 
and OR: 2.58 (1.31-5.07), respectively]. Hyperhomocysteinemia 
was signifi cantly associated with male sex and serum vita-
min B12 [OR: 2.98 (1.65-5.39) and OR: 0.999 (0.998-1.000), 
respectively]. 
 Conclusions: The frequency of vitamin B12 defi ciency is higher in 
patients receiving metformin treatment and lower intake of low fat 
dairy product. The higher serum vitamin B12 is related to the lower 
serum homocysteine. 
 P6 02
Hyperhomocysteinemia induces preterm birth in mice via the 
Gpr109a/Cox-2/PGE2 axis 
 *V. Ganapathy 1 , S. Sonne 1 , S. Offermanns 2 
 
1
 Georgia Health Sciences University, Biochemistry and Molecular 
Biology, Augusta, GA, United States 
 
2
 Max-Planck Institute for Heart and Lung Research, Pharmacology, 
Bad Nauheim, Germany 
 Preterm birth, with its increased mortality and morbidity in babies, 
is the most signifi cant problem in clinical obstetrics. Homocysteine, 
an intermediate in methionine metabolism, is a risk factor for vari-
ous placenta-mediated diseases such as preeclampsia, but its role 
in preterm birth is not known. Here we describe a mouse model 
of hyperhomocysteinemia ( Cbs  + /-  mouse), which is associated 
with preterm birth with a hundred percent penetrance. Elevated 
levels of homocysteine found in this mouse upregulate Cox-2 
expression and PGE2 production both in uterus and placenta, and 
consequently initiate premature contractility in the uterine tis-
sue. Administration of a Cox-2 inhibitor abolishes preterm birth 
in these mice. Gpr109a, a G-protein-coupled receptor for niacin, 
has pro-infl ammatory effects on uterus and induces Cox-2 expres-
sion. Homocysteine upregulates GPR109A expression, suppresses 
the activity of BKCa channel, and depolarizes human myometrial 
cells. Deletion of  Gpr109a in the hyperhomocysteinemic mice 
( Cbs  + /-  / Gpr109a  -/-  ) reverses premature birth. Thus, hyperhomo-
cysteinemia is an etiologic factor in preterm birth, and the process 
involves the Gpr109a/Cox-2/PGE2 axis. Blockade of this receptor 
with high-affi nity and selective antagonists may have potential as 
a novel and effective therapeutic approach to prevent premature 
delivery. 
 P6 03
Homocysteine, folate and vitamin B12 levels in type 2 
diabetic patiens with various stage of chronic kidney 
disease 
 A. Pastore 1 , *A. Noce 2 , G. Di Giovamberardino 1 , A. Di Stefano 3 , N. 
Di Daniele 2 , M. Dess í 3 , C. Call à 4 
 
1
 Children ’ s Hospital and Research Institute  “ Bambino Ges ù ” , 
Biochemistry Laboratory, Rome, Italy 
 
2
 “ Tor Vergata ” University Hospital, Nephrology Unit, Rome, 
Italy 
 
3
 “ Tor Vergata ” University Hospital, Laboratory Medicine, Rome, 
Italy 
 
4
 University Hospital  “ Policlinico Gemelli ” , Laboratory Medicine, 
Rome, Italy 
 Background: A lowering effect of folate supplementation on homo-
cysteine levels (tHcy) in patients with type 2 diabetes mellitus (T2D) 
was recently demonstrated by Aghamohammadi V. and collaborators 
(1), but no data on T2D with chronic kidney disease (CKD) were 
reported. 
 Aim: Aim of the study is to determine tHcy levels in T2D patients at 
various stages of CKD, and the relationship with folate and vitamin 
B 12 . 
 Methods: We recruited 40 T2D-CKD patients (stages II-IV 
according to K-DOKI guidelines). tHcy levels were measured 
as previous decribed (2). Folate and vitamin B 12 were assayed 
by an automated chemiluminescence system (Advia Centaur; 
Siemens). 
 Results: tHcy levels increases in all patients, and this rise positively 
correlate with the CKD stage (p < 0.05). Moreover, we interestingly 
found that only in stage 2 CKD tHcy concentrations negatively cor-
relates with low levels of both vitamin B12 and folate, whereas in 
stage 3 folate have no effect, and in stage 4 vitamin B 12 have no effect 
on tHcy concentrations. 
 Conclusion: We demonstrated for the fi rst time that tHcy increase in 
diabetic CKD patients and this rise correlate positively with the stage 
of kidney disease. Folate and vitamin B 12 levels have different effect 
on tHcy levels at different stages of CKD. These results may indicate 
the importance of the combined folate and vitamin B 12 therapy at 
early stage of CKD, where the levels of tHcy negatively correlates 
with both folate and vitamin B 12 . 
Brought to you by | University of Queensland - UQ Library
Authenticated
Download Date | 9/21/15 2:40 AM
Advances and Controversies in B-Vitamins and Choline, Leipzig, Germany, March 2012  A49
 P6 04
Effectiveness of short-term low-dose folic acid 
supplementation in Polish elderly 
 *A. Chmurzy n´ ska 1 , A. Malinowska 1 , J. Gawecki 1 , J. Twardowska-
Rajewska 2 
 
1
 Pozna n´ University of Life Sciences, Human Nutrition and Hygiene, 
Pozna n´ , Poland 
 
2
 Adam Mickiewicz University, Gerontology Laboratory, Pozna n´ , 
Poland 
 Background: Serum homocysteine (Hcy) concentration depends on 
nutritional factors, including B-vitamin intake, but genetic infl uenc-
esalso contribute to this trait. The signifi cant effect of the  MTHFR 
C677T polymorphism has been demonstrated. 
 Aim: The aim of the present study is to evaluate the impact of folic 
acid supplementation on serum homocysteine levels and blood bio-
chemical parameters among Polish elderly people with differing 
C677T  MTHFR genotypes. 
 Methods: 151 men and women over 60 years of age (69.8  ± 7.7) 
were recruited from the University of the Third Age and the Social 
Welfare Home in Pozna n´ . All participants were supplemented with 
0.4 mg/d folic acid for 8 weeks. The serum folate level was deter-
mined immunoenzymatically, and plasma Hcy was measured using 
the HPLC method. Blood biomarkers were analyzed using a Vitalab 
Flexor biochemical analyzer.  MTHFR genotyping was performed 
using the PCR-RFLP method. 
 Results: Basal serum Hcy concentration ranged from 4.0 to 18.7 
 μ M, while after folic acid supplementationa reduction in concen-
tration was observed (p < 0.001). The size of the decrease in homo-
cysteine level was dependent on the  MTHFR genotype, being 1.4 
 μ M in people with the CT or TT genotype, but only 0.7  μ M in CC 
homozygotes. Hcy concentration after folic acid supplementation 
was correlated with body weight and waist-to-hip ratio. Moreover, 
after dietary intervention the T-allele carriers had decreased HDL 
cholesterol and increased glucose concentration. 
 Conclusion: Short-term low-dose folic acid supplementation does 
reduce serum homocysteine concentration in the elderly, but is more 
effective in people with the CT or TT  MTHFR genotype. However, 
such dietary intervention can change also lipid metabolism. 
 P6 05
Effect of Folic Acid Supplementation on Homocysteine, 
Serum Total Antioxidant Capacity and Malondialdehyde in 
Patients with Type 2 Diabetes Mellitus 
 *B. Pourghassem Gargari 1 , V. Aghamohammadi Khiavi 1 , A. 
Aliasgharzadeh 1 , M. Hamed Behzad 1 
 
1
 Faculty of Health and Nutrition, Biochemistry and Nutrition, Tabriz, 
Iran, Islamic Republic of Iran 
 Objective: Metformin is widely used in patients with type 2 dia-
betes but may decrease vitamin B12 and folate levels and increase 
levels of homocysteine. Hyperhomocysteinemia and hyperglyce-
mia induce oxidative stress in type 2 diabetes. Thus, this study 
performed to determine the effects of supplementation of folate 
on concentration of homocysteine, total antioxidant capacity, 
malondialdehyde. 
 Methods: This was a double-blind randomized controlled clini-
cal trial. 68 men with type 2 diabetes participated voluntarily with 
written consents. Patients were randomly divided in two groups; 
folic acid 5mg/day and placebo. All the patients received the tab-
lets for 8 weeks. Anthropometric and nutrient intakes data obtained 
from each patient. Baseline and 8th week homocysteine, total anti-
oxidant capacity, malondialdehyde, folate and B12 levels were 
measured. 
 Results: After folate supplementation in folic acid group, homocys-
teine was signifi cantly decreased (15.13 ± 3.25 to 12.1 ± 3.15 μ mol/L, 
P0/05). 
 Conclusions: Pharmacological dose of folate supplementation effec-
tively lowered plasma homocysteine and serum malondialdehyde 
levels and improved the total antioxidant capacity in patients with 
type 2 diabetes. 
 Key words: Homocysteine, Malondialdehyde, Type II Diabetes 
Mellitus, Total Antioxidant Capacity. 
 P6 06
C677T Polymorphism of the Methylenetetrahydrofolate 
Reductase Gene and Hyperlipidemia affect Folic Acid, and 
Vitamin B12, but not Homocysteine Serum Levels in Algerian 
Subjects with Cardiovascular Disease 
 *B. Houcher 1 , Z. Houcher 1 , S. Begag 1 
 
1
 University, Biology, Setif, Algeria 
 Methods: This research was carried out as a prospective study on 98 
patients hospitalized in the Cardiology Section. Mean age of partici-
pants was 57 y (range 20-96 y). The genetic analysis of the MTHFR 
C677T polymorphism was performed by real-time polymerase chain 
reaction on a Light Cycler. The concentration of tHcy, folic acid and 
vitamin B12 levels were determined using a competitive immunoas-
say method. Plasmatic total cholesterol, triglyceride, glucose, crea-
tinine and urea concentrations were measured by the colorimetric 
method. 
 Results: Plasma tHcy was signifi cantly higher in the patients with 
CVD, this HHcy was associated with the presence of mildly elevated 
serum urea and creatinine (p  < 0.05). MTHFR gene mutation does 
not seem to be associated with elevation of plasma tHcy in the stud-
ied patients and this lack of correlation could be explained by the 
level of folatemia which seem must to be more lower than in our 
study. CVD patients with 677CT/TT genotypes had a higher concen-
tration of total cholesterol (TC) than those with 677CC genotype (p  < 
0.05). Although, the presence of 677T variant conjugated with hypo-
folatemia ( < 15.4 ng/mL) had a more detrimental effect on the level 
of TC (p  < 0.05). Folatemia and vitamin B12 were much higher in 
677CC genotype compared to 677CT/TT genotype in CVD subjects 
without hyperlipidemia (p  < 0.05), however in patients with hyper-
lipidemia these values became lower also with 677CC genotype. 
 Conclusions: Hyperlipidemia affects the levels of plasmatic folate 
and vitamin B12 indepedently to mutated MTHFR genotype. The 
effect of 677T variant on TC, folate and vitamin B12 can be explained 
by the adverse effect of elevated tHcy on lipid profi les and on plas-
matic folate and vitamin B12. 
 P6 07
Decreased activity of folate transporters in lipid rafts resulted 
in reduced folate uptake in chronic alcoholism in rats 
 *N. Wani 1 , R. Nada 2 , K. Khanduja 3 , J. Kaur 1 
 
1
 PGIMER, Biochemistry, Chandigarh, India 
 
2
 PGIMER, Histopathology, Chandigarh, India 
 
3
 PGIMER, Biophysics, Chandigarh, India 
 Background: Folic acid is an essential nutrient, required for one-
carbon biosynthetic processes and methylation of biomolecules. 
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Defi ciency of this micronutrient leads to disturbances in normal 
physiology of cell. Chronic alcoholism is well known to be associated 
with folate defi ciency which is due, in part to folate malabsorption. 
 Aim: The aim of present study was to delineate the regulatory 
mechanisms of folate uptake in liver in an in vivo model of chronic 
alcoholism. 
 Methods: Male Wistar rats were fed 1 g/kg body weight/day ethanol 
(20 % solution) orally for 3 months and the kinetics of folate uptake 
and expression of transporters were studied in liver basolateral mem-
brane vesicles. 
 Results: The folate transport system in liver basolateral membrane 
(BLM) was found to be carrier mediated with pH optima at acidic 
pH, with the major involvement of proton coupled folate transporter 
(PCFT) in the uptake. The folate transporters were found to be asso-
ciated with lipid raft microdomain of liver BLM. Moreover, etha-
nol ingestion decreased the folate transport by altering the Vmax of 
folate transport process and downregulating the expression of folate 
transporters in lipid rafts. The decreased transporter levels were asso-
ciated with reduced protein and mRNA levels of these transporters 
in liver and consequently resulted in reduced folate levels in liver of 
ethanol fed rats. 
 Discussion and Conclusion: The chronic ethanol ingestion led 
to decreased folate uptake in liver, which was associated with the 
decreased number of transporter molecules in the lipid rafts at the 
liver BLM, which can be ascribed to the reduced synthesis of these 
transporters. 
 P6 08
Paradoxical role of H475Y Glutamate Carboxypeptidase 
II (GCPII) genetic polymorphism in altering disease 
susceptibility 
 *P. Shree Divyya 1 , S. M. Naushad 1 , A. Addlagatta 2 , M. PVLN 1 , 
R. R. Ch 1 , R. R. Digumarthi 1 , S. R. Gottumukkala 1 , A. Kumar 1 , S. 
Rammurti 1 , V. K. Kutala 1 
 
1
 Nizams Institute of Medical Sciences, Clinical Pharmacology and 
Therapeutics, Hyderabad, India 
 
2
 Indian Institute of Chemical Technology, Chemical Biology, 
Hyderabad, India 
 Glutamate Carboxypeptidase II ( GCPII ) inhibition was found to 
confer protection against certain neurological disorders and cancer. 
Despite the pivotal role of this enzyme, the most common polymor-
phism in this crucial gene i.e.; H475Y has not been explored com-
prehensively in all its splice variants. In the current study, we have 
determined the role of this variant in different disease conditions 
such as breast and prostate cancers, autism, coronary artery disease 
(CAD) and miscarriages (N = 1561). The analysis of this variant was 
done using PCR-RFLP, which was further confi rmed by dideoxy 
sequencing. Axysm folate kit was used to measure the plasma folate 
levels.  GCPII expression was studied by semi quantitative RT-PCR. 
 In silico model was developed using PYMOL. We observed protec-
tive role of H475Y variant in cancers [breast cancer; OR (95 % CI): 
0.81 (0.55-1.19), prostate cancer: 0.00 (0.00-0.66)], and in autism 
(OR 0.47 (0.21-1.03), on the other hand infl ated risk was observed 
in CAD (OR 1.69 (1.20-2.37) and miscarriages [Maternal OR 3.26 
(2.11-5.04); Paternal 1.99 (1.23-3.21)]. Further, this variant was 
found to impair the intestinal folate absorption in subjects with 
dietary folate intake in the lowest tertile (CC vs. CT in lowest ter-
tile; 7.56 ± 0.85ng/ml vs. 2.73 ± 045ng/ml, p = 0.005).  In silico model 
of GCPII showed steric hindrance with H475Y resulting in stereo-
chemical alteration of catalytic site, thus interfering with ligand bind-
ing. There was no statistically signifi cant association was observed 
between the dietary folate levels and  GCPII expression. However, a 
positive correlation was seen between the plasma folate levels and 
 GCPII expression (r = 0.70, p < 0.05). To conclude, our data suggests 
the inhibitory role of H475Y variant on folyl glutamate carboxypep-
tidase and N-acetylated  α -linked acidic dipeptidase activities and 
probable inhibition of prostate specifi c membrane antigen. 
 P6 09
Hyperhomocysteinemia and markers of infl ammation and 
oxidative stress in patients with unstable angina pectoris 
 *A. Moiseenok 1 , I. Buko 2 , S. Zolotukhina 2 
 
1
 Food Research and Practical Center of the National Academy of 
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2
 Republican Research and Practical Center of Cardiology, 
Biochemistry, Minsk, Belarus 
 A comparison of levels of homocysteine (HC) and markers of oxi-
dative stress (OS) and infl ammation in the systemic blood fl ow is 
a topical problem in cardiology, taking into consideration a multi-
factor character of processes that lead to destabilization of the ath-
erosclerotic plague. 
 Nineteen patients with acute coronary syndrome and unstable angina 
(group 1, aged 57 ± 1 years) as well as 17 patients with coronary heart 
disease and stable angina (group 2, aged 56 ± 2years) were included 
in this study. Plasma concentrations of HC were determined by high 
performance chromatography [Williams R.H. et al., 2001]. Serum 
concentrations of high sensitivity C-reactive protein (hs-CRP) were 
measured by ELISA method. The concentrations of thiobarbituric acid 
reactive substances (TBARS) in plasma [E.N. Korobeinikova, 1989] 
and the activity of blood superoxide dismutase [Chevari S. et al., 1991] 
were determined spectrophotometrically. Spontaneous platelet aggre-
gation and ADP-induced platelet aggregation in platelet-rich plasma 
were assessed by aggregometry AP-2110 (SOLAR, Minsk, Belarus). 
 It was shown that in patients with unstable angina, hyperhomo-
cysteinemia amounted to 21.4 ± 3.7 and in those with stable angina 
- 12.8 ± 1.4 (p = 0.05). The variations in hs-CRP level were more 
pronounced: 8.82 ± 2.54 and 2.05 ± 0.30 mg/l, respectively (p = 0.001. 
Under unstable angina, platelet spontaneous and ADP-induced 
aggregation and TBARS were tended to increase, whereas superox-
ide dismutase activity was elevated by 80 % (p = 0.05). Correlation 
between the rates of coronary artery lesions and hsCRP concentra-
tions was not found. 
 P6 10
Folates induce human erythroleukemic cell line proliferation 
through foate receptors  α 1 and Notch1 signaling 
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M. P. de la Maza 1 , A. M. Ronco 1 
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 Introduction: Folic acid (FA) consumption at high levels has been 
associated with cancer risk. Several mechanisms have been proposed to 
explain this association. The Notch signal pathway and folate receptors 
(FR) have been implicated in the regulation of cellular proliferation. 
 Aim: To demonstrate that high concentrations of FA or its reduced 
form, 5-methyltetrahydrofolic acid (5-MTHF) increase human 
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erythroleukemic cell line K562 cell proliferation through an altera-
tion of Notch1 and/or folate receptors  α 1 (FR  α 1) expression. 
 Methods: K562 cells were cultured in high (100nM), low (10nM) 
or 0nM FA or 5-MTHF concentrations during 72 hours. Cell prolif-
eration was determined by the MTT method, Notch1- intracellular 
domain (NICD) as well as Folate receptor FR  α 1 α 1 (FR  α 1) levels 
were analyzed by fl ow cytometry. 
 Results: K562 cells exposed to 100nM FA or 5-MTHF showed 
higher proliferation rate than those exposed to 10 nM of FA or 
5-MTHF (p < 0.01) during 72h. On the other hand, Notch-1 intracel-
lular domain expression was reduced at higher FA or 5-MTHF con-
centrations compared with lower concentrations (0-10nM) (p < 0.01). 
Total FR  α 1 expression was similar at both FA or 5-MTHF concen-
trations (10 or 100 nM), however, external FR  α 1 expression was 
lower at higher FA or 5-MTHF concentrations (p < 0.05). 
 Conclusion: These data suggest that FA and 5-MTHF at high con-
centrations may induce down regulation of FR  α 1 inhibiting Notch1 
signaling conducing to K562 cells proliferation. 
 P6 11
Increased level of serum Homocysteine in vitiligo 
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 Background: Vitiligo is an acquired depigmenting disorder caused 
by the destruction of melanocytes. The exact aetiopathogenesis and 
mechanisms of vitiligo are not fully understood. 
 Vitamin B12 and folic acid levels are decreased in vitiligo, which are 
the important cofactors required in the metabolism of Homocysteine 
(Hcy). Consequently, Hcy level increase in the circulation. Therefore it 
is possible that increased Hcy plays a role in melanocytes destruction. 
 The aim of this study is to look for any association of vitiligo with 
serum Hcy level. 
 Method: Total 30 patients of both sexes with vitiligo and 30 control 
subjects were enrolled in this study. Sera from patients and controls 
were assayed for Hcy by Enzyme immunoassay. The collected data 
were analysed by SPSS version-16. 
 Results: The mean serum level of Hcy was signifi cantly higher in 
patients with vitiligo as compared to healthy controls and its level 
was high in male patients as compared to female patients. The Hcy 
level in vegetarian patients was signifi cantly higher as compared with 
non-vegetarian patients. The Hcy level was also signifi cantly higher 
in active vitiligo patients as compared to stable vitiligo patients. 
 Conclusion: An increased serum Hcy may be a precipitating factor 
for vitiligo in the predisposed individuals. Serum Hcy is related to 
gender of patients, activity of disease and dietary habits of vitiligo 
patients. 
 Keywords: Vitiligo, homocysteine, melanocytes, dietary habits .
 P6 12
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 In previous studies, we have demonstrated that dietary FA defi ciency 
compromises methionine metabolism, whereas supplementation 
does not show additional positive effects compared to control diet 
in growing animals. However, there is not information about the FA 
supplementation/defi ciency effect on the methionine cycle under 
induced dietary vitamin B 12 in defi ciency weaning rats. 
 The present study was conducted to examine the effects on the methi-
onine/methylation metabolism during growth according to different 
dietary levels FA and vitamin B 12 . 
 Male Sprague Dawley rats (6 weeks) were fed diets containing 0 or 
50  μ g vitamin B 12 /kg diet with 0, 2 or 8 mg FA/kg diet for 30 days. 
 Serum folate was higher in rats fed a FA control and supplement diet 
when there was B 12 defi ciency compared to corresponding B 12 con-
trol dietary levels. These results suggested that vitamin B 12 defi ciency 
originates a cellular folate accumulation in the methyl form, creating 
a methylfolate trapping scenario. For the three different FA treat-
ments plasma homocysteine level, hepatic S-adenosylmethionine 
(SAM), hepatic and cerebral S-adenosylhomocysteine (SAH) con-
centrations were also higher in B 12 defi cient groups. However, hepatic 
DNA methylation was lower in the three groups under B12 dietary 
defi ciency. This indicates that both vitamins are necessary for a nor-
mal and correct functioning of the cycle during growth and to avoid 
possible risks associated to alterations in these metabolic pathways, 
as we have demonstrated during pregnancy in other studies. In con-
clusion, metabolic priories in relative to the methionine metabolism 
during growing are clearly associated to an adequate folic acid/B12 
ratio. More studies are being/carry on in order to achieve optimal 
intakes of the FA/B12 ratio for different situations (e.g. high methy-
lation demand periods). 
 P6 13
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patients treated with antiepileptic drugs 
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 Antiepileptic drug (AED) therapy of patients with epilepsy may gen-
erate a lot of plasma molecular changes including the concentration 
of homocysteine (Hcy). Some of the research showed that Hcy may 
induce apoptosis. 
 The aim of the study was to analyze the level of plasma Hcy and its 
infl uence on expression of the apoptotic proteins (p53, Bax, Bcl-2) 
in peripheral lymphocytes and the level of apoptotic cells in epilep-
tic patients, before and during AED treatment {VPA, carbamazepine 
(CBZ) and lamotrigine (LTG), in monotherapy and polytherapy}, 
and in controls. 
 There were 23 epileptic patients at the age of 18 to 69 in the study 
group, 20 of them were treated with AEDs, 3 before initiating the 
convulsive treatment. Control group consisted of 22 individuals at 
the age of 22 to 61. The Hcy level was analyzed by HPLC, the levels 
of apoptotic proteins in peripheral lymphocytes by western blotting 
method and the level of lymphocyte apoptotic cells by active caspase 
-3 detection by fl ow cytometry. 
 The studies revealed the elevated level of Hcy ( > 16  μ m) in 65 % 
of epileptic patients treated with AEDs, especially with VPA. Mild 
hyperhomocysteinemia (HHcy) was combined with lower expres-
sion of p53 protein but higher ratio Bax/Bcl-2 and increased level of 
apoptotic cells. 
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 It appears that some AEDs generate HHcy which may stimulate 
apoptotic processes. The mechanism of apoptosis induction by AEDs 
needs further studies. 
 P6 14
The levels of vitamins and aminothiols involved in 
homocysteine metabolism in the blood plasma of 
childbearing age women. 
 *E. Moiseenok 1 , G. Alfthan 2 , A. Moiseenok 3 
 
1
 Grodno State Medical University, General Hhygiene and Ecology, 
Grodno, Belarus 
 
2
 National Institute for Health and Welfare, Biomarkers, Helsinki, 
Finland 
 
3
 Food Research and Practical Center of the NAS Belarus, Nutrition, 
Grodno, Belarus 
 The emergence of hyperhomocysteinemia (HHCy) as a marker and 
pathogenetic factor in various diseases is closely related to the meta-
bolic, genetic and nutritional factors. Investigation of the extended 
spectrum of biomarkers involved in the HHCy pathogenesis is espe-
cially important for perinatal pathology. 
 In 140 young women aged 17 to 39 years (25.4  ± 5.4 years) vol-
untarily participated in the study, blood plasma folate (FA) levels 
were examined by radioassay method; cobalamin (B 12 ) - by chemi-
luminescence microparticle intrinsic factor assay; homocysteine 
(HCy), cysteine (Cys) and cystenile-glycine (Cys-Gly) - by HPLC 
method. 
 It was found that the levels of vitamins and aminothiols are: FA - 
13.0 [8.0;23.5] nmol/l; B 12 - 256.0 [228.0;339.0] pmol/l; HCy - 7.53 
[6.7;9.2] umol/l; Cys - 190.5 [176.7;202.2] umol/l; Cys-Gly - 30.6 
[26.9;35.2] umol/l. According to percentile analysis 5 % of women 
have unsatisfactory FA and B 12 status, which is consistent with the 
development of moderate HHCy. The level of total Hcy in blood 
plasma has a moderate relationship with the content of the FA (r = 
-0.39, p < 0.01) and weakly signifi cant trend with the content of vita-
min B 12 (r = -0.21, p < 0.05). The strongest correlation was found for 
the levels of HCy and Cys (r = 0.48, p < 0.01). 
 P6 15
 N -Homocysteinylation causes hair keratin damage in 
humans and animals 
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 Background: Genetic or nutritional disorders in homocysteine 
(Hcy) metabolism elevate Hcy-thiolactone (HTL) are associated 
with heart and brain diseases. Hcy becomes a component of pro-
tein as a result of  N -homocysteinylation of protein lysine residues by 
HTL. This reaction causes a thyil radical-mediated protein damage, 
which would accumulate in long-lived proteins and could contribute 
to Hcy-related pathology. 
 Aim: To gain insights into a role of  N -homocys-teinylation in induc-
ing protein damage we studied Hcy content of hair keratin. 
 Methods: N-linked Hcy after conversion to HTL was analyzed by 
HPLC method with fl uorescent detection. 
 Results:  N -linked Hcy comprised 33 % of all Hcy content in human 
hair keratin and the remaining 67 % was  S -linked. Hair keratin from 
wild type C57BL/6J mice fed with a high methionine diet contained 
2.2-fold more  N -linked Hcy than control mice.  N -linked Hcy was 
elevated 20-, 7.3-, or 2.5-fold in hair keratin from  Cbs -/-,  Cse -/-, or 
 Mthfr -/- mice, respectively. SDS-soluble  N -linked Hcy comprised a 
10-fold smaller fraction of SDS-soluble  + SDS-insoluble  N -linked 
Hcy in hair keratin from hyperhomocysteinemic mice than from wild 
type animals (0.04 ± 0.00  vs . 0.39 ± 0.04, p = 0.0003). 
 Discussion and Conclusion:  N -linked Hcy is a component of human 
and animal hair keratin. Our fi ndings demonstrate that hair keratin 
is a target for  N -homocysteinylation  in vivo and that the modifi ca-
tion causes severe damage to hair keratin, manifested by the loss of 
SDS-solubility. 
 P6 16
Elevated Homocysteine Level is a potential Risk factor for 
osteoporosis among elderly population of Nepal 
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 Background: Low B-vitamin status and elevated homocysteine is 
a strong risk factor for osteoporosis among elderly population of 
Nepal. 
 Objective: Our objective was to examine the associations of plasma 
concentrations of vitamin B 12 and homocysteine with osteoporotic 
risk in elderly men and women. 
 Material and Methods: This was a hospital based observational 
study conducted in the patients visiting the department of bio-
chemistry, Manipal teaching hospital of Nepal. A total of 1500 
men and women (mean age 78 yrs) was incorporated in the study. 
Blood samples were collected from 2010 to 2011 were used to 
categorize participants plasma B-vitamin (normal, low, defi cient) 
and homocysteine (normal, high) groups. Descriptive statistics 
and testing of hypothesis were used to analyse the data with 
SPSS 16. 
 Result: Vitamin B 12 was inversely associated with osteoporotic risk 
(p < 0.05), yet associations were somewhat attenuated and not signifi -
cant after controlling for BMD, and homocysteine. Participants with 
high homocysteine ( > 14 μ mol/liter) had approximately 80 % higher 
osteoporotic risk but this association was attenuated after controlling 
for vitamin B12 (hazard ratio = 1.80; 95 % confi dence interval 1.22, 
2.77). 
 Conclusion: Low B-vitamin concentration may be a risk factor for 
decreased bone health, yet does not fully explain the relation between 
elevated homocysteine and osteoporotic. 
 P6 17
A link between systems: functional integration of the age-
related disorders including folic acid, vitamin B12 defi ciency 
and hyperhomocysteinemia 
 *L. Majnaric´-Trtica 1 
 
1
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 Background: Folic acid/vitamin B12 defi ciency and elevated serum 
homocystein levels (hyperhomocysteinemia) have been recognised 
as mutually related disorders, all of them associated with many age-
ing phenotypes. 
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 Aim: To achieve better understanding of the relationships among 
these important age-related disorders, we reached out for a systems 
biology methodology approach. 
 Methods: The sample,consisted of 93 patients aged 50-89 years 
(median 69), characterised with multiple chronic health disorders, 
were divided into two groups, according to the homocystein cut-off 
value indicating hyperhomocysteinemia ( > 12mM). Their health-
status were determined systematically, by using a large amount of 
parameters, including both clinical and laboratory ones. Data mining 
method was used to fi nd patterns in the data. By subsequent data 
mining, applied on particular of selected parameters, it was possible 
to get closer insight into the way selected parameters are intercon-
nected forming a functional network. 
 Results: Constructed network linked, with one another, parameters 
indicating: folic acid and vitamin B12 defi ciency, hyperhomocysteine-
mia, low creatinine clearance, the thyreoid gland hypofunction, and 
neuropsychiatric and gastroduodenal disorders, as well. 
 Discussion and conclusion: By using this method, many hidden 
relationships within the biological network including folic acid/vita-
min B12 defi ciency and hyperhomocysteinemia, have become vis-
ible, thereby improving our understanding of the issue. In a more 
broader context, intervening inside the network, might be the thera-
peutic strategy for the future. 
 P6 18
Hyperhomocysteinemia is associated with venous 
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 Background: Although hyperhomocysteinemia is an established 
cardiovascular risk factor, the role in venous thromboembolism 
(VTE) is still controversial. According to some studies, mild or mod-
erate levels of hyperhomocysteinemia are associated with 2.5-2.95 
increased risk for VTE; the administration of folate and vitamins 
B reduces the recurrences of thrombotic events with 16 % , whereas 
other studies failed to prove the benefi t. 
 Aim and Method: We aimed to detect the association between 
increased levels of homocysteine and VTE. We performed a trans-
versal, case-control study, including 127 patients diagnosed with 
VTE and 100 sex- and age matched controls, without VTE. Patients 
with chronic renal failure, thyroid diseases, or following therapy 
with methotrexate or vitamins B were excluded, due to the infl uence 
of homocysteine levels. Homocysteinemia was assessed using liquid 
chromatography high pressure reverse phase. 
 Results: The mean value of homocysteinemia was 17.39 
micromol/L. in VTE group and 14.15 micromol/L.in controls, 
p = 0.025. Patients with deep venous thrombosis (DVT) and 
hyperhomocysteinemia did not present a signifi cantly higher risk 
for pulmonary embolism in comparison with controls, p = 0.127. 
Hyperhomocysteinemia was signifi cantly associated with VTE, 
even when controlling the variables age, smoking and cancer, 
which represent risk factors for DVT as well as factors increasing 
homocysteinemia, p = 0.127. 
 Conclusions: hyperhomocysteinemia is signifi cantly associated with 
VTE and represents an independent risk factor for VTE. 
 References: [1] Ayala C, Garcia R, Cruz E et al. Homocysteine levels 
and polymorphisms of MTHFR and CBS genes in Colombian patients 
with superfi cial and deep thrombosis. Biomedica 2010;30(2):259-67 
 2. Dionisio N, Jardin I, Salido GM et al. Homocysteine, intra-
cellular signaling and thrombotic disorders. Curr Med Chim 
2010;17(27):3109-19 
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 Bony adverse effects are amongst the potentially adverse clinical 
consequences with antiepileptic drugs (AEDs). Various pathophysi-
ological mechanisms of AED-induced bone disease have been 
proposed, the most important being the hepatic induction of cyto-
chrome P450 leading to increased metabolism of vitamin D. Other 
mechanisms include secondary hyperparathyroidism, calcitonin or 
vitamin K defi ciency, deprived estrogen levels, aromatase inhibition 
etc. Antiepileptic drugs also interfere with circulating homocysteine 
(hcy) and enhance the susceptibility of epileptics to hcy-related 
adverse effects. A better understanding of these mechanisms can aid 
clinicians in identifying and monitoring vulnerable patients and in 
defi ning the optimal therapy for all affected patients. 
 For the management of AEDs associated concomitant bony effects, 
anti-osteoporotic agents can be prescribed. In our lab, we have 
focused on developing a model to study AED-induced changes 
in the bone and the effect of bisphosphonates in alleviating the 
AED-induced bone loss in rodents. We evaluated the effect of 
bisphosphonates on antiepileptic effi cacy of phenytoin and AED-
induced alterations in the biochemical markers of bone turnover, 
in comparison with calcium and vitamin D 3 (CVD) supplementa-
tion. Role of serum hcy and folic acid was assessed. We found 
bisphosphonates to lower serum hcy due to its antioxidant profi le 
and not via B-vitamin dependent remethylation pathway of hcy. 
With the newer AEDs gaining importance, our future experiments 
would focus on comparing them with the conventional AEDs and 
to examine their impact on multiple aspects of bone health and to 
identify anti-osteoporotic agents that can be prescribed safely with 
other AEDs. 
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 Background: The burden of vascular disease has shifted to the 
developing countries. Hyperhomocysteinemia, which can be caused 
by genetic polymorphisms as well as dietary defi ciencies, has been 
seen to be more commonly associated with vascular disease in the 
Indian population as compared to the western populations. 
 Aim: To identify the correlation between homocysteine levels and 
B 12 and folate levels as well as MTHFR C677T polymorphism in 
Indian patients of vascular disease. 
 Method: Blood samples of 70 patients of vascular disease and 70 
controls were subject to estimation of homocysteine, vitamin B 12 , 
folate and the presence of MTHFR C677T polymorphism (heterozy-
gous and homozygous). The data was analysed by the SPSS version 
17 statistical package. 
 Results: Homocysteine levels were observed to be signifi cantly 
higher (p < 0.001) and folate levels were signifi cantly lower (p < 0.001) 
in Indian patients of vascular disease as compared to those in the con-
trols. Correlation studies revealed that in the controls, homocysteine 
levels bore a signifi cant(p = 0.001) negative correlation with vitamin 
B 12 levels, whereas in the patients, there was a signifi cant negative 
correlation with B 12 (p < 0.001) as well as folate levels(p < 0.001). 
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Homocysteine levels did not bear a signifi cant correlation with the 
presence of MTHFR C677T polymorphism. 
 Discussion and conclusion: Since, hyperhomo-cysteinemia is asso-
ciated with vascular disease in Indian patients, large-scale means to 
lower homocysteine should be instituted to reduce the prevalence of 
vascular disease. One such means could be the fortifi cation of food 
with folate as well as vitamin B 12 . 
 P6 21 presented as oral presentation 
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 Background: Idiopathic Parkinson ’ s disease (PD) is the most com-
mon age-related, neurodegenerative disease of unknown etiology. 
A part of PD patients have cognitive dysfunction in their clinical 
course. Several studies demonstrated that hyperhomocysteinemia, 
which in PD resulted partly form L-Dopa administration, would be a 
risk factor for cognitive dysfunction. 
 Aim: The aim of this study was to investigate the relationship 
between homocysteine (Hcy) and cognitive dysfunction in PD and 
Alzheimer disease (AD). 
 Methods: Plasma total Hcy and serum folate, vitamin B12 levels 
were studied 51 PD without cognitive dysfunction (PD-), 56 PD 
with cognitive dysfunction (PD + ), 26 AD, and 145 non-demented 
aged controls (CTL). Cognitive dysfunctions estimated by MMSE, 
WAIS-R, and SDS in these groups were considered. We conducted 
multivariate analysis: p < 0.05 was considered to be signifi cant. 
 Results: Mean Hcy level in CTL was 8.3 nmol/ml and the signifi -
cantly lowest among the groups. Mean Hcy level in PD + was 15.0 
nmol/ml and signifi cantly higher than those in CTL, PD- (11.7 nmol/
ml) and AD (12.1 nmol/ml). Hcy levels were positively correlated 
with ages and negatively correlated with serum folate concentra-
tion. In PD + , Hcy levels were negatively correlated with MMSE, IQ 
scores in WAIS-R, and SDS scores. 
 Discussion and Conclusion: The increase of Hcy in PD was seemed 
to be related to cognitive dysfunction. Hcy is suggested to be a pre-
dictive marker for cognitive dysfunction in Parkinson ’ s disease. 
 P6 23 
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 Background: Dimethylarginine and homocysteine metabolism are 
closely linked and alterations of both have been observed in plasma 
and cerebrospinal fl uid (CSF) of patients with Alzheimer ’ s disease 
(AD). CSF parameters of homocysteine metabolism have recently 
found to be associated with the AD CSF biomarker phosphorylated 
tau (ptau) in AD patients. 
 Objective: To investigate possible relationships between homo-
cysteine and dimethylarginine metabolism and the AD CSF biomark-
ers ptau181 and amyloid beta 1-42 (A β 42). 
 Methods: We assessed parameters of homocysteine (CSF homo-
cysteine, SAH, SAM, 5-MTHF) and dimethylarginine metabolism 
(plasma and CSF asymmetric dimethylarginine (ADMA), symmet-
ric dimethylarginine (SDMA), L-arginine) as well as CSF A β 42 
and ptau181 in 98 controls and 51 AD patients. Logistic regres-
sion analyses were performed to assess interrelations between each 
parameter. 
 Results: SAH concentrations independently predicted CSF ADMA 
levels, and CSF ADMA and L-arginine predicted ptau181, but not 
A β 42 concentrations in AD patients. When including concentrations 
of Hcys, 5-MTHF, SAM and SAH into the analysis, CSF ADMA 
concentrations independently predicted ptau181 levels in AD patients 
but homocysteine-related metabolites were associated with ptau181 
only when ADMA was removed from the analysis model. 
 Conclusion: These results suggest that CSF ADMA may interact with 
CNS homocysteine metabolism and may contribute to neurodegener-
ation and accumulation of phosphorylated tau in AD. Functional and 
interventional studies are needed to further proof this hypothesis. 
 P6 24 
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 Homocysteine and its metabolites, common risks factor for many 
cardiovascular and CNS disorders, induces seizures via different, but 
still not-well-known mechanisms. We showed recently the involve-
ment of gasotransmitter NO, produced by family of NO synthases 
(NOS), in homocysteine convulsive activity, but the role of inducible 
NOS (iNOS) has not been studied. 
 The aim of the present study was to examine the effects of amin-
oguanidine, selective inhibitor of iNOS, on seizures in adult rats 
induced by subconvulsive dose of D,L homocysteine-thiolactone 
(Hct). 
 Adult male Wistar albino rats were intraperitoneally (i.p.) treated 
with Hct 5.5 mmol/kg and observed for seizure behavioral manifes-
tations during next 90 min. Increasing doses of aminoguanidine (50, 
75 and 100 mg/kg, i.p., n = 8 per group) or saline (n = 9) were injected 
30 min prior to Hct administration. Seizure behavior was assessed 
by seizure incidence, latency time to fi rs seizure onset, number of 
seizure episodes and its severity assessed by descriptive scale with 
4 grades. 
 Seizure incidence was signifi cantly increased by aminoguanidine 
75 (p < 0.05) and 100 mg/kg (p < 0.01). Aminoguanidine in dose-
dependent manner also signifi cantly increased number of seizure 
episodes induced by Hct and its severity. Seizure latency time was 
signifi cantly shortened in rats receiving aminoguanidine 100 mg/kg 
(p < 0.05) before subconvulsive dose of Hct. 
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 It could be concluded that aminoguanidine, iNOS inhibitor, mark-
edly aggravates behavioral manifestations of Hct-induced seizures in 
adult rats, showing functional involvement of iNOS in homocysteine 
convulsive mechanisms. 
 P6 25 
Prevalence of Homocysteine in patients with cardiovascular 
disorders in Pakistan 
 *N. B. Rizvi 1 , S. A. Nagra 1 
 
1
 Institue of Chemistry, Chemistry, Lahore, Pakistan 
 Cardiovascular disease (CVD) describes conditions caused by an 
interrupted or diminished blood fl ow through the coronary arter-
ies to the heart muscle. The main CVD are heart attack, angina, 
stroke and peripheral vascular disease.CVD is determined by 
many risk factors such as age, gender, diabetes, Dyslipidemia, high 
blood pressure, smoking and elevated levels of risk markers lipo-
protein a, Homocysteine (tHcy), C-reactive protein and uric acid. 
Elevated tHcy has also been established as an independent risk fac-
tor for CVD in type 2 diabetic patients compared to non-diabetic 
patients. In Pakistan over the past three decades, the incidence of 
coronary heart disease has increased. A study was conducted to 
investigate the prevalence of plasma tHcy in CV patients, males 
and females, belonging to two age groups. i.e. below and above 50 
years. Homocysteine was determined in plasma quantitatively with 
IMMULITE 1000 systems. The control value for tHcy in females 
was observed as 9.15 ± 2.02 in the age group less than 50 years and 
9.97 ± 1.68 in the age group above 50 years. Males showed a higher 
value of 10.5 ± 1.98 in the age group less than 50 years and 9.9 ± 3.2 
in the age group above 50 years. Reference values for adult male and 
female have been reported as 5-15mmol/l respectively.It was further 
reported that female in reproductive age have lower tHcy values than 
males and postmenopausal women. tHcy is responsible for various 
atherosclerotic events. It is reported that Homocysteine concentra-
tion in serum/plasma of healthy individual varies with age, gender, 
geographical distribution and genetic factors. Overall, male showed 
higher concentration of plasma Homocysteine when compared with 
their female counterpart. 
 P7  – Genetics & Epigenetics 
 P7 01 
Cystathionine  β -synthase defi ciency causes infertility by 
impairing decidualization and gene expression networks in 
uterus implantation sites 
 M. Nu ñ o Ayala 1 , N. Guillen 1 , C. Arnal 2,3 , J. M. Lou Bonafonte 4 , A. 
de Martino 3,5 , J. A. Garcia-de Jalon 3 , S. Gascon 2,1 , L. Osaba 6 , J. 
Osada 2,1 , *M. Navarro Ferrando 2,1 
 
1
 I + CS. University of Zaragoza, Biochemistry, Zaragoza, Spain 
 
2
 CIBER Obn, ICIII, SPAIN, Spain 
 
3
 University of Zaragoza, Animal Patology, Zaragoza, Spain 
 
4
 University of zaragoza, physiology, Zaragoza, Spain 
 
5
 I + CS, Zaragoza, Spain 
 
6
 Progenika Biopharma, Derio, Spain 
 Hyperhomocysteinemia has been reported in human reproduction as 
a risk factor for early pregnancy loss, preeclampsia and congenital 
birth defects like spina bifi da. Female infertility was also observed 
in cystathionine beta synthase defi cient mice ( Cbs -KO) as an animal 
model for severe hyperhomocysteinemia. The aim for the present 
research was to elucidate the time-point of pregnancy loss and to 
pinpoint gene and cellular changes involved in the underlying patho-
logical mechanism. By mating 90-day-old wild-type and  Cbs -KO 
female mice with their homologous male partners, we found that 
pregnancy loss in  Cbs -KO occurred between the 8 th and 12 th gestation 
day during placenta formation. DNA micro-arrays were carried out 
on uterus from implantation and inter-implantation samples obtained 
on day 8 th . The results allowed us to select changing genes potentially 
involved in embryo death which were individually confi rmed by 
RT-qPCR and their expressions were also followed throughout preg-
nancy. We found that changes in expression of  Calb1, Ttr, Expi, Inmt, 
Spink3, Rpgrip1, Krt15, Mt-4 ,  Gzmc, Tdo2 and  Afp were important 
for pregnancy success, since a different regulation in  Cbs -KO mice 
was found. Also, differences in relationships among selected genes 
were observed, indicating a dysregulation of these genes in  Cbs -KO 
females. In conclusion, our data provide more information on the 
gene expression cascade and its timely regulated process required for 
a successful pregnancy. In addition, it unveils new potential avenues 
to explore further investigations in pregnancy loss. 
 P7 02 
Relationship between plasma B-vitamins and LINE-1 
methylation in leukocytes of patients with a history of 
colorectal adenomas 
 *A. Jung 1 , A. Botma 2 , C. Lute 2 , F. Nagengast 3 , H. Blom 4 , P. Ueland 5,6 , 
G. Kvalheim 5 ,  Ø. Midttun 7 , W. Steegenga 2 , E. Kampman 1,2 
 
1
 Radboud University Nijmegen Medical Center, Epidemiology, 
Biostatistics & HTA, Nijmegen, Netherlands 
 
2
 Wageningen University, Human Nutrition, Wageningen, 
Netherlands 
 
3
 Radboud University Nijmegen Medical Center, Gastroenterology, 
Nijmegen, Netherlands 
 
4
 VU University Medical Center, Internal Medicine and Metabolic 
Unit, Amsterdam, Netherlands 
 
5
 University of Bergen, Section for Pharmacology, Institute of 
Medicine, Bergen, Norway 
 
6
 Haukeland University Hospital, Laboratory of Clinical Biochemistry, 
Bergen, Norway 
 
7
 Bevital A/S, Laboratory Building 9th Floor N-5021, Bergen, 
Norway 
 Background: Considerable epidemiological evidence suggests that 
high intake of certain B-vitamins is associated with a decreased risk 
of colorectal cancer.Folate and other B-vitamins play a key role in 
DNA methylation. Global DNA methylation is thought to contribute 
to carcinogenesis by affecting e.g. chromosomal stability and gene 
expression regulation. 
 Aim: The aim was to evaluate whether methylation of LINE-1 
repetitive elements is related to plasma concentrations of B-vitamins 
among patients with at least one histologically confi rmed colorectal 
adenoma ever in their life. We also investigated if these relationships 
were modifi ed by family history in a fi rst degree relative. 
 Methods: Global DNA methylation levels in leukocytes of 281 
colorectal adenoma patients were estimated using LINE-1 bisulfi te 
pyrosequencing and were expressed as  % 5-methylated cytosines over 
the sum of methylated and unmethylated cytosines. Multivariable 
linear regression was used to analyze the correlation between 
B-vitamins and LINE-1 methylation. 
 Results: Preliminary results revealed signifi cant inverse associations 
between plasma folate, plasma pyridoxal (PL), and plasma 4-pyr-
idoxic acid (PA) with LINE-1 methylation in those with at least 2 
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lifetime adenomas. Additional analyses revealed signifi cant inverse 
associations between plasma folate ( β = -3.54, 95 % CI = -6.92, -0.16), 
plasma ribofl avin ( β = -2.51, 95 % CI = -4.71, -0.31), plasma pyri-
doxal 5 ’ -phosphate ( β = -4.51, 95 % CI = -8.44, -0.57), and plasma PA 
( β = -2.92, 95 % CI = -5.62, -0.21) with LINE-1 methylation in those 
with at least 2 adenomas and family history of CRC. 
 Discussion and Conclusion: Our results show statistically signifi -
cant inverse associations between B-vitamins and LINE-1 methyla-
tion in those with at least two lifetime adenoma. Family history of 
colorectal cancer modifi ed these associations. 
 P7 03 
FB1 fumonisin treatment acts synergistically with methyl 
donor defi ciency during rat pregnancy to produce alterations 
of H3- and H4- histone methylation patterns in foetuses 
 *H. Pellanda 1 , T. Forges 1 , A. Bressenot 1 , A. Chango 1 , J.-P. 
Bronowicki 1 , J.-L. Gu é ant 1 , F. Namour 1 
 
1
 INSERM U954, Facult é de M é decine, Vandoeuvre les Nancy, 
France 
 Background: Folate derivatives transfer one-carbon units inside 
the cell. Prenatal methyl donor malnutrition leads to epigenetic 
alterations that could enhance susceptibility to disease in later life. 
Methyl donor defi cient diet induces hepatocarcinogenesis in rodents. 
Fumonisin FB1 is a mycotoxin, capable of contaminating corn world-
wide and is associated with various cancers. Fumonisin toxicity may 
originate from interference with folate metabolism, in HepG2 cells. 
 Aim: We used a gestational rat model to investigate the impact of 
methyl-group donors and fumonisin on the pattern of global histone 
modifi cations. 
 Methods: In this study, dams are exposed to methyl donors defi -
ciency and/or fumonisin FB1 and foetuses (E20) are analyzed. We 
have investigated 4 histone modifi cations associated with hetero-
chromatin assembly in the liver: H4K20me3, H3K9me3, H3R2me2. 
 Results: Combined exposition to methyl donor defi ciency and fumo-
nisin decreased folate receptor and reduced folate carrier protein, 
compared to methyl donor defi ciency only. Methyl donor defi ciency 
decreased H4K20me3. Combining fumonisin administration to 
methyl donor defi ciency led to an even more signifi cant decrease of 
H4K20me3 and to an increase of H3K9me3. The elevated H3K9me3 
can be viewed as a defence mechanism inciting the cell to resist het-
erochromatin disorganisation. H3R2me2 varied also according to the 
defence mechanism hypothesis. 
 Conclusion and Discussion: Methyl donor defi ciency and fumoni-
sin act synergistically to alter selective markers of heterochromatin 
assembly thus providing a mechanism that can contribute to DNA 
instability. 
 P7 04 
Can seasonality of one-carbon metabolism in Gambian 
mothers explain differences in their offspring DNA 
methylation ? 
 *P. Dominguez-Salas 1 , B. J. Hennig 1 , S. E. Moore 1 , A. M. Prentice 1 , 
S. E. Cox 1 
 
1
 LSHTM, EPH, London, United Kingdom 
 Background: Animal models show that periconceptual supplemen-
tation with folic acid or betaine induces differences in the offspring 
phenotype, mediated by one-carbon metabolism and DNA methyla-
tion. In humans, season of conception in rural Gambia appears to 
correlate with DNA methylation patterns. 
 Aims: To investigate i), dietary intake and blood nutritional status of 
one-carbon-metabolism-related substances in rural Gambia women 
and ii), possible associations between maternal blood biomarker sta-
tus and infant epigenetic patterns. 
 Methods: We followed 30 Gambian women (18-45 y) monthly for 
one year, to measure dietary intake of choline, betaine, folate, methi-
onine and vitamins B2, B6 and B12 and blood concentrations of 
those nutrients, as well as SAM, SAH, homocysteine and DMG. We 
also recruited 180 women conceiving in the rainy or dry season, to 
assess early pregnancy biomarkers and offspring DNA methylation 
of previously identifi ed metastable epialleles. 
 Results: Seasonal patterns were seen for all biomarkers with higher 
SAM (4.6 % ), betaine (25.5 % ), and B2 (12.2 % ), and lower SAH 
(-14.2 % ), DMG (-15.3 % ), and B12 (-5.6 % ) levels in the rainy 
versus the dry season. Dietary intake and epigenetic analyses are 
underway. 
 Discussion: The higher SAM:SAH ratio (21.9 % ) suggests higher 
methylation potential in the rainy season. Whether this is due to sea-
sonal variation in dietary intake and whether this affects infant DNA 
methylation patterns remains to be determined; results will be pre-
sented at the Leipzig meeting. 
 P7 05 
PABA (B-Vitamin) decreases the level of DSBs in DNA of 
mammalian blood leukocytes 
 *S. Vasilieva 1 , *D. Streltsova 1 , A. Osipov 2 
 
1
 Institute of Biochemical Physics RAS, theoretical genetics, Moscow, 
Russian Federation 
 
2
 Institute of Chemical Physics RAS, Moscow, Russian Federation 
 Background: Depending on the dosage NO serves the universal sig-
nal molecule or extremely toxic agent. Up to date there is no data 
on the natural compounds being effective regulators of toxic and 
genotoxic potencies of NO. Our experimental results have shown 
that PABA (B-Vitamin) was a very strong inhibitor of the SOS DNA 
repair response and mutagenic processes, induced by alkylation, oxi-
dative and UV- damages in E. coli (Vasilieva S.V.Res. in Microbiol., 
2002, V.153). 
 Aim: The aim of this work was to estimate the effi ciency of PABA 
against DNA damages induced in DNA of mammalian blood leuko-
cytes by NO- donating agents, the potent SOS-inducers. 
 Methods: The neutral Comet Assay was used to quantify the double-
stranded breaks (DSBs) in DNA. The water solutions of crystalline 
NO-donors - iron-tetranitrosyl complexes (ITNCs, from the Institute 
of Problems of Chemical Physics RAS) were studied as DSBs induc-
ers in vitro. 
 Results: It was fi rstly demonstrated that incubation of the cells 
with ITNCs leads to a statistically signifi cant dose-dependent linear 
increase in the levels of DSBs in all experiments. The reliable reduc-
ing of DSB ’ s level (up to 70 % ) was monitored when the cells were 
incubated with ITNCs in the presence of PABA and wasn ’ t watched 
if the cell were pretreated with PABA. 
 Discussion and Conclusion : The DSB-inhibiting phenomenon of 
PABA can rely on interplay that takes place between NO-donors, 
intracellular DNA and PABA. We suppose that the decreasing 
of the total positive charge on DNA being contacted with PABA 
should decrease the local concentration of positively charged 
genotoxic ITNCs in the vicinity of DNA target and decrease 
the DSBs in DNA. In our particular experiments in vitro PABA 
didn ’ t change the physical and chemical characteristics of ITNCs 
tested. 
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 P8  – Methodology 
 P8 01 
Novel assays for the determination of biologically active 
B-vitamins and folic acid 
 K. Hartmann 1 , R. Wetzstein 2 , *T. Dschietzig 1 , F. P. Armbruster 1 
 
1
 Immundiagnostik AG, Vitamindiagnostik, Bensheim, Germany 
 
2
 Charit é - University Medicine Berlin, Campus Mitte, Cardiology 
and Angiology, Berlin, Germany 
 Question: Higher plasma homocysteine (HC) is associated with a 
higher cardio-vascular risk. Apart from renal insuffi ciency, defi cien-
cies of vitamin B6, B12, and folic acid (FA) represent the most com-
mon causes of moderately elevated HC. 
 Aim: We have developed novel, micro-titer plate-based turbidimet-
ric kits (ID-Vit) to determine  biologically active B6, B12 and FA by 
measuring bacterial growth in factor-defi cient media. This is the fi rst 
clinical application in patients with coronary artery disease (CAD). 
 Methods: We collected serum from 18 control patients (C), 13 
electively admitted CAD patients (CAD), and 37 patients admitted 
urgently due to acute coronary syndrome (ACS). We then compared 
ID-Vit kits with established standard assays for B6 (HPLC deter-
mination), B12 (measurement of serum cobalamin, Roche-Elecsys), 
and FA (Roche-Elecsys method). HC was measured by HPLC. 
 Results: HC values did not differ between C, CAD, and ACS (15.2  ± 
5.9 vs. 14.4  ± 3.4 vs. 14.0  ± 2.7  μ mol/l) and were not signifi cantly 
elevated. Thirty four  % of patients had serum creatinine values  > 1.5 
mg/dl. Means of B6, B12, and FA, measured either by standard assay 
or ID-Vit, did not differ between groups. Individual ID-Vit values 
were similar to standard values for B6, signifi cantly higher for B12, 
and lower for FA . ID-Vit data correlated signifi cantly with standard 
data, with correlation coeffi cients between 0.58 and 0.66. Neither 
standard nor ID-Vit values correlated with HC levels. 
 Conclusions: The fi rst application of ID-Vit assays proved their 
feasibility and good correlations to standard methods. The lack of 
correlation between B-vitamins or FA and HC can be accounted for 
by the fact that HC was in the high-normal range and that a relevant 
percentage of patients had renal insuffi ciency. 
 P8 02 
Determination of B-complex vitamins ’ stability during rye 
sourdough bread production using LC-MS and stable isotope 
dilution assay 
 *K. H ä lvin 1,2 , A. Mihhalevski 1,2 , I. Nisamedtinov 1,2,3 , A. O š eka 2 , T. 
Paalme 1,2 
 
1
 Tallinn University of Technology, Department of Food Processing, 
Tallinn, Estonia 
 
2
 Competence Center of Food and Fermentation Technologies, 
Tallinn, Estonia 
 
3
 Lallemand, Inc., Montr é al, Estonia 
 Rye sourdough bread is a traditional bread, which is widely con-
sumed in North-West Russia, Baltic countries, Finland, and the 
North of Germany. Besides other nutritionally valuable compounds 
it is considered as a good source of B-complex vitamins. 
 The aim of this work was to study the stability of thiamine, ribo-
fl avin, nicotinamide, nicotinic acid, pantothenic acid, pyridoxal and 
pyridoxine in a rye sourdough bread production. 
 The concentration of B-complex vitamins were determined in the 
used raw materials (rye fl ours, white and red rye malt, yeast) and rye 
breads using LC-MS and stable isotope dilution assay. 
 During baking the concentration of vitamins decreased by 40-45 % in 
the case of thiamine, 20-40 % in the case of ribofl avin, 0-40 % in the 
case of nicotinic acid, 10 % in the case of pantothenic acid, 50-60 % 
in the case of pyridoxal and 35-50 % in the case of pyridoxine. By 
contrast, the concentration of nicotinamide increased by 12-19 times. 
This increase in the nicotinamide concentration was shown to be to 
result from lactic acid fermentation of the dough by  L. panis N915 
during rye sourdough processing. 
 In conclusion, the LC-MS combined with stable isotope dilution 
assay is a promising method for studying B-complex vitamins stabil-
ity during food processing. 
 P8 03 
UPLC-MS/MS as a Rapid Tool for the Simultaneous Analysis 
of B-Vitamins in Human Milk 
 *D. Hampel 1 , L. H. Allen 1 
 
1
 USDA/ARS, WHNRC, Davis, United States 
 Introduction: Low concentrations of B-vitamins in human milk due 
to poor maternal status can result in infant defi ciency and associated 
health risks. Data on the B-vitamin content of human milk is sparse 
and based on outdated and time consuming methods, but is vital for 
setting maternal and infant recommended intakes and potentially 
useful for status assessment. 
 Aim: Simultaneous, rapid analysis of multiple B-vitamins in human 
milk. 
 Methods: We developed a rapid Ultra-Performance-Liquid-
Chromatography Mass Spectrometry (UPLC-MS/MS) method to 
simultaneously analyze thiamin, ribofl avin, FAD, nicotinamide 
and pyridoxal (PL) in human milk. Several sample preparations 
were tested for suitability and optimized conditions were used for 
validation. 
 Results:  
 
 Vitamin  DRI  USA  India  p-value 
 [mg/L]  mdn  mdn 
Thiamin 0.2 0.03 0.01  < 0.05
Ribofl avin  + FAD 0.35 0.31 0.14  < 0.05
Nicotinamide 1.8 1.18 0.35  < 0.05
Pyridoxal 0.13 0.03 0.12  < 0.05
 
 Discussion and Conclusion: Best results were obtained after meth-
anol precipitation and removal of non-polar matrix constituents. 
Analysis of human milk from the US and India revealed that the vita-
min concentration differs by geographic origin (p-value  < 0.05) and 
only vitamin B2 (USA) and PL (India) meet the values assumed for 
setting recommended intakes. Samples from additional countries are 
being analyzed. 
 P8 04
Folate forms quantifi cation in serum and whole blood 
using stable-isotope dilution ultra performance liquid 
chromatography tandem mass spectrometry 
 *S. H. Kirsch 1 , W. Herrmann 1 , R. Obeid 1 
 
1
 Universit ä tskliniken des Saarlandes, Klinische Chemie & 
Laboratoriumsmedizin, Homburg/Saar, Germany 
 Background: Low folate status is associated with increased risk of 
neural tube defects, cardiovascular diseases, cognitive dysfunction, 
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and cancer. Alterations in folate metabolome might have serious 
effects on human health. 
 Aim: We aimed at developing an ultra performance liquid chroma-
tography tandem mass spectrometry (UPLC-MS/MS) method for the 
quantifi cation of 5-methyltetrahydrofolate (5-methylTHF), 5-form-
ylTHF, 5,10-methenylTHF, THF, and folic acid in serum and whole 
blood (WB) hemolysates. 
 Methods: We describe an UPLC-MS/MS method for the quantifi ca-
tion of key folate forms. After an Oasis MAX solid-phase extraction 
step, folates were eluted by methanol containing 1 % formic acid. 
Dried eluates were resuspended in H 2 O/methanol (60:40, v/v) con-
taining 0.1 % formic acid and 1 g/L ascorbic acid. Sample separation 
and measurement was performed within 2.5 min. 
 Results: We observed quantitative oxidation of THF to folic acid 
in WB. Due to interconversions, WB folate was summarized as 
5-methylTHF and non-methylTHF. The method was linear over 0.2-
200 nmol/L (r 2  ≥  0.9999). In serum and WB, limits of detection were 
between 0.119-0.669 nmol/L. Interassay CVs were between 2.8-
15.4 % for the different folates. In non-supplemented adults median 
(10 th -90 th percentile) 5-methylTHF concentrations in serum samples 
(n = 32) were 15.9 (5.6-26.7) nmol/L and THF 2.07 ( < LOD-4.05) 
nmol/L. 5-MethylTHF in WB samples (n = 48) was 445 (240-955) 
nmol/L in addition to 71.2 (47.9-129) nmol/L non-methylTHF. 
 Discussion and Conclusion: Our UPLC-MS/MS method has high 
sensitivity and selectivity for the folate quantifi cation. The fast 
sample preparation and analysis allows the use in large-scale clinical 
studies. THF oxidation to folic acid can give wrong estimation of 
folic acid in WB. 
 P8 05
Plasma phospholipids quantifi cation by ultra performance 
liquid chromatography tandem mass spectrometry 
 *Y. Rabagny 1 , S. H. Kirsch 1 , W. Herrmann 1 , J. Geisel 1 , R. Obeid 1 
 
1
 Universit ä tskliniken des Saarlandes, Klinische Chemie & 
Laboratoriumsmedizin, Homburg/ Saar, Germany 
 Background: Phospholipids (PL ’ s) are important components of cell 
membranes and Lipoproteins. Changes in the concentrations PL ’ s 
have been observed in cancer, dementia and diabetes. PL ’ s might be 
biomarkers related to the methylation cycle via the PEMT pathway. 
 Aim: To develop a new method for the quantifi cation of PL ’ s in 
human plasma. 
 Methods: The presented UPLC-MS/MS method utilises two external 
calibrators and one internal standard for each class. The chromatog-
raphy takes 15 min. To compare the method with others we analyzed 
the plasma of 34 apparently healthy volunteers (eight males, age 
24-80 years). 
 Results: Mean concentrations (SD) in apparently healthy people 
were: total phosphatidylcholine (PC) 2020 (376)  μ M, total sphin-
gomyelin (SM) 399 (77)  μ M, total lysophosphatidylcholine (LPC) 
109 (36)  μ M and total phosphatidylethanolamine (PE) 27 (15)  μ M. 
We quantifi ed 41 individual PL species. The relative concentration 
of the species in healthy volunteers was comparable with the litera-
ture. Inter-assay coeffi cients of variation were  < 10 % for the most 
abundant species and  < 20 % for all quantifi ed PC, LPC, and SM 
species and the three most abundant PE species. Quantifi cation was 
linear over the physiological ranges for PE-, LPC-, and SM- and up 
to 500  μ mol/L for PC-Species. Coeffi cients of linear regression were 
R 2 > 0.98. Mean recoveries were between 83 % and 123 % . The limits 
of detection were 0.37  μ mol/L for PC, 0.86  μ mol/L for SM, 4.02 
 μ mol/L for LPC and 3.75  μ mol/L for PE. 
 Conclusion: We present a UPLC-MS/MS method for the quanti-
fi cation of total PC, PE, LPC, and SM and several species within 
these classes in EDTA-plasma. The method is simple, fast, simple 
and robust and it complements the available range of validated 
methods. 
 P9  – Molecular and cellular mechanisms 
 P9 01 – WITHDRAWN
 P9 02
Evaluation of the genotoxicty of three isofl ovone 
phytoestrogens in wing spot test of D. melanogaster using 
mutant strains and role of folic acid in genomic stability of 
somatic cells 
 * H. Uysal 1, H. As¸ kin 1 
 
1
 Ataturk University, Department of Molecular Biology amd Genetics, 
Erzurum, Turkey 
 In this study, the potential genotoxic effects of three different phytoe-
strogens (genistein, quercetin and glisitein) whose biological effects 
bear similarities in natural and cultured plants which are used in fed-
ing animals and human beings, and antimutagenic effects of folic 
acid were researched via using  Drosophila wing somatic mutation 
and recombination test (SMART)(1). In the exrepiments, larvae of 
72 ± 4 hours trans-heterozygote which have the  mwh/fl r  3  genotype of 
 Drosophila melanogaster , were used. We worked on four concentra-
tions of each of the 3 phytoestrogens whose genotoxic effects were 
researched. The larvae were fed chronically with  Drosophila instant 
medium containing different concentrations of phytoestrogens. The 
effects of phytoestrogens used were evaluated considering the mutant 
trichomes. 
 In the second stage of our study, we applied by far the highest dosage 
of these phytoestrogens, which is 10mM, together with the 10mM 
dosage of folic acid on the larva in the same feeding environment. 
The wing preparates of the obtained individuals were prepared for 
 mwh/fl r  3  (normal wing phenotype) and  mwh/TM3 (serrat wing phe-
notype) genotype. 
 As a result of the applications glisitein yielded in all concentrations 
either negative or inconclusive genotoxicity. However the other two 
phytoestrogens on the whole showed positive genotoxicity depend-
ing on the increase in concentration. Total mutation frequency for 
normal wing phenotype the order of the genotoxicity was: quercetin 
0.89 % , genistein 0.58 % and gilisitein 0.19 % . When these phytoe-
strogens were applied together with the folic acid, total mutation fre-
quency decreased, respectively for kuersetin 0.46 % , genistein 0.28 % 
and gilisitein 0.16 % . The negative or positive genotoxic effects of 
the plant estrogens used in this study were determined and it was 
found out that folic acid is anti-genotoxic against these effects. 
 P9 03
Methyl donor status infl uences global DNA methylation and 
DNMT expression in ervical cancer cells 
 *N. Poomipark 1 , J. Flatley 1 , M. Hill 1 , B. Mangnall 1 , E. Azar 1 , H. 
Powers 1 
 
1
 University of Sheffi eld, Faculty of Medicine, Dentistry and Health, 
Sheffi eld, United Kingdom 
 Background: Epidemiological studies suggest that folate may 
modulate cervical cancer risk and progression. This effect may 
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be mediated by altered DNA instability and aberrant DNA 
methylation. 
 Aim: To develop a model of folate and of folate and methionine 
depletion of cervical cancer cells in culture; to examine effects on 
global DNA hypomethylation and expression of DNA methyl trans-
ferases (DNMTs), and to determine whether any such effects are 
reversible. 
 Methods: The human cervical cancer cell line, C4-II, was grown 
in folate and methionine-replete, folate-depleted, and folate and 
methionine-depleted medium. Intracellular folate and homocysteine 
export were measured. DNA global methylation status of cells was 
investigated using a fl ow cytometric method.DNMT expression was 
determined using RT-PCR. A minimum of three independent experi-
mental replicates were carried out. 
 Results : We have generated a cervical cancer cell model of methyl 
donor depletion characterised by low intracellular folate, accumu-
lation of homocysteine and enhanced export. Combined depletion 
of folate and methionine led to an 18 % reduction in global DNA 
methylation. Folate and methionine depletion resulted in a signifi -
cant down-regulation of DNMT3a and DNMT3b, showing a 2.63 
and 3.57-fold reduction in expression respectively, after 8 days of 
depletion. Effects on DNMT1 expression were less consistent, but 
nevertheless a mean 1.75-fold reduction in expression was seen 
by 8 days of depletion. Early results suggest that these effects are 
reversible. 
 Discussion and conclusions: Methyl donor status may infl uence 
cervical cancer risk and progression, through effects on DNA methy-
lation, perhaps via modulation of DNMT expression. 
 P9 04
Effect of methylation on amyloid precursor protein (APP) in 
Down syndrome fi broblasts 
 *R. Obeid 1 , M. Kasoha 1 , W. Herrmann 1 
 
1
 Universit ä tskliniken des Saarlandes, Klinische Chemie & 
Laboratoriumsmedizin, Homburg/Saar, Germany 
 Background: Dementia is a major health problem world wide. 
Neuritic amyloid plaques are typical neuropathological hallmarks 
of AD. Amyloid in senile plaques is the product of cleavage of 
the amyloid precursor protein (APP) by a series of proteases,  β - 
and  γ -secretases. Epidemiologic studies confi rmed an association 
between elevated concentrations of total homocysteine (tHcy) and 
cognitive dysfunction. Folate, vitamin B12 and B6 are important 
cofactors for key enzymes that mediate Hcy metabolism. Patients 
with Down syndrome have additional copies of APP and cystathion-
ine beta synthase genes, thus combining disturbances in the methyla-
tion cycle and increased dementia risk. 
 Aim: We aimed at testing the link between disorders in one carbon 
metabolism and protein levels of full length APP and its by-product 
C99. 
 Methods: Down syndrom fi broblasts were incubated either in a 
vitamin-rich medium or in medium free of vitamins B12, B6 and 
folate. Different concentrations of Hcy, S-adenosyl homocysteine 
(SAH), S-adenosyl methionine (SAM), or lovastatin were added 
for 24 hours. Protein expressions of APP and C99 in cell extracts 
were investigated by western blot. Results were normalized for 
 β -actin. 
 Results: Hcy did not affect and SAH increased total APP in cell 
extracts. SAM caused reduction of APP protein expression only 
in cells grown in a vitamin-free medium. Lovastatin lowered 
APP in cells incubated in a vitamin-rich medium. Inhibitors of 
b- and  γ -secreatases reverted the effect of SAH, SAM and that of 
lovastatin on protein expression of APP and the effect of Hcy on 
C99. Inhibitors of b- and  γ -secreatases reverted the effect of SAH 
and that of SAM on protein expression of APP and the effect of 
dLHcy on C99 protein. 
 Conclusion: Alterations in methylation conditions in Down syn-
drome fi broblasts caused changes in key proteins in the amyloido-
genic pathway. Furthermore, the possible effect of lovastatin against 
dementia seems to depend on B-vitamins status. 
 P10  – Other topics 
 P10 01
Effect of Nicotinamide on Experimental Induced Diabetes 
 *F. Q. Alenzi 1 
 
1
 King Saud University, College of Applied Medical Sciences, 
Immunology, Al-Kharj, Saudi Arabia 
 Insulin dependent diabetes mellitus (IDDM) results from irrevers-
ible loss of beta cells ( β -cells) of the pancreas. A Streptozotocin 
(STZ)-induced diabetes in animal model mimics, in some aspects, 
recent onset IDDM. This study was conducted to investigate the 
effect of nicotinamide on experimentally-induced IDDM. Thirty 
Spraque Dawley rats were divided into 3 groups; a control group, 
a diabetic group which received an intraperitoneal (i.p.) injection 
of 55 mg/kg STZ and a nicotinamide group (1g/kg/day) which 
were dosed orally for 3 days followed by (i.p.) STZ (55 mg/kg) 
with the nicotinamide treatment continuing for an additional 14 
days. Rats receiving STZ became diabetic after 2 weeks. This 
diabetic group showed hyperglycemia, and a very low level of 
C-peptide. 
 Furthermore, pancreatic islets exhibited increased nitric oxide (NO) 
production together with an increased apoptotic index (as detected by 
TUNEL and electron microscopy). Nicotinamide treatment prevented 
STZinduced diabetes, it also antagonized an increase in NO, and 
inhibited  β -cell apoptosis. Fasting blood glucose, serum insulin and 
serum C-peptide were all within the normal range in the nicotinamide 
group. The nicotinamide protection of  β -cells may be facilitated via 
inhibition of apoptosis and nitric oxide generation. It is suggested 
that nicotinamide might be considered an effective agent for the pre-
vention and treatment of IDDM in prediabetic, and early stages, of 
IDDM. 
 P10 02
Potential role of dietary folate and choline as radio-protective 
agents 
 *V. Batra 1 , T. P. A. Devasagayam 1 
 
1
 Bhabha Atomic Research Centre, RBHSD, Mumbai, India 
 Background: Radiation exposure poses a major risk for workers in 
the nuclear power plants and other radiation related industry. Folate 
and choline might be of radio-protective value as they are, within 
broad dose ranges, non-toxic to humans. 
 Aim:  1) To investigate choline dependent adaptive response to 
cytotoxic effect of folate defi ciency and gamma ( γ )-radiation. 2) To 
demonstrate that  γ -radiation is an effi cient DNA demethylating agent 
and its injurious effect can be minimized by dietary methyl supple-
ments (folate, choline and vitamin B12). 3) To examine the effect 
of  γ -radiation on choline and choline containing moieties in choline 
defi cient subjects. 
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 Methods: Male Swiss mice maintained on various combinations of 
folate and choline suffi cient and defi cient diets, were subjected to 
total body  γ -irradiation. It was followed by investigation of the pro-
fi le of downstream metabolites and activity of one-carbon (C 1 ) fl ux 
generating enzymes. Liver and brain samples were also subjected to 
histo-pathological examinations. 
 Results: 1) Folate defi ciency modulated purine/pyrimidine 
free sites in DNA 2) Modifi cation in levels of folate and choline 
metabolism regulatory enzymes, 3) Release of choline reserves 
from liver to serum and 4) Enhanced C1 fl ux towards DNA 
methylation. 
 Conclusions: 1) Folate deprivation and  γ -radiation interacted to 
mobilize additional choline reserves of hepatic tissue, for redis-
tribution to other organs 2) Maintenance of genomic DNA methy-
lation under  γ -radiation stress involved increased one-carbon 
fl ux through various metabolites. 3) Interaction between cho-
line defi ciency and  γ -radiation substantially enhanced liver 
adipogenesis. 
 P10 03
Does SAMe Hurt Your Heart - A Literature Review 
 *D. Wahner-Roedler 1 , B. Bauer 1 , L. Loehrer 1 , M. Thompson 2 
 
1
 Mayo Clinic, General Internal Medicine, Rochester, MN, United 
States 
 
2
 Waukesha Health Care-Oncology, Medical Oncolocy/Hematology, 
Waukesha, WI, United States 
 Background: S-adenosyl-L-methionine (AdoMet, SAMe), a dietary 
supplement has been studied for treatment of depression, liver cir-
rhosis, degenerative joint disease, fi bromyalgia, and neurologic 
disorders. AdoMet is metabolized to S-adenosyl-L-homocysteine, 
which can then be hydrolyzed to homocysteine (Hcy) and ade-
nine. This pathway raises the possibility that individuals who take 
AdoMet could develop elevated levels of Hcy, a potential unfavor-
able outcome. 
 Aim : To determine if exogenous AdoMet increases plasma levels of 
Hcy. 
 Methods: Literature review. 
 Results: We located 3 studies: 
 Loehrer et al (1997) studied the effect of one oral dose of 400 mg i. 
AdoMet on plasma Hcy in 14 healthy human subjects over a 24 
hour period. Plasma Hcy did not change signifi cantly. 
 G ö ren et al (2004) reported on 15 healthy human subjects who ii. 
received oral AdoMet 1,600 mg/day for 4 weeks. No patient de-
veloped increased Hcy levels. 
 Thompson et al (2009) performed a placebo-controlled, double-iii. 
blind, randomized trial involving 52 healthy human volunteers 
receiving placebo or AdoMet (800 mg/day for 4 weeks). AdoMet 
did not signifi cantly affect plasma Hcy levels. 
 Discussion and Conclusion: The studies described were performed 
on healthy human subjects over a short period of time. Changes in 
Hcy may take place over a longer period of time and may be dif-
ferent in patients with elevated Hcy levels. Future clinical tri-
als are therefore needed. The results of an ongoing trial at Baylor 
(NCT00473200) evaluating the effect of oral AdoMet (1200 mg/day) 
for 6 weeks with and without supplementation of folate, vitamin B12 
and B6, on plasma Hcy levels in patients with vascular disease and 
moderate hyperhomocysteinemia should help to assess the effect of 
AdoMet use. 
 P10 04
Purifi cation and Characterization of Acidic Protease from 
 Aspergillus oryzae BCRC 30118 
 *L.-J. Yin 1 , Y.-H. Chou 2 , S.-T. Jiang 3,2 
 
1
 National Kaohsiung Marine University, Department of Seafood 
Science, Kaohsiung, Taiwan 
 
2
 National Taiwan Ocean University, Department of Food Science, 
Keelung, Taiwan 
 
3
 Providence University, Department of Food and Nutrition, Taichung, 
Taiwan 
 Background: Acid proteases are frequently used in the production 
of seasoning materials, protein hydrolysate, soy sauce, or used as 
digestive aids. They are also widely used to improve the texture of 
fl our paste, to tender the fi bril muscle, and to clear beer and fruit 
juice. Many free amino acids and peptides are produced during fer-
mentation of soy source, as a result of the hydrolysis of soybean pro-
tein by various proteolytic enzymes produced by  Aspergillus oryzae . 
However, the properties of these enzymes have not yet been com-
pletely elucidated. 
 Aim: This study aimed to purify and characterize the acid protease 
produced from  Aspergillus oryzae BCRC 30118. 
 Methods: Amicon ultrafi ltration (cutoff: 10 kDa), DEAE Sephacel 
and Sephacryl S-200 HR chromatographs were used to purify the 
acidic protease from 3-day cultivation of  Aspergillus oryzae BCRC 
30118 at 25 o C. The purity and molecular weight were determined 
using SDS-PAGE. Substrate, metal ions and inhibitor effects were 
assayed. The enzyme kinetics were also determined. 
 Results: The specifi c activity, yield and purifi cation fold were 
121.61 kU/mg, 15.1 % and 6.9 fold, respectively. The MW of puri-
fi ed acidic protease was 41.0 kDa estimated by SDS-PAGE, while 
the optimal pH and temperature were 3.0 and 60 o C, respectively. 
It was stable at pH 3.0-6.0 and 4-35 o C, respectively, inhibited by 
Fe 2 +  , Hg 2 +  , Fe 3 +  and pepstatin A, and slightly by leupeptin and 
TPCK. 
 Discussion and Conclusion: According to the substrate specifi c-
ity and inhibitor study, it was considered to be chymotrypsin-like 
protease. The activation energy was 37.5 kcal/mol, while the  K 
m
 , 
 V 
max
 and  K 
cat for the hydrolysis of hemoglobin were 0.12 mM, 14.29 
 μ mol/min and 14.55 sec -1 , respectively. 
 P10 05
Nucleocytoplasmic distribution of hepatic methionine cycle 
enzymes in hepatopathy 
 *M. A. Pajares 1,2 , M. Delgado 1 , F. Garrido 1 , J. Perez-Miguelsanz 3 , 
D. Perez-Sala 4 
 
1
 Instituto de Investigaciones Biomedicas Alberto Sols (CSIC-UAM), 
Metabolism and Cellular Signaling, Madrid, Spain 
 
2
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3
 Facultad de Medicina. Universidad Complutense de Madrid, 
Anatom í a y Embriolog í a Humana I, Madrid, Spain 
 
4
 Centro de Investigaciones Biologicas (CSIC), Madrid, Spain 
 Background: Enzymes of the methionine cycle have been tra-
ditionally identifi ed in the cellular cytoplasm, but recent reports 
described some of these proteins also in the cell nucleus. This is 
the case of S-adenosylhomocysteine hydrolase (SAHH), glycine 
N-methyltransferase and, more recently, of methionine adeno-
syltransferases (MATs) I/III and II. Mechanisms that regulate the 
nucleocytoplasmic localization of these enzymes and its putative 
relationship to disease remain unknown. 
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 Aim: The present work was designed to gain insight into the mecha-
nisms that regulate localization of methionine cycle enzymes, and 
to investigate whether D-galactosamine induced hepatopathy associ-
ates with changes in nuclear levels. 
 Methods: Confocal microscopy, immunohisto-chemistry, subcellu-
lar fractionation, western blot, activity measurements, and gel fi ltra-
tion chromatography are the main methods used to determine the 
changes derived from the treatment. 
 Results: Our results indicate a role for oxidative stress in nuclear 
localization of MAT I/III and SAHH and their nuclear accumula-
tion upon D-galactosamine treatment. No changes in SAHH oligo-
meric state were detected in the nucleus, whereas an increase in MAT 
activity together with a boost in the amount of MAT I was observed 
upon comparison of nuclear profi les from control and galactosamine-
treated rats. 
 Discussion and  Conclusions: Altogether these results suggest a 
higher need of nuclear AdoMet production and AdoHcy elimina-
tion during hepatopathy. Such a need might be related to epigenetic 
changes affecting trimethylation of H3K27 preferentially, the main 
epigenetic modifi cation previously described as altered by nuclear 
accumulation of MAT I/III 1 . 
 
1
 Reytor et al. (2009) FASEB J 23, 3347-3360. 
 P10 06
Short-term creatine supplementation does not reduce 
increased homocysteine concentration induced by acute 
exercise in humans. 
 *R. Deminice 1 , F. Troncon Rosa 1 , G. Franco 2 , E. Cristine Freitas 2 , 
A. Afonso Jordao 1 
 
1
 University of Sao Paulo, Nutrition and Metabolism, Ribeir ã o Preto, 
Brazil 
 
2
 University of Sao Paulo, School of Physical Education and Sports of 
Ribeirao Preto, Ribeir ã o Perto, Brazil 
 Background: Studies in rats have shown that creatine supplementa-
tion modulates the fl ux of transmethylation reactions and decreases 
blood homocysteine (Hcy) levels. However, this effect in humans is 
poorly known, specially after acute exercise. 
 Aim: To evaluate the effect of creatine supplementation on Hcy lev-
els after acute exercise in humans. 
 Methods: Twenty-three sub-20 soccer players were divided 2 groups: 
creatine supplemented (Cr) and placebo (Pla). The supplementation 
was performed in double-blind controlled manner using creatine or 
placebo tablets with 3 g/kg during 7 days. Before and after 7 days 
of supplementation, the athletes performed an acute high-intensity 
anaerobic exercise (two consecutive RAST protocol consisted in 6 x 
35 m sprint with 10 s between them). Blood samples were collected 
before and after 7 days supplementation as well as 0 h and 1 h after 
exercise protocol. 
 Results: Plasma creatine concentration was signifi cant increased 
( P  < 0.05) (Pla 107.5 ± 10.2 vs Cr 330.2 ± 52.3, umol/L). Controver-
sially, creatine supplementation did not change Hcy after 7 days 
supplementation (Pla 6.9 ± 0.2 vs Cr 7.2 ± 0.2, umol/L) nor after 
acute exercise (Pla 8.2 ± 0.3 vs Cr 8.4 ± 0.3, umol/L). Hcy concentra-
tion signifi cant increased ( P  < 0.05) 1 h after acute exercise (18 % ). 
Acute exercise also decreased red blood cell SAM 30 % , but with-
out changes in SAM/SAH ratio. Also, it was not found changes in 
plasma concentration of vitamin B12 and folate as well as cysteine 
and methionine. 
 Conclusions: Acute anaerobic intense exercise increased Hcy con-
centration in plasma. However, creatine supplementation did not 
decreased plasma Hcy induced by exercise. These results are differ-
ent from experiments in rats. 
 Supported by: Prodoc-Capes, Brazil. 
 P10 07
Inhibitory effect of vitamin B6, pyridoxal 5 ’ -phosphate on 
lymphangiogenesis 
 *K. Matsubara 1 , N. Kato 2 
 
1
 Hiroshima University, Human Life Sciences Education, 
Higashihiroshima, Japan 
 
2
 Hiroshima University, Molecular and Applied Bioscience, 
Higashihiroshima, Japan 
 Background: Accumulating evidence suggests that consumption of 
vitamin B6 may lower the risk of colorectal cancer. As the mecha-
nisms, reducing cell proliferation, angiogenesis and infl ammation 
have been demonstrated. However the mechanisms have not been 
fully understood yet. Lymphangiogenesis, formation of new lym-
phatic vessels, is involved in infl ammation, which is linked to tum-
origenesis. We hypothesized that the suppressive effect of vitamin 
B6 on colorectal tumorigenesis might be due to in part anti-lymp-
hangiogenic effect. 
 Aim: The aim of this study is to clarify the effect of vitamin B6 
(pyridoxal 5 ’ -phosphate; PLP) on lymphangiogenesis. 
 Methods: The effect of PLP was evaluated in ex vivo lymphangio-
genesis model, in which rat thoracic ducts were isolated and cut 
ducts (lymphatic rings) were cultured in collagen gel. In addition, we 
examined the effect in vitro models using human lymphatic endothe-
lial cells (LYECs). 
 Results: PLP suppressed outgrowth of microvessels from lymphatic 
ring in ex vivo lymphangiogenesis model, showing PLP has anti-
lymphangiogenic activity. PLP also inhibited LYEC tube formation 
and proliferation. 
 Discussion and Conclusion: In this study we clearly show that PLP 
suppress lymphangiogenesis in both ex vivo and in vitro lymphangio-
genesis models. PLP exerts its inhibitory effect through suppressing 
LYEC tube formation and proliferation. The inhibitory effect of vita-
min B6 (PLP) on lymphangiogenesis might in part lower the risk of 
colorectal cancer. 
 P10 08
Ribofl avin defi ciency inhibits the viability and activity of 
macrophages RAW 264.7 
 *A. Mazur-Bialy 1 , B. Plytycz 2 
 
1
 Jagiellonian University Collegium Medicum, Department of 
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2
 Jagiellonian University, Department of Evolutionary Immunology, 
Krakow, Poland 
 Background: Ribofl avin as a vitamin is necessary for the proper 
functioning of our body. Its level in plasma is mainly conditioned 
by the content of the diet. Therefore, we can observed states of its 
defi ciency (3.1 nM in plasma) or enrichment in case of tablets taking 
(300 nM). 
 Aim: The aim of this study was to investigate the effect of ribofl avin 
concentrations on the viability and activity of macrophages. 
 Methods: Studies was performed on RAW 264.7 cells, cultured 
in customized medium with ribofl avin concentration 3.1; 10.4 
or 300 nM, supplemented with antibiotics (1 % ) and fetal bovine 
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serum (10 % ). Cells were cultured for up to 4 days in presence 
or absence of LPS (1 ug/ml, for the last 24 hr). We investigated 
cell viability, and activity (cell cycle progression, cell adhe-
sion, respitatory burst, phagocytosis), and cell activation (nitric 
oxide and cytokine/chemokine released, and iNOS, TLR4, CD14 
production). 
 Results: We found that culturing of RAW 264.7 cells in low ribo-
fl avin content (R; 3.1 nM) leads to inhibition of proliferation, 
increased cell death by apoptosis, and to disruption of cell activity. 
Moreover ribofl avin defi ciency caused impairs of cells response 
to LPS activation by reduction of TLR4 and iNOS expression, 
affected cytokine/chemokine production as well as nitric oxide 
released. 
 Discussion and Conclusion: The present study provided evidence 
that RAW 264.7 cells are sensitive to changes of ribofl avin concen-
tration and show signs of its defi ciency within only 4 days. Inhibition 
of macrophages activation by ribofl avin defi ciency can lead to the 
breakdown of innate immune defense and increased the susceptibil-
ity to infections. 
 This work was supported by a grant DEC-2011/01/D/NZ6/02704. 
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Alcohol increases homocysteine concentration in Nepalese 
Population: A Hospital Based Observational Study from 
Western Nepal 
 *B. Sathian 1 , A. Mittal 2 
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 Background: Alcoholic liver disease (ALD) is a common disorder 
which causes serum liver enzyme elevation. Elevated homocysteine 
levels was demonstrated in Alcoholic liver disease and chronic liver 
failure. 
 Objective: To fi nd out whether there is an association between 
homocysteine levels and ALD. 
 Methods: 128 patients with ALD and 317 healthy adults enrolled 
in the study. Fasting blood samples were obtained and serum homo-
cysteine levels were measured by fl uorescence polarization immuno-
assay (FPIA) technology. Oral glucose tolerance test was performed 
and serum insulin, c-peptide, and lipoprotein levels were also 
measured. 
 Results: The mean serum homocysteine levels ( + /-SD) were 
14.94 ± 2.10  μ mol/L and 13.12 ± 1.01  μ mol/L in ALD and the con-
trol group, respectively. Mean serum homocysteine level in the 
ALD group was signifi cantly higher than in control group (p < 0.01). 
Fasting blood glucose, insulin, total cholesterol and low density 
lipoprotein (LDL) cholesterol were all found higher than the control 
group. 
 Conclusion: Non invasive tests have demonstrated a reasonable 
ability to identify signifi cant fi brosis, cirrhosis in particular, nor 
is it surprising that liver disease specialists and patients favour a 
non invasive approach. The serum homocysteine levels were sig-
nifi cantly higher in patients with ALD than in control group. This 
may point out that high homocysteine levels may be associated with 
ALD. 
 P10 12
Lipid Rafts Cross-talk with Toll-Like Receptors (TLRs): 
relevance to the CONVERSION of PrPc to PrPSc in Prion 
Disease Pathogenesis 
 *O. N. Ofodile 1 
 
1
 Charite-Universit ä tsmedizin Berlin, Center for Cardiovascular 
Research (CCR), Institute of Pharmacology and Toxicology, AG: 
THEURING, Berlin, Germany 
 Direct evidence has been collected regarding the involvement of 
infl ammation and unregulated aggregation of proteins in the patho-
genesis of a range of neurodegenerative disorders such as Alzheimer 
disease, Morbus Parkinson and prion disease. Infl ammatory signaling 
is generally triggered by the cytokine-responsive tumor necrosis fac-
tor (TNFR) and toll-like receptor (TLR) super families. Prion protein 
is a cell-surface glycosylphosphatidylinositol (GPI)-anchored protein 
that is normally expressed in neurons, various non -neuronal tissues 
and leukocytes. Transmissible spongiform encephalopathies (TSEs) 
or prion diseases are fatal neurodegenerative diseases in mammalian 
species that are sporadic, but also have been traced to mutations and 
to infectious transmission, including iatrogenic transfer. TSEs include 
kuru, Creutzfeldt-Jakob disease (CJD), Gerstemann-Str ä ussler syn-
drome (GSS), and fatal familial insomnia (FFI) in human beings, as 
well as scrapie in sheeps and goats, bovine spongiform encephalopa-
thy (BSE) in cattle, and encephalopathies in mink, cats, mule, deer, 
elk, and several exotic ungulates. Neuron loss, spongiform degenera-
tion and glial proliferation are the main pathological consequences 
of TSEs. The exact nature of the causative agent for TSE has yet to 
be fully determined. However, it is widely believed that an abnormal 
form, (PrPSc) of a host cellular prion protein (PrPc) may compose 
the substantial parts of the infectious agent. At present there is no 
treatment or cure for prion disease. Extensive data from literature 
indicates that the fundamental event in TSE disease is the conver-
sion of the normal, detergent-soluble, proteinase K-sensitive isoform 
or prion protein, PrPc to an abnormal, detergent-insoluble, partially 
proteinase K-resistant isoform, PrPSc, and the accumulation of this 
abnormal isoform in the central nervous system of infected animals. 
Despite enormous investigative work on prion diseases, the mecha-
nisms underlying the process of PrPc to PrPSc conversion remain 
incompletely understood. However, heparan sulfate, heat shock pro-
teins, and glycosylphosphatidylinositol (GPI)-anchor and specifi c 
RNA molecules have been argued to be implicated in this process. In 
addition, fi ndings from work in cell biology and biophysical studies 
suggest an important role for lipid rafts in PrPc to PrPSc conversion. 
Although signal transduction activity of lipid rafts is well established, 
limited information is available regarding the signaling pathways and 
the nature of receptors responsible for both cell to cell interactions, 
and the biological effects of the cells embedded in the lipid rafts in 
the process of PrPc to PrPSc conversion. PrPc, for instance, being a 
GPI-anchored protein, lacks a cytoplasmic domain and thus cannot 
interact directly with cells on the cytoplasmic face of plasma mem-
brane. In particular, how the activation signals mediated by PrPc (a 
GPI-anchored glycoprotein), are transmitted across the plasma mem-
brane remains unclear. Now, recent advances in immunology have 
disclosed the presence of a family of transmembrane protein, termed, 
Toll-like receptors (TLRs). The TLRs are important sensors of the 
innate immune system that serve to identify conserved microbial 
components, ranging from lipids, lipoproteins, proteins and nucleic 
acids and also non- microbial motifs such as heparan sulfate, heat 
shock proteins, small synthetic molecules and cell-injured molecules. 
In line with the aforementioned, and coupled with the fi ndings that 
similar to PrPc, many engulfi ng receptors including, CD36 (a sen-
sor of diacylglycerides: TLR-2 ligands), CD44, CD14 (a prominent 
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co-receptor with TLR4) are present in lipid rafts, and the fact that 
despite the diversity of GPI-anchored molecules found in parasitic 
protozoa, fungi and mammalian cells, all eukaryotic GPI-membrane 
anchors have a common core structure consisting of a conserved tri-
mannosylglucosaminyl glucan(Man α 1,2-Man α 1,6-Man α 1,4-GlcN-,) 
linked to the inositol residue of a phosphatidylinositol(Man3-GIN-PI) 
and the recent fi ndings that TLRs mediate the activity of a G protein-
coupled receptor formyl peptide receptor like 1 (FPRL1),which had 
been reported to mediate binding activity of PrP 106-126 (PrPSc peptide 
mimetic), I am tempted to suggest that Toll-like Receptors might have 
an important role in driving the process of PrPc to PrPSc conversion 
in prion disease pathogenesis. Proactively addressing this subject may 
highlight new avenues for future investigation into the prevention, 
and possibly, the treatment of TSEs and related diseases. 
 P10 13
MORBUS ALZHEIMER and Human Cartilage Glycoprotein-
39 (HC-gp39) : relevance to the Pathology of Alzheimer ’ s 
Disease and Disease Management – Dedicated to the Memory 
of Prof. Mark Anthony SMITH: a Unique Colleague 
 *O. N. Ofodile 1 
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THEURING, Berlin, Germany 
 Abundant evidence now exists indicating that oxidative damage to 
macromolecules, dysregulated infl ammatory responses, endothelial 
dysfunction and aberrant immune/chaperone alterations play impor-
tant roles in the neurodegenerative processes in many neurological 
diseases including Parkinson ’ s Disease, Creutzfeldt-Jakob Disease 
and Morbus Alzheimer. Another important phenomenon in these 
lesions is deregulated autophagic process. Alzheimer ’ s disease (AD), 
Multiple Sclerosis, Huntingston ’ disease, Morbus Parkinson and 
Creutzfeld-Jakob Disease (CJD), are all neurodegenerative disorders 
(ND) in humans, which terminate in untimely death in the fi nal reso-
lution of disease development and progression. The eatiology of these 
disorders is unknown and there is presently no drugs to completely 
arrest the progression of the associated neurodegenerative processes. 
Alzheimer ’ s disease, apparently the most widespread ND associ-
ated with aging, results in a progressive loss of cognitive function 
and dementia, the prevelance of which increases exponentially with 
aging and thus, represents a serious public health burden worldwide. 
Precise mechanism(s) that underpin neurodegeneration in AD brain 
is not completely understood. However, converging evidence derived 
from postmortem brain from Alzheimer ’ s disease patients and trans-
genic mouse model of AD suggest that oxidative stress, disordered 
infl ammatory response and deregulated autophagy are associated 
with mitochondria in early AD progression. Amyloid beta (A ß ) and 
amyloid precursor protein, and tau are known to localize to mito-
chondrial membranes block important transportation routes to the 
mitochondria,disrupt the electron transport chain,enhance the genera-
tion of reactive oxygen species, bring about mitochondrial damage 
and thus, prevent normal neuronal function. Additionally, in commen-
surate to this, accumulation of amyloid beta (the most proteinacious 
molecule that characterizes plagues in the brain of individuals with 
AD) and tau at synaptic terminals might contribute to synaptic dam-
age and, thereby, to 2cognitive decline in patients with AD. These 
further buttress the concept that these dysfunctions (oxidative stress, 
deregulated infl ammatory responses and defective autophagy), work-
ing in concert and/or independently, are potentially detrimental to 
AD patients. A plethora of infl ammatory mediators and macrophage-
derived molecules have been associated with AD pathology. Now, 
emerging large body of literature associated exaggerated serum levels 
of HC-gp39 with severity of disease processes in a range of neuro-
degenerative diseases and many other human disorders characterized 
by infl ammation and endothelial dysfunction, thereby indicating that 
HC-gp39 is present in the brain and also participates in the pathogen-
esis of the disorders. The hypothesis that HC-gp39 is implicated in the 
pathogenesis of neurodegenerative disease was fi rst proposed in 1997 
(Okom Ofodile, PhD-thesis) and has subsequently been proven by a 
variety of experiments (Rudy Castellani et al 2005, Tsuji et al 2002,) 
including genetic methods (Riemer et al. 2000). HC-gp39, a heparin 
and collagen-binding glycoprotein and a chitin-binding lectin, is a 
pathogenesis-related protein and, a mammalian chitinase-like protein 
without enzymatic activity. The physiological and pathophysiologi-
cal role of HC-gp39 and the cellular receptors critically underlying 
its physiological effects remain enigmatic. Perhaps most impor-
tantly, the mechanisms by which HC-gp39 mediates its biological 
effects is almost completely unknown. In this context, unraveling the 
mechanism(s) by which HC-gp39 exerts its biochemical effects will 
be instrumental in understanding the pathophysiology of a plethora of 
human disorders including Alzheimer ’ s disease and CJD. Now, after 
scrutiny of the work of Annaliese. Recklies et al (2002, 2004) and, 
studying the havoc associated with high serum levels of HC-gp39, a 
Hypothesis was formulated in 2010 (Okom Ofodile) : HC-gp39 may 
mediate its biochem. effects by: 1) Modulation of autophagic program, 
2) Direct and indirect activation of the complement, 3) Triggering 
ROS generation (contribution of oxidative stress could lead to vicious 
circles as it impinges upon mitochondrial dysfunction, excitotoxicity, 
lipidoxidation, and infl ammation), 4) perturbation of TRIF regulatory 
function (TRIF is an Adapter protein that transduces signal from Toll-
like Receptor 4(TLR4) and TLR3, 3permits the induction of many 
cytokines, including interferon beta which signals Type I interferon 
receptor) function- leading to signifi cant amplifi cation of the infl am-
matory environment. 5) Triggering accelerated hyperimmunity of 
autoimmunity, and 6) Induction of  “ Autotoxicity: a phenomenal pro-
cess fi rst described by McGeer PL/McGeer EG. Autophagy (Greek 
word for  “ Eating oneself ” ) is an evolutionarily conserved homeostatic 
process, whereby cytosolic components are targeted for removal or 
turnover in membrane-bound components (autophagosomes) that 
fuse with lysosome. Autophagy process regulates the turnover of 
damaged organelles and long-lived proteins that are too large to be 
delivered to the proteosome. Defective autophagy has been mecha-
nistically linked to cancer, neurodegenerative diseases, myodegenera-
tion and cardiomyopathy. Given the emerging functions of autophagy 
in immune cell homeostasis, immune cell activation and impacts in 
oxidative and infl ammatory cascades, coupled with the hovac associ-
ated with high levels of HC-gp39,it seems reasonable to contemplate 
that the ability of HC-gp39 to impact upon autophagic machinery 
(Okom Ofodile), might represent the central mechanisms through 
which HC-gp39 affects its biological Effects (Okom Ofodile, 2010). 
The above considerations indicate that HC-gp39-mediated activities 
are critical in AD pathogenesis and should be signifi cant in evaluating 
anti-infl ammatory and antioxidant therapy for Alzheimer ’ s disease. 
Further, HC-gp39 has the ability to display biphasic dose response 
(Hormesis) and, because the hormetic biphasic response relationship 
of HC-gp39 may constitute excellent putative therapeutic targets, 
functional characterization of the  “ Dose-Response Relationship “ 
( “ the overlapping phase ” ) may have great potential for drug discovery. 
Thus, delineating the role of specifi c signaling pathways governing 
the expression of HC-gp39 and the specifi c signaling pathways gov-
erning the expression of HC-gp39 and the specifi c signaling pathways 
that underpin the Crosstalk between HC-gp39 and autophagy during 
infl ammatory processes may yield therapeutically relevant insights 
to AD disease and many other degenerative disorders characterized 
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by infl ammation, endothelial dysfunction and deregulated autophagy. 
Here, we discuss the possible 4role of HC-gp39 in the development 
and the resolution of the pathology of Morbus Alzheimer and along-
side suggest possible therapeutic implications. 
 P10 14
A cohort study of 359 Chinese patients with methylmalonic 
aciduria in Mainland China 
 *Y. Yang 1 , Y. Liu 1 , T. Wu 1 , Q. Wang 1 , J. Song 1 , Y. Ma 1 , X. Li 1 , Y. Zhang 1 
 
1
 Peking University First Hospital, Department of Pediatrics, Beijing, 
China 
 Background: As the improvement of the medical technology, the 
number of the inherited metabolism disorders that could be screened 
and treated is increasing. Methylmalonic aciduria is the most common 
disorder of organic acidurias in China. Early diagnosis and adequate 
treatment contributes a lot to improve the prognosis of the patients. 
 Aims: To investigate the profi le of 359 Chinese patients with methyl-
malonic aciduria in Mainland and to emphasize the importance of the 
neonatal screening to the treatable congenital metabolism disorders. 
 Methods: From 1996 to 2011, a total of 359 patients from 19 provinces 
or cities of Mainland China were diagnosed in our hospital by urine 
organic acids analysis using GCMS. Serum and urine total homocysteine 
were determined using a fl uorescence polarization immunoassay. 
 Results: 248 of the 359 patients had combined methylmalonic acidu-
ria and homocysteinemia (69.0 % ). Isolated methylmalonic aciduria 
was found in 111 cases (31.0 % ). 324 cases came from the 11 northern 
provinces or cities of Mainland China. Among them, 92, 71 and 47 
were referred from Hebei, Shandong and Beijing. 35 patients came 
from southern China. 
 Discussion and Conclusion: Combined methyl-malonic aciduria and 
homocysteinemia is a common type of methylmalonic aciduria in 
Mainland China. Serum and urine total homocysteine determination is 
essential to distinguish isolated methylmalonic aciduria and combined 
type. Neonatal screening programs should be expanded in China for 
methylmalonic aciduria and other treatable metabolism disorders to 
reduce the morbidity and mortality. Nation-wide study is important. 
 P10 15  – WITHDRAWN 
 P10 16 
Haptocorrin, transcobalamin and CD320 in liver cancer 
patients, before and after abaltive treatment 
 *K. Simonsen 1 , H. Gr ø nb œ k 2 , H. Vilstrup 2 , E. Nex ø 3 
 
1
 Aarhus University Hospital, Department of Clinical Biochemistry/
Medical Gastroenterology, Aarhus C, Denmark 
 
2
 Aarhus University Hospital, Department of Medicine V (Hepatology 
& Gastroenterology), Aarhus, Denmark 
 
3
 Aarhus University Hospital, Department of Clinical Biochemistry, 
Aarhus, Denmark 
 Background: The cobalamin binding protein, haptocorrin (HC) has 
shown promise as a tumor marker in patients with fi brolamelar hepa-
tocellular carcinoma, but little is known concerning its concentration 
in other types of HCC. 
 Aim: To explore whether HC and the other cobalamin binding protein, 
transcobalamin (TC), including its holoform (holoTC) and its receptor 
(CD320) would be suitable as a tumor marker in patients with HCC. 
 Methods: Blood Samples were collected from 42 patients diagnosed 
with HCC, before and 1, 4 and 12 weeks after ablative treatment 
of the tumor. The total level of HC, holo- and total TC and the TC 
receptor CD320 was analyzed by in-house assays. 
 Results: We report 13 patients to show values above the interval of 
reference (240-630 pM) for HC, but none displayed values above 
1100 nmol/L. TC was within the interval of reference (500-1500 
pM) for all but four patients. One patient with cryptogenic cirrhosis 
showed markedly increased TC values of 17000 pM. Surprisingly, 
holoTC displayed markedly increased levels in 13 patients. CD320 
displayed relatively low values except for two patients showing 
markedly increased values. None of the parameters showed system-
atic changes following ablation treatment. 
 Discussion/conclusion: None of the biomarkers proved suitable as 
tumor markers for HCC. However, changes in one or the other of the 
cobalamin related proteins were observed in more than half of the 
patients, an observation that warrants further studies in order to under-
stand the changes in cobalamin metabolism in relation to liver diseases. 
 P10 17 
The Effect of Choline Administration in Normal and Diabetic 
Rats Using 99mTc Tin Colloid (TIN) and 99mTc Mebrofenin 
(BrIDA) Functional Liver Imaging 
 *F. AlSaeedi 1 
 
1
 Kuwait University, Nuclear Medicine, Jabriya, Kuwait 
 To investigate the effect of choline administration in experimentally-
induced diabetes mellitus (DM) in the rat using 99mTc Tin Colloid 
(TIN) and 99mTc mebrofenin (BrIDA) liver functional imaging. 
Methods: Four groups of rats (total n = 80, n = 20 each group) were 
studied for both TIN and BrIDA imaging: group C (control), group 
D (diabetic untreated), group C/Ch (control treated with choline) and 
group D/Ch (diabetic treated with choline) for 2 weeks.Imaging was 
obtained in each group and 2 weeks after induction of DM using 
streptozotocin (55 mg/kg ip) or choline administration (5 g/kg ip). 
Dynamic acquisition was performed for 1 h after injection of 37 
MBq TIN or BrIDA. Organ distribution was determined by drawing 
regions of interest then obtaining ratios as cumulative count rate over 
heart or liver or spleen to WB for TIN and liver, liver parenchyma, 
biliary tree, or abdomen to WB for BrIDA for all groups. Statistical 
analysis was done using Student ’ s t-test and ANOVA. 
Results: TIN uptake ratios (mean ± SE) showed a highly signifi cant 
lower liver uptake (0.73 ± 0.01) in D as compared to C (0.81 ± 0.01). 
Choline administration showed highly signifi cantly difference 
between D and D/Ch and C/Ch that brought back the diabetes liver 
uptake ratio in D/Ch (0.80 ± 0.001) to control levels. While the car-
diac blood pool and spleen showed signifi cant higher uptake in the D 
group rats vs controls. Choline signifi cantly returns the cardiac blood 
pool (0.17 ± 0.005) to control levels (0.15 ± 0.006) as well as spleen 
uptake ratios in D and D/Ch and C/Ch. Choline administration has 
no effect on BrIDA uptake ratios on diabetes. 
Conclusions: Choline has detectable changes in the liver phagocytic 
function after induction of DM compared to controls. 
 P10 18 
Lethal thiamine defi ciency in several bird species in the 
Baltic Sea 
 *L. Balk 1 , P. H ä gerroth 1 , T. Hansson 1 , U. Tj ä rnlund 1 , H. Gustavsson 1 , 
T. M ö rner 2 , G.  Å kerman 1 
 
1
 Stockholm University, Department of Applied Environmental 
Science (ITM), Stockholm, Sweden 
 
2
 National Veterinary Institute (SVA), Department of Wildlife, Fish, 
and Environment, Uppsala, Sweden 
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 Thiamine defi ciency has recently been demonstrated in several spe-
cies of wild birds, both adults and newly hatched young, in connec-
tion with extensive mortality in a paralytic disease in the Baltic Sea. 
This thiamine defi ciency may be the dominating cause of the observed 
population declines in many bird species during the last three decades. 
Accordingly, the need for an understanding of this problem is urgent. 
 Our research team has found reduced thiamine concentrations in 
the egg-yolk, liver, and brain, as well as reduced activities of the 
thiamine-dependent enzymes transketolase and  α -ketoglutarate 
dehydrogenase in the liver and brain. In these organs, there were 
also very high proportions of apoenzyme of these enzymes. The 
thiamine status of females in the fi eld was critical for the degree 
of breeding failure. The many observations of advanced thia-
mine defi ciency in adult birds strongly suggest that also varying 
degree of moderate thiamine defi ciency occurs among the affected 
species. 
 One effect of moderate thiamine defi ciency is altered behaviour. We 
have made plenty of observations of reduced aggressiveness and low 
noise level in bird colonies, as well as incomplete nest building and 
egg laying in nests of other species. The observed degree of thia-
mine defi ciency suggests that the birds also suffer from weakening 
of the blood-brain barrier and immune suppression. This is not only 
an obvious threat to ecosystem sustainability. For example, infec-
tious diseases may be more easily spread to humans by immunosup-
pressed birds. The thiamine defi ciency may be induced either by a 
causative agent(s) acting directly on the affected individual, and/or 
by insuffi cient transfer of thiamine between the trophic levels in the 
food web. 
 P10 19 
Periconceptioanal folic acid and folic acid containing 
multivitamins for the prevention of cardiovascular 
malformations 
 *A. Vereczkey 1 , Z. Kosa 1 , A. E. Czeizel 2 
 
1
 Versys Clinics, Human Reproduction Institute, Budapest, 
Hungary 
 
2
 Foundation for the Community Control of Hereditary Diseases, 
Budapest, Hungary 
 The prevention of neural-tube defects with periconceptional folic 
acid or folic acid-containing multivitamin supplementation is 
accepted by the scientifi c community and used in the medical prac-
tice though the fi ndings of intervention trials and observational 
studies showed also the effi cacy of this preventive method for 
cardiovascular malformations, the most common structural birth 
defects. The aim of this presentation is to summarise the fi ndings 
of previous studies regarding the prevention of cardiovascular mal-
formations by folic acid or folic acid-containing multivitamin in 
early pregnancy completed by the recent results of the Hungarian 
population-based case-control studies in the different types of car-
diovascular malformations. 
 P10 20 
Preterm birth preventive effect of folic acid 
 *A. E. Czeizel 1 
 
1
 Foundation for the Community Control of Hereditary Diseases, 
Budapest, Hungary 
 Recently the fetal weight promoting effect of folic acid (FA) has been 
stated by some medical doctors as an argument against this preventive 
method, because the large birthweight may associate with a higher risk 
for birth complications of newborns. The population-based dataset of 
the Hungarian Case-Control Surveillance of Congenital Abnormalities 
was appropriate to test the hypothesis regarding the possible fetal 
growth promoting and/or preterm birth reduction effect of FA supple-
mentation during pregnancy, particularly in the third trimester. Only 
one type of 3 mg FA tablet was available in Hungary during the study 
period. The reference group included pregnant women without FA and 
multivitamin supplementation before conception (at least 3 months) 
and during the study pregnancy. Our sample included 38,151 new-
borns, thus represented 1.8 % of Hungarian births, and 19,102 (50.0 % ) 
had mothers with FA supplementation. The mean gestational age 
at delivery was 39.5 + 2.0 and 39.2 + 2.1 in pregnant women with FA 
supplementation and in the reference group, respectively (p  < 0.0001). 
The mean birth weight was 3,294 + 501 g in the newborns of pregnant 
women with FA supplements and 3,262 + 509 in the reference group 
(p = 0.82). The rate of preterm births was 7.6 % in the group of pregnant 
women with FA supplementation while 11.1 % in the reference group, 
and this 3.5 % difference was signifi cant (OR with 95 % CI: 0.68, 0.63-
0.73). The rate of low birthweight was also lower in the FA group 
(5.1 % ) than in the reference group (6.8 % ) but this 1.1 % difference 
was not signifi cant (OR with 95 % CI: 0.88, 0.62-1.14). In the next 
step the possible association of longer gestational age and particularly 
the lower rate of preterm births after FA supplementation were ana-
lyzed according to different trimesters. The longest gestational age and 
lowest rate of preterm birth was found after FA supplementation dur-
ing the entire pregnancy, i.e. I-III trimesters (39.8 wk and 4.9 % ) and 
the II-III trimesters (39.9 wk and 3.8 % ), followed by the III trimester 
alone (39.5 wk and 7.6 % ). This trend resulted in 39.8 wk of mean ges-
tational age and 4.8 % rate of preterm birth in the group of III trimester 
together (III  + II-III  + I-III trimesters). Our data suggest that the third 
trimester is a key time window of FA supplement use for the reduction 
of preterm births. 
 P10 21 
Primary prevention of congenital abnormalities with 
specifi ed origin 
 *F. B á nhidy 1 , A. E. Czeizel 2 
 
1
 Semmelweis University, Second Department of Obstetrics and 
Gynecology, School of Medicine, Budapest, Hungary 
 
2
 Foundation for the Community Control of Hereditary Diseases, 
Budapest, Hungary 
 These studies were based on the large population-based Hungarian 
Case-Control Surveillance of Congenital Abnormalities, 1980-1996 
including 22,843 cases with different congenital abnormalities (CAs) 
and 38,151 matched controls without any CA. 
 Maternaldiabetes mellitus (DM) during pregnancy associates with a 
higher risk of CAs in their offspring. Our study was focused on preg-
nant women with DM-1, and a 1.5-fold higher risk of CAs was found 
in the offspring of these pregnant women. However, there was no 
higher risk of total CA in the offspring of diabetic pregnant women 
with folic acid supplementation. NTD and renal a/dysgenesis did not 
occur, and there was no higher risk of obstructive CAs of urinary 
tract. However, the risk of cardiovascular CAs and multiple CAs has 
remained higher in the subgroup of diabetic pregnant women with 
folic acid supplementation. 
 Epilepsyis one of the most frequently studied maternal diseases 
during pregnancy because most epilepsies had an early onset there-
fore epilepsy occurs in 0.3-0.6 % of pregnant women and their 
treatment with antiepileptic drugs associates with the higher rate 
of CA-syndromes (e.g. fetal hydantoin/phenytoin and fetal val-
proate syndrome/effect) and isolated CAs. The teratogenic potential 
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of carbamazepine, phenobarbital, phenytoin and primidone was 
reduced but not eliminated by folic acid supplementation in early 
pregnancy. 
 High fever related maternal infectious diseasessuch as infl uenza, 
common cold with secondary complications and tonsillitis showed 
an increased risk for total CAs explained by some specifi c CAs if 
these diseases occurred in the critical period of these CAs. Our data 
showed that folic acid/multivitamin supplementation can reduce and/
or protect against the teratogenic effects of high fever in neural-tube 
defect and cleft lip  ± palate, but not all CAs, e.g. cannot reduce the 
high fever related risk of multiple CA. 
 P10 22 
Low Hydrogen Sulfi de and Chronic Kidney Disease: A 
Dangerous Liaison 
 *A. Perna 1 , D. Ingrosso 2 
 
1
 Second University of Naples, Department of Cardiothoracic and 
respiratory sciences, Naples, Italy 
 
2
 Second University of Naples, Faculty of Medicine and Surgery, 
Department of Biochemistry and Biophysics  “ F. Cedrangolo ” , 
Naples, Italy 
 Hydrogen sulfi de, H 2 S, is a gaseous compound involved in a number 
of biological responses, e.g. blood pressure, vascular function, energy 
metabolism. In particular, H 2 S is able to lower blood pressure, to pro-
tect from injury in models of ischemia-reperfusion, and to induce a 
hypometabolic state. In chronic kidney disease (CKD), low plasma 
hydrogen sulfi de levels have been established in humans and in ani-
mal models. The enzymes involved in its production are cystathionine 
b-synthase, cystathionine g-lyase, and 3-mercaptopyruvate sulfurtrans-
ferase. The mechanisms for H 2 S decrease in CKD are related to the 
reduced gene expression (demonstrated in uremic patient blood cells) 
and decreased protein levels (in tissues such as liver, kidney, brain in 
a chronic kidney disease rat model). It has been shown that alterations 
in this pathway complicate the uremic state and are linked to chronic 
kidney disease progression. It remains to be established if low H 2 S 
is causally linked to CKD progression and if interventions aimed to 
restore the status quo ante are able to modify this picture. 
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